<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by David Stachura, PhD on Medium]]></title>
        <description><![CDATA[Stories by David Stachura, PhD on Medium]]></description>
        <link>https://medium.com/@davidstachura?source=rss-f5f2bd708a77------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*O2-SnA4Djzq_nWLlXyF-pQ.jpeg</url>
            <title>Stories by David Stachura, PhD on Medium</title>
            <link>https://medium.com/@davidstachura?source=rss-f5f2bd708a77------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sun, 22 Nov 2026 22:00:01 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@davidstachura/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Most humane way to kill mice and rats]]></title>
            <link>https://medium.com/@davidstachura/most-humane-way-to-kill-mice-and-rats-ed2abfbe21b7?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/ed2abfbe21b7</guid>
            <category><![CDATA[david-stachura]]></category>
            <category><![CDATA[rodent-control]]></category>
            <category><![CDATA[mouse]]></category>
            <category><![CDATA[art]]></category>
            <category><![CDATA[pest-control]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Wed, 11 Nov 2026 17:41:46 GMT</pubDate>
            <atom:updated>2026-11-11T17:41:46.629Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*87s7FKBtMXRhETXg" /></figure><p>Photo by <a href="https://unsplash.com/@jcotten?utm_source=medium&amp;utm_medium=referral">Joshua J. Cotten</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></p><p>As the days get shorter and colder, mice and rats naturally try to find an easier source of food and shelter. Unfortunately, that usually means they start heading into houses, garages, warehouses, or anywhere warmer than outside. It makes sense, but most of us don’t really want to share our homes with rodents due to the fact that they spread disease, destroy property, contaminate food, and generally just destroy things in their quest for survival. Mice and rats breed all year round, and have a gestation period of about 21 days. As these rodents generally have litters of about 8 pups, a small infestation can quickly get out of hand if you don’t act proactively.</p><p>If you’re a property owner, you’ve probably gone into an attic or crawlspace and seen the tell-tale droppings of rodents or shredded material that they use to make their nests. While it’s nice to think you can keep rodents out of your property, it’s been my experience that it is really tough. No matter how much you try and block entrances, they will find a way in.</p><h3>How to kill rodents humanely</h3><p>I recently had a rodent infestation in my property and thought: how should I kill them? As a laboratory scientist and researcher, I’ve worked with mice and rats for over 20 years; I’ve killed many a rodent in the laboratory. But in the lab, we have strict processes for killing them to reduce stress and harm on the animal. Believe it or not, most people working with animals don’t want to hurt animals, but instead want them to not suffer. While training exists for researchers, very little information exists for average homeowners. So I thought I would put together some best practices.</p><p>In general, there are four main ways to kill rodents in your home:</p><h4>Snap traps</h4><p>These are the classic traps that are spring loaded and release when a rodent steps on them. The metal bar snaps down quickly, breaking the rodent’s spine and killing them. You can load the “trigger” with food like peanut butter to entice the rodents to get on the trap.</p><p><strong>Pros</strong>: This method is fast, quick, cheap, and if it hits the right spot on the animal’s spine it’s relatively painless. I reuse these traps after catching animals, too.</p><p><strong>Cons</strong>: Most rodents I’ve come across somehow can gently take the food off the trigger without setting off the trap. Remember- rodents are smart! Also, beware of the flimsy plastic versions that look like “teeth;” I’ve never had one of those traps work effectively.</p><p><strong>Best practice</strong>: Put these along baseboards or walls out of reach of pets and kids. Try to put them by areas where you think rodents might run along and come in contact with the traps.</p><h4>Glue traps</h4><p>These traps are basically super sticky glue on a piece of cardboard. The rodent approaches, gets stuck in the glue, can’t get away, and eventually dies.</p><p><strong>Pros</strong>: Cheap and easy to deploy. Will catch whatever skitters across it.</p><p><strong>Cons</strong>: I really do not recommend this method- it is super cruel. Animals get stuck in the glue and fight to get out, usually causing them to get more stuck in the glue. They try to chew their way out, which might include trying to gnaw off their limbs. Eventually they’ll probably die of starvation after struggling for a long time. Another downside? Sometimes the animal will flip and somehow move the trap (with them attached) into an area you can’t access. Then you’ll get to enjoy the small of a rotting animal somewhere in your house that you physically can’t do anything about. I got to experience this when one tumbled behind my friend’s staircase during the San Diego summer. It was not a pleasant time.</p><p><strong>Best practice: </strong>Avoid glue traps for a rodent infestation. They are inhumane and there are better ways to deal with rats and mice.</p><h4>Poison</h4><p>This seems like an obvious choice, and one that people employ quite a bit. The formulations vary quite a bit and have different methods of action. Some rodent poisons are anti-coagulants that prevent the rodent from clotting blood, which will eventually result in massive internal hemorrhaging (internal bleeding). Some poisons are neurotoxins that cause the animal to have muscle tremors, seizures, and paralysis, followed by death. Other poisons cause a buildup of toxins in the blood which causes kidney failure and cardiac arrest. Finally, some poisons actually cause a production of toxic gas when ingested. Rodents have no ability to regurgitate food, so once they eat these poisons they’ll eventually die. Doesn’t sound very pleasant, does it?</p><p><strong>Pros:</strong> Cheap and easy to apply to large areas. Effective.</p><p><strong>Cons:</strong> I don’t recommend this method of rodent control, either. The poisons are cruel to rodents. And, you have to be very careful about where you place the poison. Have kids, dogs, other animals? Definitely don’t use this technique. Poisoned animals will try and get away in an inaccessible place to die, so you may also have the same issue with the glue traps- rotting animals hidden somewhere in your property. Not fun. Also, think about the downstream animals that may eat a dead rodent out in the open; there’s a risk to them, and whatever animal may pick up the rodent and move it somewhere else (like your cat, birds, etc.</p><p><strong>Best practice</strong>: Avoid the use of these chemicals. We don’t need them in our ecosystem.</p><h4>Bucket traps</h4><p>Bucket traps are the best for capturing lots of rodents at once. They basically are a trap door on top of a 5 gallon bucket. There is a lure at the end of the plank, so the rodent walks up the ramp to investigate the food and gets trapped in the bucket below. I know there are lots of these on the market, but I recently got one from <a href="https://www.vulcanpest.com/?syclid=06a64a51-e287-45d0-99f0-d1bd8ffd6629">Vulcan</a> and was shocked at how many rodents I trapped with this method. Vulcan says it will only trap rats, but I also have caught lots of mice with this trap. They’re heavy enough to trigger it.</p><p><strong>Pros</strong>: Humane way to capture lots of animals. Reusable. Not dangerous for people or pets.</p><p><strong>Cons:</strong> These things really work. They aren’t as cheap as snap traps, but they are worth it.</p><p><strong>Best practice:</strong> So hopefully I’ve established the bucket trap as my favorite rodent trapping method. It’s humane, quick, painless, and effective. But now you have another problem; you’ve got a bucket full of rats. Not ideal. What are your options?</p><p>Of course, you could always re-home the rodents. I really don’t recommend this method. They figured out a way into your property before- they’ll find a way back again. In fact, rodents commonly use pheromones and urine to scent their burrows. They’ll find their way in again. Or, another bunch of rats will; they seek out other dens via the same olfactory signals. And sure- you can let them out into the wild to fend for themselves. But really you’re just sending them off to be killed by some predator outside.</p><p>You could let them starve to death in the bucket. That’s pretty inhumane. Rodents can survive 2–7 days without food, but not longer than 2 days without water. So, you’ve got a bunch of animals basically just wasting away in a bucket. Also, sometimes they’ll cannibalize each other if times get tough. That’s definitely not a humane way to deal with the situation.</p><p>Some people suggesting filling the bucket with water so the rodents drown. I don’t suggest this, either. Mice can only swim for a few hours until exhaustion, but rats can swim for several days. You read that right- days. So this is not a preferred method, either. Also, imagine the pleasure of cleaning up a bucket of wet, dead rats. Yeah. That’s what I thought.</p><p>You could certainly just put the snap traps in the bottom of the bucket, but in the confined enclosure sometime this doesn’t work very well. And if you have quite a few rodents in there it is not ideal.</p><p>In my opinion, the most humane way to kill rats and mice with with carbon dioxide (CO2) by asphyxiation. Basically you reduce the amount of oxygen the animal breathes in, causing death within minutes. It’s painless and quick. In a laboratory, we would pump the gas directly into the container. But you probably don’t have CO2 tanks laying around (unless you brew beer or have a soda machine on site). Instead, use dry ice, which is the solid form of carbon dioxide; you can purchase a small block at the grocery store. Just put it in a small cardboard box and drop it into the bucket. The box will keep the mice and rats from touching it and rapidly freezing, but the gas will escape and asphyxiate the rodents. If you’re too squeamish? You can place the dry ice on top of the bucket trap; carbon dioxide is heavier than air and will sink down into the bucket.</p><p>To make sure that you have killed the mice and rats, just leave the dry ice for a few hours. Animals can revive if not properly asphyxiated. In the laboratory, we always confirm death by a secondary method, usually by cervical dislocation (breaking the rodents neck) or by diaphragm puncture. I don’t recommend following up with these methods, as wild rodents may be carrying disease or parasites- handle them as little as possible.</p><h3>Conclusion</h3><p>In essence, I think the most humane way to kill mice and rodents is by asphyxiation. Catching the animals and dispatching them with carbon dioxide (CO2 in the form of dry ice or the gas) is the preferred way to make sure they die quickly and painlessly.</p><h3>About the Author</h3><p><a href="https://www.linkedin.com/in/davidstachura/">Dr. David Stachura</a> is a biotechnology consultant as well as the Chief Scientific Officer (CSO) and Chief Operating Officer (COO) of <a href="https://specbio.com/">SpecBio</a> and <a href="http://www.factorfiveskin.com/">FACTORFIVE Skincare</a>. Dr. Stachura is the recipient of numerous competitive National Institute of Health (NIH) grants and has published over 40 impactful manuscripts on stem cell biology and regenerative medicine. Previously the head of the <a href="http://www.stachuralab.com/">Stachura Lab</a>, Dr. Stachura now focuses on developing innovative science-focused skincare and developing treatments for human wounds. Dr. Stachura has worked with rodents in a laboratory setting for over 25 years and was the chair of the Institutional Animal Care and Use Committee (IACUC) at CSU Chico.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ed2abfbe21b7" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Bridging the Laboratory and Marketplace: Dr. David Stachura on Driving Biotech Commercialization]]></title>
            <link>https://medium.com/@davidstachura/bridging-the-laboratory-and-marketplace-dr-david-stachura-on-driving-biotech-commercialization-93a638a03844?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/93a638a03844</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[biotech]]></category>
            <category><![CDATA[skincare-science]]></category>
            <category><![CDATA[executive-leadership]]></category>
            <category><![CDATA[regenerative-medicine]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Wed, 12 Aug 2026 00:41:44 GMT</pubDate>
            <atom:updated>2026-08-12T00:41:44.301Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Bridging the Laboratory and Marketplace: Dr. David Stachura on Driving Biotech Commercialization as COO of SpecBio</strong></h3><figure><img alt="Dr. David Stachura Chief Scientific Officer" src="https://cdn-images-1.medium.com/max/1024/1*kU4zjy8z6gbJL2Mr2_U0Bw.jpeg" /></figure><p>The transition from academic breakthrough to consumer application is one of the most complex journeys in modern science. For <a href="https://www.linkedin.com/in/davidstachura/">Dr. David Stachura</a>, stepping into the dual role of Chief Scientific Officer (CSO) and Chief Operations Officer (COO) of <a href="http://www.specbio.com/">SpecBio</a> and <a href="https://factorfiveskin.com/">FACTORFIVE Skincare</a> represents a deliberate move to scale cellular biology innovations into real-world medical and cosmetic solutions, respectively.</p><p>“In academia, success is measured by high-authority publications and securing National Institutes of Health (NIH) grants,” says <a href="https://www.stachuralab.com/">Dr. David Stachura</a>. “In the public sector, success is measured by human impact — taking regenerative medicine from the laboratory bench directly to the bedside.”</p><h3>From the Stachura Lab to Biotechnology Industry</h3><p>Prior to his executive appointments at SpecBio and FACTORFIVE, Dr. Stachura spent a decade running the highly successful <a href="http://www.stachuralab.com/">Stachura Lab</a>. His foundational research used zebrafish models to study hematopoiesis (blood cell formation), development of the immune system, growth of tissue ex vivo, and drug development.</p><p>While his peer-reviewed scientific manuscripts earned wide acclaim, his vision extended beyond theoretical biology. Moving to the private sector allowed him to apply his knowledge of adult stem cell biology to treating human disease. By coaxing human mesenchymal stem cells to secrete proteins and extracellular vessicles, he is using this patented technology to develop not only innovative cosmetic skincare, but also develop treatments for severe human wounds.</p><h3>Operational Leadership in Modern Biotechnology</h3><p>As COO, Dr. Stachura oversees both the physical operations and scientific trajectories of SpecBio’s parent entity, <a href="https://www.linkedin.com/company/xytogen-biotech-inc/">Xytogen Biotechnology</a>. His day-to-day leadership focuses on:</p><ul><li>Streamlining tissue culture and extracellular vesicle manufacturing pipelines through research and development</li><li>Filing patents for developing advanced stem cell media to treat disease</li><li>Mentoring the next generation of cosmetic and industrial scientists</li></ul><p>By positioning himself as a biotechnology consultant and operational strategist, <a href="https://www.davidstachura.com/">Dr. David Stachura</a> continues to bridge the gap between rigorous, complex clinical science and consumer product accessibility.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=93a638a03844" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Validation of Extracellular Vesicles in FACTORFIVE’s EXOFECTA LyoBeads]]></title>
            <link>https://medium.com/@davidstachura/validation-of-extracellular-vesicles-in-factorfives-exofecta-lyobeads-65d53007b070?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/65d53007b070</guid>
            <category><![CDATA[skincare]]></category>
            <category><![CDATA[stem-cells]]></category>
            <category><![CDATA[david-stachura]]></category>
            <category><![CDATA[exosome]]></category>
            <category><![CDATA[exofecta]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Sun, 16 Nov 2025 19:10:23 GMT</pubDate>
            <atom:updated>2025-11-18T20:58:29.203Z</atom:updated>
            <content:encoded><![CDATA[<p><a href="https://www.linkedin.com/in/davidstachura/">David L Stachura</a>, <a href="https://www.linkedin.com/in/kristen-rueb-ba4557202/">Kristen F Rueb</a>, Dustin Hadley, Batuhan Bozkurt, Randy P Carney, <a href="https://www.linkedin.com/in/john-aylworth-phd-83078636/">John Aylworth</a></p><figure><img alt="Cryo-EM image of extracellular vesicles (EVs) present in lyophilized culture media that had been secreted from adipose-derived mesenchymal stem cells (ADMSCs) prepared at University of California Davis from media prepared by David Stachura and Kristen Rueb in Chico CA." src="https://cdn-images-1.medium.com/max/564/1*7qH2_AR4ikvOy3MwbpeXDQ.png" /><figcaption>Cryo-Electron Microscopy (Cryo-EM) image of extracellular vesicles (EVs) present in lyophilized culture media that had been secreted from adipose-derived mesenchymal stem cells (ADMSCs)</figcaption></figure><h3><strong>Objective</strong></h3><p>The objective of this project was to determine if extracellular vesicles (EVs) were present in FACTORFIVE’s EXOFECTA LyoBeads to validate flash freezing and subsequent lyophilization as an effective EV preservation method.</p><h3><strong>Summary</strong></h3><p>EVs were isolated from resuspended EXOFECTA LyoBeads using differential ultracentrifugation and subjected to further characterization techniques such as nanoparticle tracking analysis (NTA), single particle flow cytometry, and cryo-electron microscopy (cryo-EM). First, NTA revealed particles with size distributions and concentrations consistent with the expected characteristics of EVs, indicating successful isolation from samples. Secondly, flow cytometry was performed using antibodies targeting the canonical EV tetraspanins CD9, CD63, and CD81. Detection of these markers supported the presence of enriched EVs in the samples. Finally, cryo-EM was performed to confirm the existence of vesicular bodies and their morphology. Visualization of the samples revealed membrane-enclosed particles with a visible lipid bilayer, consistent with EVs. Overall, the results support EVs were in EXOFECTA LyoBeads, indicating EV retention in the final product after FACTORFIVE’s method of flash freezing, stabilizing, and lyophilization.</p><h3><strong>Background</strong></h3><p>Extracellular vesicles (EVs) are membrane-bound particles naturally released from cells, which cannot replicate and play a role in intercellular communication. They have been identified from almost every cell or organism examined, indicating their ubiquity in all empires of living things (reviewed in Woith et al., 2019). EVs are commonly referred to as “exosomes”, but exosomes are only a subset of EVs that derive from a specific biogenic origin whereby the multivesicular body in the cell fuses with the plasma membrane. In addition to exosomes, cells also secrete numerous different EV subtypes (Buzas, 2022), with more and more diversity emerging regularly as the field advances. Since exosome-type EVs can only be identified by visualizing their biogenesis in cells, most assays used in the laboratory to examine exosomes are actually examining heterogeneous EVs. Due to this fact, the International Society for Extracellular Vesicles (ISEV) recommends to refer more generally to these particles simply as EVs (as we do in this report) or even extracellular particles (EPs) (Welsh et al., 2024).</p><p>EVs have attracted significant interest due to their ability to carry bioactive molecules. This capability has made them promising candidates for diagnostic, prognostic, and therapeutic applications (see van Niel et al., 2018; Simons and Raposo, 2009). In essence, EVs are discrete packages that can contain cellular proteins, glycans, signaling molecules, growth factors, DNA/RNA, including microRNAs (which are important for regulating gene expression). They are wrapped in a lipid bilayer, so they can effectively fuse with neighboring or distant cells and release their cargo directly or potentiate surface-mediated signal transduction via binding. EVs enable long distance communication, transmitting their cargo with minimal diffusion, dilution, or degradation compared to unpackaged cargo (Wolf and Casadevall, 2014). Some EVs also contain matrix remodeling enzymes on their surface such as matrix metalloproteinases and hyaluronidases (Nawaz et al., 2018). These enzymes play roles in extracellular matrix (ECM) turnover and composition in several physiological and pathological conditions. Additionally, EVs play active roles in tissue regeneration by stimulating repair processes (Fatima et al., 2017).</p><p>Mesenchymal stem cells (MSCs) are adult stem cells that can regenerate more of themselves and differentiate into adipocytes (fat), osteocytes (bone), and chondrocytes (cartilage) (Uccelli et al., 2008). They can also differentiate into fibroblasts, which are important components of connective tissue (X. Tanaka et al., 2022). MSCs were first discovered in the bone marrow, but are also present in the hypodermis, which is the lowest, fat-filled layer of skin; these are called adipose-derived MSCs (ADMSCs) (Zuk et al., 2001). There is a high frequency of ADMSCs in fat (Strioga et al., 2012 and Hass et al., 2011), and over 1.5 million liposuction surgeries are performed globally every year; the fat removed is regarded as waste and can be collected without additional risk to the donor. ADMSCs can differentiate into epidermal stem cells (Derby et al., 2014) and fibroblasts (X. Tanaka et al., 2022), indicating that they are likely the most important stem cell population for skin.</p><p>ADMSCs communicate to surrounding cells by secreting signaling proteins, as well as ECM molecules. ADMSCs contribute to the regeneration of skin (Lynch and Pei, 2014; Kim et al., 2008; Zhang et al., 2014) and secrete ECM proteins like collagen and elastin that reduce fine lines and wrinkles (Novoseletskaya et al., 2020), as well as signaling molecules that instruct cells to grow and migrate to an injury (Pittenger et al., 2019). Proteins produced by ADMSCs remodel scar tissue, increase blood flow, and modulate the immune system (Melief et al., 2013). Additionally, they secrete antioxidants (Kim et al., 2008 and Zhang et al., 2014). Transplantation studies indicate young ADMSCs rejuvenate aging skin (Bernardini et al., 2015 and Gennai et al., 2017) and secrete growth factors that promote cellular homeostasis and repair (Park et al., 2008). Studies show that using the proteins secreted from ADMSCs helps with a multitude of skin issues, including reducing the appearance of aging. Importantly, ADMSCs also secrete EVs that activate signaling pathways involved in wound healing (Zhou et al., 2021), encourage angiogenesis (Liang et al., 2016),<a href="https://en.wikipedia.org/wiki/Mesenchymal_stem_cell"> </a>and mediate immune responses (Matwiejuk et al., 2025). In addition, EVs induce the expression of several essential growth factors in ADMSCs (reviewed in Fang et al., 2019). For these reasons, cellular secretions from ADMSCs hold great promise to accelerate skin healing and regeneration and increase skin health.</p><p>Unfortunately, EVs are notoriously finicky biomolecular assemblies. They are sensitive to temperature and are typically stored below -80°C for long-term preservation (reviewed in Ahmadian et al., 2024). Studies indicate that rapid freezing in liquid nitrogen preserves EV particle numbers compared to slow freezing (Wright et al, 2022) and that lyophilization maintains EV size, morphology, protein content, and bioactivity when accompanied by appropriate cryoprotectants like trehalose (Lyu et al., 2022 and Neupane et al., 2021). Based on these previous studies, we hypothesized that it was possible to make a stabilized cosmetic product that contained EVs.</p><p>We obtained consent to isolate ADMSCs from human lipoaspirate samples from patients between 20 and 25 years of age and then tested those cells to ensure they had no communicable diseases. Then, ADMSCs were grown with a patent-pending process to generate Dynamic Culture Medium (DCM). In essence, DCM contains secreted proteins including growth factors, cytokines, immunomodulatory proteins, antioxidants, ECM proteins, and ECM remodeling proteins. DCM also contains EVs.</p><p>To generate a product that captured all the proteins and EVs from ADMSC secretions, we created EXOFECTA. Simply, EXOFECTA is DCM that has added trehalose to stabilize EVs, as well as GHK-Cu copper peptides which are proven to speed wound healing, activate stem cells, increase antioxidant activity, repair fibroblasts, increase collagen production, and rejuvenate skin (reviewed in Pickart and Margolina, 2012). This solution is flash frozen in liquid nitrogen, creating small 20 µL droplets. These droplets are then lyophilized, creating EXOFECTA LyoBeads. After freeze drying, the LyoBeads are packed in sterile glass vials. When needed, they are reconstituted in sterile, injection-grade hyaluronic acid and utilized for skincare treatments.</p><p>In this product note, we report a simple characterization analysis in collaboration with the <a href="https://core-directory.or.ucdavis.edu/core/12075/view">UC Davis Extracellular Vesicles Acquisition and Analysis Core</a> (EV Core). We utilized the <a href="https://pubmed.ncbi.nlm.nih.gov/38326288/">Minimal Information for Studies of Extracellular Vesicles (MISEV) 2023 guidelines</a> to design and perform these experiments. MISEV guidelines focus on characterizing EVs using multiple complementary platforms to assess physical characteristics, biochemical composition, and mode of biogenesis (e.g., if specific subpopulation nomenclature such as exosomes or microvesicles is desired). In alignment with the MISEV guidelines, this report emphasizes methodological transparency and standardization. Adhering to these community-established criteria enhances data reproducibility, facilitates comparison across studies, and supports the credibility of findings for regulatory and translational purposes. This study was completed in partial compliance of core MISEV 2023 criteria, with further orthogonal and functional validations to follow. Overall, we report that the characterization results are consistent with those expected for enriched EVs, supporting their presence in EXOFECTA.</p><h3><strong>Methods</strong></h3><h4><strong><em>Samples</em></strong></h4><p>The samples were EXOFECTA LyoBeads provided to the EV Core by FACTORFIVE.</p><h4><strong><em>EV Isolation</em></strong></h4><p>Samples underwent differential ultracentrifugation (UC) to enrich EVs (<strong>Figure 1</strong>). The process included the following steps:</p><p>1. <em>Initial clarification and removal of cells, debris, and larger vesicles (e.g., microvesicles)</em>: Samples were centrifuged at 300 x g for 10 min, 2,000 x g for 15 min, and 10,000 x g for 30 min. Each time, the supernatant was carried over to the next step.</p><p>2. <em>EV pelleting</em>: Supernatant from the previous step was centrifuged at 120,000 x g for 70 min in a Beckman Coulter Optima TLX. The supernatant was collected and retained.</p><p>3. <em>EV washing</em>: The pellet from the previous step was resuspended with filtered phosphate buffered saline (PBS) and centrifuged again at 120,000 x g for 70 min. The supernatant was collected and retained. The pellet was resuspended, aliquoted, and frozen at -80°C until used for downstream characterization.</p><figure><img alt="Experimental design for EV isolation and validation shows the process of isolating EVs with centrifugation" src="https://cdn-images-1.medium.com/max/1023/1*L_Kcb-1lepFL5LGGHVKv_w.jpeg" /><figcaption>Figure 1: Experimental design for EV isolation and validation</figcaption></figure><h4><strong><em>Nanoparticle Tracking Analysis (NTA)</em></strong></h4><p>Samples were analyzed using a Malvern NanoSight LM14. Prior to each measurement, samples were diluted with 0.02 µm filtered PBS to fall within the optimal particle concentration range recommended by the manufacturer for reliable quantification. Measurements were performed using a camera level/laser power setting of 13 and a detection threshold of 2. Each sample was analyzed from three technical replicates, with each replicate consisting of a 90 sec video capture. Key metrics obtained included particle concentration (particles/mL), size distribution, and mode diameter.</p><h4><strong><em>Flow Cytometry</em></strong></h4><p>Flow cytometry was performed using the Beckman Coulter CytoFLEX Nano, a nanoflow cytometer with sufficient sensitivity to detect and analyze single particles. This approach aligns with MISEV 2023 recommendations for the detection of EV surface markers. Samples were stained with a panel of antibodies targeting the canonical tetraspanin markers CD9, CD63, and CD81 (Andreu and Yanez-Mo, 2014).</p><p>Samples were incubated in the dark at room temperature for 90 min. Following incubation, excess antibodies were removed using Izon qEV 35 nm SEC columns. An antibody-only negative control and a HEK293T-derived EV positive control were included to support marker specificity and instrument QC.</p><p>Data were analyzed using fluorescence intensity thresholds and gating strategies informed by the negative control. The presence of CD9, CD63, and CD81 signals support the EV nature of the particles analyzed.</p><h4><strong><em>Cryo-Electron Microscopy (Cryo-EM)</em></strong></h4><p>Cryo-EM imaging was performed to confirm the existence of vesicular bodies and their morphology. Samples were applied to glow-discharged grids and plunge frozen using the PELCO easiGlow system and the Vitrobok Mk IV. Grids were imaged using a 200 kV transmission electron microscope, the TFS Glacios Cryo-TEM, at magnifications ranging from 11,000x to 45,000x.</p><p>Images were evaluated for EV characteristics such as round, lipid bilayer-enclosed structures. Size and morphology were annotated and measured with ImageJ. Diameter used the outer leaflet to measure Feret diameter.</p><h3><strong>Results</strong></h3><h4><strong><em>Yield and Size Distribution of EVs with NTA</em></strong></h4><p>Two individual samples of EXOFECTA LyoBeads were processed and enriched for EVs (<strong>Figure 1</strong>) and examined with NTA (<strong>Figure 2</strong>). NTA indicated an average number of 1.1010 EVs that were 104.14 nm in size present in the two samples examined (<strong>Figure 2</strong> and <strong>Table 1</strong>). The yield and size of particles observed from NTA suggested these particles were EVs that should be examined further by flow cytometry and cryo-EM.</p><figure><img alt="EVs are present in reconstituted EXOFECTA LyoBeads as measured by NTA. A) Average of EVs detected by NTA samples B and C denoted by the red bar, with SD indicated by the error bars. B) Particle size distribution of EXOFECTA sample B (orange line) and sample C (red line) indicate the presence of EVs in the samples." src="https://cdn-images-1.medium.com/max/1024/1*WSyYmEnRwOK47dShDEibXw.png" /><figcaption><strong>Figure 2: EVs are present in reconstituted EXOFECTA LyoBeads as measured by NTA. </strong>A) Average of EVs detected by NTA samples B and C denoted by the red bar, with SD indicated by the error bars. B) Particle size distribution of EXOFECTA sample B (orange line) and sample C (red line) indicate the presence of EVs in the samples.</figcaption></figure><figure><img alt="Table showing quantitation of EV numbers and size present in EXOFECTA LyoBead samples. Numbers are the average of sample B and C. Data shown in Figure 1." src="https://cdn-images-1.medium.com/max/1024/1*dYduykRwMZlkAzU1HF67AA.png" /><figcaption><strong>Table 1: Quantitation of EV numbers and size present in EXOFECTA LyoBead samples. </strong>Numbers are the average of sample B and C. Data shown in Figure 1.</figcaption></figure><h4><strong><em>Expression of Tetraspanins on EVs with flow cytometry</em></strong></h4><p>Flow cytometry was used to detect the presence of the canonical EV surface markers CD9, CD63, and CD81. All samples demonstrated detectable expressions of these tetraspanins, supporting the presence of EVs (<strong>Figure 3</strong>).</p><figure><img alt="EVs are present in reconstituted EXOFECTA LyoBeads as measured by flow cytometry for CD9, CD63, and CD81. (A) Diagram showing the mode of measurement via primary-labeled fluorescent antibodies for EVs with CD9 (green), CD63 (blue), and CD81 (red) tetraspanins present. (B) Top row shows HEK293T-derived positive controls for CD9 (green, left column), CD63 (blue, middle column), and CD81 (red, right column) tetraspanins. EXOFECTA sample B (middle row) and EXOFECTA sample C (bottom row) sh" src="https://cdn-images-1.medium.com/max/1024/1*dTCJd5J0QC4HO7G8IM_Tvw.png" /><figcaption><strong>Figure 3: EVs are present in reconstituted EXOFECTA LyoBeads as measured by flow cytometry for CD9, CD63, and CD81. (A)</strong> Diagram showing the mode of measurement via primary-labeled fluorescent antibodies for EVs with CD9 (green), CD63 (blue), and CD81 (red) tetraspanins present. <strong>(B)</strong> Top row shows HEK293T-derived positive controls for CD9 (green, left column), CD63 (blue, middle column), and CD81 (red, right column) tetraspanins. EXOFECTA sample B (middle row) and EXOFECTA sample C (bottom row) show the presence of the three proteins on the surface of EVs. <strong>(C)</strong> Quantification of CD9 (green bars), CD63 (blue bars), and CD81 (red bars) with SD (error bars). Data are from counts in <strong>(B)</strong>.</figcaption></figure><h4><strong><em>Morphology with cryo-EM analysis</em></strong></h4><p>To examine if EVs from EXOFECTA exhibited typical morphology of EVs, cryo-EM was performed. Vesicular structures consistent with EVs were observed in EXOFECTA samples post-EV enrichment (<strong>Figure 4</strong>).</p><figure><img alt="Unilamellar EV identified after cryo-EM analysis. Blue arrow indicates the presence of an EV on a cryo-EM grid." src="https://cdn-images-1.medium.com/max/946/1*UzvW539lT4CXYUOxt8UdPw.png" /><figcaption><strong>Figure 4: Unilamellar EV identified after cryo-EM analysis. </strong>Blue arrow indicates the presence of an EV on a cryo-EM grid.</figcaption></figure><p>The EV sizes observed during cryo-EM analysis were notably smaller than the 100 nm mode suggested by NTA results (<strong>Figure 5</strong>). These data indicated that there was a large fraction of EVs smaller than the limit of detection of the NTA device (compare to <strong>Figure 2</strong> and <strong>Table 1</strong>).</p><figure><img alt="Figure 5: Many EVs are below the detection limit of NTA. 25 individual EVs were measured via cryo-EM (black dots and violin plot) from the lyophilized sample, plotted against results obtained from NTA (thin red line) from a frozen sample." src="https://cdn-images-1.medium.com/max/767/1*Rei3O1B8D0wG-gvzRe3GCQ.png" /><figcaption><strong>Figure 5: Many EVs are below the detection limit of NTA. </strong>25 individual EVs were measured via cryo-EM (black dots and violin plot) from the lyophilized sample, plotted against results obtained from NTA (thin red line) from a frozen sample.</figcaption></figure><h3><strong>Discussion</strong></h3><p>EVs were successfully identified in the lyophilized EXOFECTA LyoBead samples. NTA results showed similar particle concentrations between previously frozen and lyophilized samples (data not shown). Flow cytometry confirmed tetraspanins commonly observed with EVs were present in the samples. Cryo-electron microscopy of the samples revealed membrane-enclosed particles with a visible lipid bilayer, consistent with EVs. Additionally, measurement of EV size with cryo-EM indicated that NTA analysis is likely underestimating the size and number of EVs present in the samples.</p><p>The study meets several MISEV criteria, with further characterization recommended to fully satisfy these community-established guidelines. Of the characterization performed, NTA’s detection threshold of ~70 nm underrepresents smaller EVs and their heterogeneity. Morphological analysis via cryo-EM can address some uncertainty for the presence of smaller EVs and the impact of lyophilization. Molecular analysis via flow cytometry corroborates evidence of EVs due to the presence of EV-associated proteins in the lipid bilayer. Future plans to characterize EXOFECTA LyoBeads will focus on protein and miRNA contents of the isolated EVs, as well as performing additional orthogonal measures of size, concentration, and molecular analysis.</p><h3>Author information</h3><p><a href="http://www.david-stachura.com/">David L Stachura</a> is the Chief Scientific Officer and Chief Operations Officer at <a href="http://www.factorfiveskin.com/">FACTORFIVE Skincare</a> located in Chico, CA, USA</p><p>Kristen F Rueb is the Laboratory Director and Stem Cell Scientist at FACTORFIVE Skincare located in Chico, CA, USA</p><p>Dustin Hadley and Batuhan Bozkurt are Scientists at the Extracellular Vesicle Acquisition and Analysis Core Facility located at the University of California Davis in Davis, CA, USA</p><p>Randy P Carney is an Associate Professor of Biomedical Engineering and the Extracellular Vesicle Acquisition and Analysis Core Facility Director at University of California Davis in Davis, CA, USA</p><p>John Aylworth is the Chief Executive Officer and Founder of FACTORFIVE Skincare located in Chico, CA, USA</p><h3>Conflict of Interest Statement</h3><p><a href="https://www.drdavidstachura.com/">David Stachura </a>is a scientific consultant and has received compensation from <a href="https://finlessfoods.com/">Finless Foods, Inc.</a> and <a href="https://www.linkedin.com/company/xytogen-biotech-inc/">Xytogen Biotech, Inc</a>. He is the founder and CEO of <a href="https://www.nonprofitbiotech.com/">Philanthropic Pharma</a> and the Chief Scientific Officer and Chief Operating Officer of <a href="https://factorfiveskin.com/">FactorFive Skincare</a> and <a href="https://www.specbio.com/">SpecBio</a>. Kristen Rueb is an employee of <a href="https://factorfiveskin.com/">FactorFive Skincare</a>. John Aylworth is the CEO and founder of <a href="https://factorfiveskin.com/">FactorFive Skincare</a> and and <a href="https://www.linkedin.com/company/xytogen-biotech-inc/">Xytogen Biotech, Inc</a>. All other authors declare no competing interests.</p><h3><strong>Works Cited</strong></h3><p>Ahmadian, S., Jafari, N., Tamadon, A. <em>et al.</em> Different storage and freezing protocols for extracellular vesicles: a systematic review. <em>Stem Cell Res Ther</em> <strong>15</strong>, 453 (2024).</p><p>Andreu Z, Yáñez-Mó M. Tetraspanins in extracellular vesicle formation and function. <em>Front Immunol.</em> 2014 Sep 16;5:442.</p><p>Bernardini FP, Gennai A, Izzo L, Zambelli A, Repaci E, Baldelli I, Fraternali-Orcioni G, Hartstein ME, Santi PL, Quarto R. Superficial Enhanced Fluid Fat Injection (SEFFI) to Correct Volume Defects and Skin Aging of the Face and Periocular Region. <em>Aesthet Surg J</em>. 2015 Jul;35(5):504–15.</p><p>Buzas, E.I. The roles of extracellular vesicles in the immune system. <em>Nat Rev Immunol</em> <strong>23</strong>, 236–250 (2023).</p><p>Derby BM, Dai H, Reichensperger J, Cox L, Harrison C, Cosenza N, Yang M, Bueno RA, Neumeister MW. Adipose-derived stem cell to epithelial stem cell transdifferentiation: a mechanism to potentially improve understanding of fat grafting’s impact on skin rejuvenation. <em>Aesthet Surg J</em>. 2014 Jan 1;34(1):142–53.</p><p>Fang Y, Zhang Y, Zhou J, Cao K. Adipose-derived mesenchymal stem cell exosomes: a novel pathway for tissues repair. <em>Cell Tissue Bank</em>. 2019 Jun;20(2):153–161.</p><p>Fatima F., Ekstrom K., Nazarenko I., Maugeri M., Valadi H., Hill A.F., Camussi G., Nawaz M. Non-coding RNAs in Mesenchymal Stem Cell-Derived Extracellular Vesicles: Deciphering Regulatory Roles in Stem Cell Potency, Inflammatory Resolve, and Tissue Regeneration. <em>Front. Genet</em>. 2017;8:161.</p><p>Gennai A, Zambelli A, Repaci E, Quarto R, Baldelli I, Fraternali G, Bernardini FP. Skin Rejuvenation and Volume Enhancement with the Micro Superficial Enhanced Fluid Fat Injection (M-SEFFI) for Skin Aging of the Periocular and Perioral Regions. <em>Aesthet Surg J</em>. 2017 Jan;37(1):14–23.</p><p>Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. <em>Cell Commun Signal</em>. 2011 May 14;9:12.</p><p>Kim WS, Park BS, Kim HK, Park JS, Kim KJ, Choi JS, Chung SJ, Kim DD, Sung JH. Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. <em>J Dermatol Sci</em>. 2008 Feb;49(2):133–42.</p><p>Liang X, Zhang L, Wang S, Han Q, Zhao RC. Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. <em>J Cell Sci</em>. 2016 Jun 1;129(11):2182–9.</p><p>Lynch K, Pei M. Age associated communication between cells and matrix: a potential impact on stem cell-based tissue regeneration strategies. <em>Organogenesis</em>. 2014;10(3):289–98.</p><p>Lyu N, Knight R, Robertson SYT, Dos Santos A, Zhang C, Ma C, Xu J, Zheng J, Deng SX. Stability and Function of Extracellular Vesicles Derived from Immortalized Human Corneal Stromal Stem Cells: A Proof of Concept Study. <em>AAPS J</em>. 2022 Dec 5;25(1):8.</p><p>Matwiejuk M, Mikłosz A, Myśliwiec H, Chabowski A, Flisiak I. Adipose-derived mesenchymal stem cells and their derivatives in inflammatory skin diseases: a systematic review. <em>Front Immunol</em>. 2025 Aug 22;16:1617157.</p><p>Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. <em>Stem Cells Transl Med</em>. 2013 Jun;2(6):455–63.</p><p>Nawaz M, Shah N, Zanetti BR, Maugeri M, Silvestre RN, Fatima F, Neder L, Valadi H. Extracellular Vesicles and Matrix Remodeling Enzymes: The Emerging Roles in Extracellular Matrix Remodeling, Progression of Diseases and Tissue Repair. <em>Cells</em>. 2018 Oct 13;7(10)</p><p>Neupane YR, Huang C, Wang X, Chng WH, Venkatesan G, Zharkova O, Wacker MG, Czarny B, Storm G, Wang JW, Pastorin G. Lyophilization Preserves the Intrinsic Cardioprotective Activity of Bioinspired Cell-Derived Nanovesicles. <em>Pharmaceutics</em>. 2021 Jul 9;13(7):1052.</p><p>Novoseletskaya E, Grigorieva O, Nimiritsky P, Basalova N, Eremichev R, Milovskaya I, Kulebyakin K, Kulebyakina M, Rodionov S, Omelyanenko N, Efimenko A. Mesenchymal Stromal Cell-Produced Components of Extracellular Matrix Potentiate Multipotent Stem Cell Response to Differentiation Stimuli. <em>Front Cell Dev Biol</em>. 2020 Sep 22;8:555378.</p><p>Park BS, Jang KA, Sung JH, Park JS, Kwon YH, Kim KJ, Kim WS. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. <em>Dermatol Surg</em>. 2008 Oct;34(10):1323–6.</p><p>Pickart L, Margolina A. Antiaging Activity of the GHK Peptide- the Skin and Beyond. <em>Journal of Aging Research &amp; Clinical Practice</em>. 2012,1 (1).</p><p>Simons M, Raposo G. Exosomes — vesicular carriers for intercellular communication. <em>Curr Opin Cell Biol</em>. 2009 Aug;21(4):575–81.</p><p>Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. <em>NPJ Regen Med</em>. 2019 Dec 2;4:22.</p><p>Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. <em>Stem Cells Dev</em>. 2012 Sep 20;21(14):2724–52.</p><p>Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. <em>Nat Rev Immunol</em>. 2008 Sep;8(9):726–36.</p><p>van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. <em>Nat Rev Mol Cell Biol</em>. 2018 Apr;19(4):213–228.</p><p>Welsh, J. A., Goberdhan, D. C. I., O’Driscoll, L., Buzas, E. I., Blenkiron, C., Bussolati, B., Cai, H., Di Vizio, D., Driedonks, T. A. P., Erdbrügger, U., Falcon-Perez, J. M., Fu, Q.-L., Hill, A. F., Lenassi, M., Lim, S. K., Mahoney, M. G., Mohanty, S., Möller, A., Nieuwland, R., … Witwer, K. W. (2024). Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. <em>Journal of Extracellular Vesicles</em>, 13, e12404.</p><p>Woith E, Fuhrmann G, Melzig MF. Extracellular Vesicles-Connecting Kingdoms. <em>Int J Mol Sci</em>. 2019 Nov 14;20(22):5695.</p><p>Wolf, J.M.; Casadevall, A. Challenges posed by extracellular vesicles from eukaryotic microbes. <em>Curr. Opin. Microbiol.</em> 2014, <em>22</em>, 73–78.</p><p>Wright A, Snyder OL, Christenson LK, He H, Weiss ML. Effect of Pre-Processing Storage Condition of Cell Culture-Conditioned Medium on Extracellular Vesicles Derived from Human Umbilical Cord-Derived Mesenchymal Stromal Cells. <em>Int J Mol Sci</em>. 2022 Jul 13;23(14):7716.</p><p>X. Tanaka K, Ogino R, Yamakawa S, Suda S, Hayashida K. Role and Function of Mesenchymal Stem Cells on Fibroblast in Cutaneous Wound Healing. <em>Biomedicines</em>. 2022 Jun 12;10(6):1391.</p><p>Zhang S, Dong Z, Peng Z, Lu F. Anti-aging effect of adipose-derived stem cells in a mouse model of skin aging induced by D-galactose. <em>PLoS One</em>. 2014 May 15;9(5):e97573.</p><p>Zhou, Y., Zhao, B., Zhang, XL. <em>et al.</em> Combined topical and systemic administration with human adipose-derived mesenchymal stem cells (hADSC) and hADSC-derived exosomes markedly promoted cutaneous wound healing and regeneration. <em>Stem Cell Res Ther</em> <strong>12</strong>, 257 (2021).</p><p>Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. <em>Tissue Eng</em>. 2001 Apr;7(2):211–28.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=65d53007b070" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Cannabinoid Receptor 2 (CNR2) Agonist AM1241 Fails to Expand Adult Danio rerio (Zebrafish)…]]></title>
            <link>https://medium.com/@davidstachura/cannabinoid-receptor-2-cnr2-agonist-am1241-fails-to-expand-adult-danio-rerio-zebrafish-2db2d6321d15?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/2db2d6321d15</guid>
            <category><![CDATA[chico-state]]></category>
            <category><![CDATA[blood]]></category>
            <category><![CDATA[zebrafish]]></category>
            <category><![CDATA[cannabinoids]]></category>
            <category><![CDATA[david-stachura]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Fri, 03 Oct 2025 02:30:32 GMT</pubDate>
            <atom:updated>2025-10-03T02:30:32.315Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Cannabinoid Receptor 2 (CNR2) Agonist AM1241 Fails to Expand Adult Danio rerio (Zebrafish) Hematopoietic Stem and Progenitor Cells (HSPCs) <em>In Vitro</em></strong></h3><p><a href="http://www.stachuralab.com/">Francis Wright</a>, <a href="http://www.stachuralab.com/">Gabriel Marquez</a>, <a href="https://www.linkedin.com/in/davidstachura/">David L Stachura</a></p><figure><img alt="Zebrafish stem cells visualized in the laboratory of Dr. David Stachura at Chico State that have differentiated into erythroid (red blood cells) and myeloid cells like neutrophils and macrophages with brightfield." src="https://cdn-images-1.medium.com/max/1024/1*1zYfbLftHT-AL3cyjRSuxg.jpeg" /><figcaption>Zebrafish hematopoietic stem and progenitor cells (HSPCs) grown in methylcellulose supplemented with erythropoietin (Epo), granulocyte colony stimulating factor (Gcsf), and carp serum for 5 days form “ruffled” colonies comprised of erythroid and myeloid cells, and “spread” colonies mostly consisting of myeloid cells and macrophages.</figcaption></figure><h4>Abstract</h4><p>Cannabinoids have various effects on hematopoietic stem and progenitor cell (HSPC) function. In zebrafish embryos, cannabinoid receptor 2 (CNR2) stimulation with AM1241 increased the proliferation and migration of HSPCs, while CNR2 antagonism with AM630 had the opposite effect. However, it was unclear if these effects were secondary, affecting the hematopoietic niche. To determine if the measured increase in HSPCs was due to a cell autonomous signaling cascade acting directly on HSPCs we added AM1241 to isolated zebrafish whole kidney marrow (WKM) and performed a clonal methylcellulose assay. These clonal assays allow direct testing of drugs to monitor HSPC expansion <em>in vitro</em>, which is useful for the identification of compounds that can be utilized in the clinic to expand HSPCs to treat a multitude of human diseases. We determined that HSPCs treated with AM1241 or AM630 showed decreased proliferation <em>in vitro</em>, indicating that the expansion of HSPCs treated with cannabinoid antagonists <em>in vivo</em> is likely not due to a cell autonomous effect on HSPCs. These results highlight the role of the multitude of molecular signaling pathways involved in the generation, emergence, and proliferation of HSPCs, and the need to develop specialized assays to further understand the role of the diverse hematopoietic niches responsible for these activities. It also highlights the fact that not all chemicals identified with <em>in vivo</em> assays will be successful for expanding HSPCs for clinical use.</p><h4>Introduction</h4><p>The process of blood formation, called hematopoiesis, begins with hematopoietic stem cells (HSCs), which have the capability of self renewing and differentiating into every mature blood cell type of an organism (reviewed in 1–3). This is a tightly regulated developmental process; HSCs undergo ordered developmental restriction into mature blood cell types responsible for the circulation of oxygen, prevention of blood loss, and fighting infections that threaten an organism’s survival for its entire life. In healthy humans this process generates about 10 trillion cells per day to replenish mature blood cells, most of which are post-mitotic and have finite lifespans. HSCs must also self renew so that the system is never exhausted. Hematopoiesis is tightly controlled, so that an organism doesn’t develop too few blood cells, which can lead to anemia, bleeding disorders, or an impaired immune system. The system also must be regulated so that too many cells are not generated, resulting in leukemia. Although the hematopoietic system has been well studied for many years, the regulation of how HSCs are generated and their subsequent proliferation and differentiation programs is still enigmatic.</p><p>To study hematopoiesis, a popular model system employed is <em>Danio rerio </em>(zebrafish), which have recognizable counterparts to all mammalian hematopoietic cell types. While zebrafish have many benefits for studying blood, their popularity mainly stems from their transparency, fecundity, and genetic tractability, making them an excellent model system for performing genetic screens to identify genes essential for blood cell formation (4–8). Just as importantly, drug screens performed in zebrafish have been extremely successful at elucidating pathways essential for the production and expansion of hematopoietic stem and progenitor cells (HSPCs) (9–13).</p><p>However, most of these drug screens are performed on whole zebrafish embryos, so it is impossible to tell how the drugs are eliciting their effects. In other words: do these compounds <strong>directly</strong> stimulate HSPCs to proliferate in a cell autonomous manner? Or do they stimulate other cells (such as the hematopoietic niche) to instruct/<strong>allow</strong> HSPCs to proliferate in a non cell-autonomous manner? Clinically, it is more useful to have a drug that works directly on the cell in question: that way HSPCs can be isolated and treated with a drug compound, allowing expansion before being utilized to treat disease. If a drug can directly expand HSCs, it can help expand cells <em>in vitro</em>, allowing patients to more quickly and efficiently recover from bone marrow transplants, radiation poisoning, chemotherapy, and a host of other serious diseases.</p><p>Eicosanoids are a large family of lipid modifiers that include epoxyeicosatrienoic acids, prostaglandins, endocannabinoids (eCBs), and leukotrienes. Eicosanoids are related to aracadonic acid, modify adult HSC function (14), and their synthesis and signaling pathways are closely linked. Prostaglandin E2 (PGE2) is an eicosanoid identified in a drug screen that expands HSPCs in developing zebrafish (15). Further studies validated that PGE2 works in a cell autonomous manner to expand HSPCs (15), and the compound is in human clinical trials to measure its efficacy for treating patients recovering from bone marrow transplants (16). Importantly, these studies also identified several other drug compounds that expanded HSCs in embryos, including an agonist of the cannabinoid receptor-2 (CNR2) called AM1241. AM1241 is specific for CNR217, and also upregulated PGE2 synthesis and accelerated the migration of HSPCs (18) in the developing embryo. Many more eicosanoids were identified in these drug screens that likely have an effect on HSPC expansion and development; many of these compounds are likely of clinical value for treating human disease.</p><p>Sensitive <em>in vitro </em>methods<em>, </em>including clonal semi-solid methylcellulose assays, have been developed to investigate individual blood progenitors in zebrafish. These assays require the addition of exogenous cytokines to encourage the proliferation and differentiation of HSPCs in a tissue culture plate, allowing the examination of autonomous signaling. Importantly, these assays can measure the effectiveness of drugs in increasing HSPC numbers; adding synthetic vitamin D (also identified in a screen for chemicals that expand HSPCs in the developing zebrafish) autonomously expands progenitor colonies (19), validating the assay’s usefulness. Before we performed these studies, AM1241 had not been tested for its ability to autonomously expand blood cells <em>in vitro; </em>this knowledge would inform if AM1241 has therapeutic potential for progenitor cell expansion.</p><h4>Objective</h4><p>The objective of this study was to see if HSPCs could be expanded <em>in vitro</em> by adding AM1241 to stimulate their proliferation. Prior research indicates that stimulation of HSPCs with PGE2 expanded and autonomously expanded HSCs in mouse and human cell culture assays (15), so there is evidence that eicosanoids can stimulate growth in a cell autonomous manner. Additionally, HSPCs have CNR2 on their surface (14), indicating that cell autonomous signaling may affect their biology.</p><p>Overall, the long-term objective of this study was to see if zebrafish clonal assays were a good method to validate hits from a whole-embryo genetic screen to determine drugs that function cell autonomously. While the next step in this discovery process is to validate if the drugs work on other vertebrates (such as humans), clonal assays are potentially an easy, cheap method to see if a drug shows promise in that regard. Discovering drugs that act directly to expand HSPCs would be useful to treat immune diseases, help increase the survival rate of patients undergoing bone marrow transplants, and for understanding critical biological processes involved in regenerative medicine.</p><h4>Results and Discussion</h4><p>To determine if CNR2 agonism would expand HSPC numbers, we first isolated zebrafish whole kidney marrow (WKM). In adult zebrafish, the kidney is the main site of hematopoiesis, and all HSPCs reside in this organ. WKM was isolated from fish, and plated in methylcellulose with carp serum, zebrafish recombinant erythropoietin (Epo), and granulocyte colony stimulating factor a (Gcsfa); these exogenous proteins support myeloid and erythroid differentiation <em>in vitro</em>. Then, increasing amounts of AM1241, an agonist of CNR2, was added to the cultures. AM1241 did not expand the numbers of HSPC-derived colonies produced at 1 mM, and inhibited growth when added at 10 mM and 20 mM (<strong>Figure 1, </strong>green bars). Expansion of embryonic HSPCs was seen previously <em>in vivo</em> at 10 mM (18). To antagonize CNR2 signaling, AM630 (20) was added to the cultures. AM630 moderately reduced the numbers of HSPCs at all concentrations examined (<strong>Figure 1, </strong>red bars). To ensure that the assay was functioning properly, exogenous PGE2 was added to the cultures, which increased the number of colonies in culture (data not shown). Overall, agonism and antagonism of CNR2 had little effect on the expansion or growth of HSPCs <em>in vitro</em>.</p><figure><img alt="Bar chart showing that agonism (with AM1241) and antagonism (with AM630) of CNR2 has a negative effect on zebrafish whole kidney marrow (WKM) colony forming unit (CFU) numbers." src="https://cdn-images-1.medium.com/max/916/1*YoYiQq8ETch1M9N-XVHZ6Q.jpeg" /><figcaption><strong>Figure 1: Agonism (with AM1241) and antagonism (with AM630) of CNR2 has a negative effect on zebrafish whole kidney marrow (WKM) colony forming unit (CFU) numbers.</strong> Zebrafish WKM was plated in methylcellulose with no cytokines (left most bar, black) and carp serum, Epo, and Gcsfa (gray bar) with increasing concentration of AM1241 (CNR2 agonist, green bars) or AM630 (CNR2 antagonist, red bars). All drug conditions used the “no drugs” condition to determine fold change. Numbers inside bars denote the number of biological replicates performed. N.S. = not significant, * denotes p &lt; 0.005, ** denotes p &lt; 0.0005</figcaption></figure><h4><strong>Conclusions</strong></h4><p>Our conclusion from these studies is that the agonism and antagonism of CNR2 had little effect on the expansion of HSPCs. This is in disagreement with previous studies that indicate that AM1241 stimulated an increase of HSPCs, which was retarded with the addition of AM630 (18). However, AM1241 addition caused an upregulation of PGE2 in embryonic zebrafish (18). Therefore, it is likely that AM1241 activates the release of PGE2 from the hematopoietic niche in the developing zebrafish, which in turn stimulates HSPC expansion. AM1241 also accelerates migration of HSPCs in the developing zebrafish (18), which may increase their expansion by moving HSCs to a more supportive niche for progenitor proliferation. In other words, it appears that the stimulation of CNR2 signaling appears to affect zebrafish HSPCs in a non-cell autonomous manner.</p><h4><strong>Limitations</strong></h4><p>One important limitation of this study is that clonal methylcellulose assays are not optimized for all hematopoietic cell types. With Epo and Gcsfa added, the only readout is myeloid and erythroid. While zebrafish thrombopoietin (Tpo) has been identified and validated in related studies (21), it was not added to these cultures. Lymphoid cells are especially difficult to grow in methylcellulose, as T cells require cell-cell Notch mediated signaling and no B cell supportive factors have been identified thus far in zebrafish.</p><p>Another limitation is that these experiments were performed on adult WKM, and not embryonic HSPCs. If the biology of these cells is different, then CNR2 signaling may play different roles in them. Additionally, CNR2 signaling may be important for the formation of embryonic HSPCs, but play no role in their expansion later on in development.</p><p>Finally, these clonal <em>in vitro</em> experiments only examine the agonism or antagonism of the CNR2 receptor on it’s own. If HSPC expansion <em>in vitro</em> requires the agonism of CNR2 and some other undefined pathway at the same time, this would be overlooked in this assay. In other words, there could always be more than one input to HSPCs that “fine-tunes” their response to proliferative signals.</p><h4><strong>Conjectures</strong></h4><p>These studies indicate that not all drugs that expand HSPCs identified in a genetic screen of whole animals will work cell autonomously and have therapeutic value for expanding HSPCs <em>in vitro</em>. However, these studies are a good first pass technique to see if follow up experiments are warranted. Importantly, they also show that the biology of HSPC formation, expansion, and migration is complex, and requires more thorough study.</p><h4>Methods</h4><p>WKM isolation and culture in methylcellulose was performed as previously described (22). Samples were given carp serum, Gcsfa (23), and Epo (24) to stimulate myeloid and erythroid differentiation. Stocks of AM1241 and AM630 (Cayman Chemical, Ann Arbor, MI) were dissolved in DMSO at 3 mg/mL and 10 mg/mL, respectively. Cultures were incubated at 32°C and 5% CO2 for 7–10 days and observed with an Olympus IX53 inverted microscope (Olympus, Center Valley, PA) at 40x to enumerate colony forming units (CFUs). Relative fold change was done by setting the “no drug” control as the standard. To discern statistical difference, data were analyzed using an unpaired two-tailed Student’s T test. * = p&lt;0.005, ** = p&lt;0.0005, and N.S. = no significance.</p><h4><strong>Funding Statement</strong></h4><p>This research was supported by the California State University Program for Education and Research in Biotechnology (CSUPERB; New Investigator Grant to <a href="http://www.davidstachura.com/">David Stachura</a>), a California State University Chico (Chico State) Research, Scholarship, and Creativity Activity Award (to <a href="http://www.david-stachura.com/">David Stachura</a>), and a California State University Chico Student Award for Research and Creativity (to <a href="http://www.stachuralab.com/">Francis Wright</a>).</p><h4><strong>Ethics Statement</strong></h4><p>Wildtype zebrafish fish lines (AB) used in these studies were raised and maintained in accordance with California State University, Chico (Chico State) IACUC guidelines. All experiments were approved by the IACUC committee before being performed.</p><h4>Conflicts of Interest</h4><p><a href="https://www.drdavidstachura.com/">David Stachura </a>is a scientific consultant and has received compensation from <a href="https://finlessfoods.com/">Finless Foods, Inc.</a> and <a href="https://www.linkedin.com/company/xytogen-biotech-inc/">Xytogen Biotech, Inc</a>. He is the founder and CEO of <a href="https://www.nonprofitbiotech.com/">Philanthropic Pharma</a> and the Chief Scientific Officer and Chief Operating Officer of <a href="https://factorfiveskin.com/">FactorFive Skincare</a> and <a href="https://www.specbio.com/">SpecBio</a>. These consulting and employment arrangements are unrelated to this study. All other authors declare no competing interests.</p><h4><strong>References</strong></h4><p>1. Cumano, A. &amp; Godin, I. Ontogeny of the hematopoietic system. <em>Annual review of immunology</em> <strong>25</strong>, 745–785 (2007).</p><p>2. Orkin, S. H. &amp; Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell biology. <em>Cell</em> <strong>132</strong>, 631–644, doi:10.1016/j.cell.2008.01.025 (2008).</p><p>3. Eaves, C. J. Hematopoietic stem cells: concepts, definitions, and the new reality. <em>Blood</em> <strong>125</strong>, 2605–2613, doi:10.1182/blood-2014–12–570200 (2015).</p><p>4. Driever, W.<em> et al.</em> A genetic screen for mutations affecting embryogenesis in zebrafish. <em>Development</em> <strong>123</strong>, 37–46 (1996).</p><p>5. Weinstein, B. M.<em> et al.</em> Hematopoietic mutations in the zebrafish. <em>Development</em> <strong>123</strong>, 303–309 (1996).</p><p>6. Ransom, D. G.<em> et al.</em> Characterization of zebrafish mutants with defects in embryonic hematopoiesis. <em>Development</em> <strong>123</strong>, 311–319 (1996).</p><p>7. Amsterdam, A.<em> et al.</em> A large-scale insertional mutagenesis screen in zebrafish. <em>Genes Dev</em> <strong>13</strong>, 2713–2724 (1999).</p><p>8. Gaiano, N.<em> et al.</em> Insertional mutagenesis and rapid cloning of essential genes in zebrafish. <em>Nature</em> <strong>383</strong>, 829–832, doi:10.1038/383829a0 (1996).</p><p>9. Yeh, J. R.<em> et al.</em> Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. <em>Nat Chem Biol</em> <strong>5</strong>, 236–243, doi:10.1038/nchembio.147 (2009).</p><p>10. Paik, E. J., de Jong, J. L., Pugach, E., Opara, P. &amp; Zon, L. I. A chemical genetic screen in zebrafish for pathways interacting with cdx4 in primitive hematopoiesis. <em>Zebrafish</em> <strong>7</strong>, 61–68, doi:10.1089/zeb.2009.0643 (2010).</p><p>11. Ridges, S.<em> et al.</em> Zebrafish screen identifies novel compound with selective toxicity against leukemia. <em>Blood</em> <strong>119</strong>, 5621–5631, doi:10.1182/blood-2011–12–398818 (2012).</p><p>12. North, T. E.<em> et al.</em> Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. <em>Nature</em> <strong>447</strong>, 1007–1011, doi:10.1038/nature05883 (2007).</p><p>13. Astuti, Y.<em> et al.</em> A Functional Bioluminescent Zebrafish Screen for Enhancing Hematopoietic Cell Homing. <em>Stem Cell Reports</em> <strong>8</strong>, 177–190, doi:10.1016/j.stemcr.2016.12.004 (2017).</p><p>14. Hoggatt, J. &amp; Pelus, L. M. Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. <em>Leukemia</em> <strong>24</strong>, 1993–2002, doi:10.1038/leu.2010.216 (2010).</p><p>15. Goessling, W.<em> et al.</em> Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. <em>Cell</em> <strong>136</strong>, 1136–1147, doi:10.1016/j.cell.2009.01.015 (2009).</p><p>16. Cutler, C.<em> et al.</em> Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. <em>Blood</em> <strong>122</strong>, 3074–3081, doi:10.1182/blood-2013–05–503177 (2013).</p><p>17. Malan, T. P., Jr.<em> et al.</em> CB2 cannabinoid receptor-mediated peripheral antinociception. <em>Pain</em> <strong>93</strong>, 239–245 (2001).</p><p>18. Esain, V.<em> et al.</em> Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P-Selectin Activity. <em>Stem Cells</em> <strong>33</strong>, 2596–2612, doi:10.1002/stem.2044 (2015).</p><p>19. Cortes, M.<em> et al.</em> Developmental Vitamin D Availability Impacts Hematopoietic Stem Cell Production. <em>Cell Rep</em> <strong>17</strong>, 458–468, doi:10.1016/j.celrep.2016.09.012 (2016).</p><p>20. Ross, R. A.<em> et al.</em> Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. <em>Br J Pharmacol</em> <strong>126</strong>, 665–672, doi:10.1038/sj.bjp.0702351 (1999).</p><p>21. Svoboda, O.<em> et al.</em> Dissection of vertebrate hematopoiesis using zebrafish thrombopoietin. <em>Blood</em> <strong>124</strong>, 220–228, doi:10.1182/blood-2014–03–564682 (2014).</p><p>22. Svoboda, O.<em> et al.</em> Ex vivo tools for the clonal analysis of zebrafish hematopoiesis. <em>Nat Protoc</em> <strong>11</strong>, 1007–1020, doi:10.1038/nprot.2016.053 (2016).</p><p>23. Stachura, D. L.<em> et al.</em> The zebrafish granulocyte colony-stimulating factors (Gcsfs): 2 paralogous cytokines and their roles in hematopoietic development and maintenance. <em>Blood</em> <strong>122</strong>, 3918–3928, doi:10.1182/blood-2012–12–475392 (2013).</p><p>24. Paffett-Lugassy, N.<em> et al.</em> Functional conservation of erythropoietin signaling in zebrafish. <em>Blood</em> <strong>110</strong>, 2718–2726, doi:10.1182/blood-2006–04–016535 (2007).</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2db2d6321d15" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[rapunzel5 (rpz5) is necessary for normal hematopoietic development in Danio rerio (zebrafish)]]></title>
            <link>https://medium.com/@davidstachura/rapunzel5-rpz5-is-necessary-for-normal-hematopoietic-development-in-danio-rerio-zebrafish-a2fdb683a29d?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/a2fdb683a29d</guid>
            <category><![CDATA[chico-state]]></category>
            <category><![CDATA[hematopoiesis]]></category>
            <category><![CDATA[stem-cell-research]]></category>
            <category><![CDATA[zebrafish]]></category>
            <category><![CDATA[david-stachura]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Sun, 10 Aug 2025 18:33:03 GMT</pubDate>
            <atom:updated>2025-08-10T18:33:03.951Z</atom:updated>
            <content:encoded><![CDATA[<p><a href="https://www.linkedin.com/in/samrat-t-6564131a5/">Samrat Thapa</a>, William <a href="https://www.linkedin.com/in/will-dowell-8401012b5/">Dowell</a>, <a href="https://www.linkedin.com/in/elena-harris-608052122/">Elena Harris</a>, <a href="https://www.linkedin.com/in/davidstachura/">David Stachura</a>.</p><figure><img alt="Zebrafish embryo imaged in brightfield (above) and for mpx:GFP+ fluorescent myeloid cells (below). Image was made by David Stachura while a professor at California State University Chico (Chico State)." src="https://cdn-images-1.medium.com/max/1024/1*ghN92XPRY9NhHGChBJCmJA.jpeg" /><figcaption>Myeloid cells visualized in a fluorescent mpx:GFP zebrafish</figcaption></figure><h3><strong>Abstract</strong></h3><p>The molecular mechanisms regulating the highly complex process of hematopoiesis in vertebrates is still enigmatic. This system begins with the controlled differentiation of adult hematopoietic stem and progenitor cells (HSPCs), which can proliferate and generate all types of mature blood cells. Identifying the underlying factors and mechanisms that allow HSPCs<em> </em>to differentiate and proliferate is an essential issue in stem cell biology and tissue homeostasis; disruptions in these processes can cause severe diseases. A transcriptomic screen of hematopoietic-supportive zebrafish stromal tissues identified <em>rapunzel5 (rpz5) </em>was likely involved in vertebrate hematopoiesis.<em> </em>We performed loss-of-function experiments in zebrafish embryos at the one-cell-stage with morpholinos to determine if blood cell production was affected by <em>rpz5</em>. <em>rpz5</em> knockdown resulted in reduced amounts of red blood cells, myeloid cells, and thrombocytes, and adding back exogenous <em>rpz5</em> rescued these deficiencies. Further analysis with methylcellulose assays indicated that there was also a significant reduction in HSPCs following <em>rpz5</em> reduction. Together, these findings suggest that zebrafish <em>rpz5</em> is essential for normal formation, differentiation, and proliferation of HSPCs, specifically down the erythroid and myeloid pathway. Fully understanding the roles of novel genes such as <em>rpz5</em> is essential for understanding the evolution of vertebrate hematopoiesis and for treating hematological diseases in the future.</p><h3><strong>Introduction</strong></h3><p>Hematopoiesis is the development of blood cells that an organism needs during its whole life span. At the core of this system are hematopoietic stem cells (HSCs), which have the unique property of self-renewal and differentiation down the myeloid and lymphoid pathways. This allows HSCs to constantly replenish themselves while simultaneously creating and maintaining red blood cells and the cells of the innate and adaptive immune system. This complex process of hematopoiesis is regulated by various molecular pathways that affect hematopoietic stem and progenitor cell (HSPC) growth, differentiation, proliferation, and homeostasis. When this process becomes disordered, multiple types of blood disorders can occur, such as anemia, thrombocytopenia, leukopenia, as well as blood cancers (leukemia). While the hematopoietic system has been studied for decades, molecular pathways are still being discovered that regulate the process of blood production. These pathways help us understand not only the evolution of the hematopoietic system, but also potential mechanisms that could be exploited for therapeutic use in the future.</p><p><em>Danio rerio</em> (zebrafish) are a powerful model organism to study hematopoiesis (reviewed in 1–3). In recent decades, this model has permitted numerous studies of blood disorders. Zebrafish develop <em>ex utero</em> and are extremely fecund. Their ease (and low cost) of maintenance and husbandry, coupled with their genomic conservation with higher vertebrates allows inexpensive but thorough genetic assessments to be performed quickly and easily. Importantly, zebrafish are transparent during early embryonic stages which allow for <em>in vivo</em> visualization of development in real time. This is further enhanced by the plethora of blood-specific promoters that drive fluorescent protein expression and allow for live visualization of various blood cell types. Additionally, reverse genetic engineering methods such as clustered regularly intercepted short palindromic repeats RNA-guided Cas9 nucleases (CRISPR/Cas9) and transcription activator-like effector nucleases (TALENs) can be easily utilized for genetic manipulation, while forward genetic screens utilizing mutagenic chemicals and retroviruses have already elucidated a multitude of previously unknown pathways important for blood formation (4–15). Finally, zebrafish are an excellent model for large scale drug screens to treat and prevent hematopoietic disease (16–20). In fact, many drugs have been discovered through screens of zebrafish that are now in clinical trials for human use.</p><p>Previous work in <a href="https://www.stachuralab.com/">our laboratory</a> identified highly expressed transcripts in hematopoietic supportive cell lines (21–22). <em>rapzunel5</em> (<em>rpz5</em>) was among those genes highly expressed in zebrafish embryonic stormal trunk cells (ZEST; 23), kidney stromal cells (ZKS; 24), and caudal hematopoietic embryonic stromal tissue (CHEST; 21); all essential sites for regular hematopoiesis. Importantly, all of these cell lines support hematopoiesis <em>in vitro</em>, so they are excellent model systems to study signals necessary for HSPC support, proliferation, and differentiation.</p><p><em>rapunzel</em> was first identified in an ENU mutagenesis screen, with the mutant having a skeletal overgrowth phenotype (25). The homozygous mutant embryos were also lethal at 4–5 dpf, which may have been from body axis deformities, pericardial edema, or poorly formed fin folds and jaws (25). Importantly, they also had defects in their vasculature and hematopoiesis, although these defects were not described in any detail (25). In the ENU mutated area of the genome were three paralogous genes, which were named <em>rpz</em>, <em>rpz2</em>, and <em>rpz3</em>. Two other paralogues (<em>rpz4</em> and <em>rpz5</em>) were found in other downstream areas of the genome after sequence comparisons were performed. Although not detected in mammals, <em>rpz5</em> plays an important role in the interferon response of teleosts (26). In this study, we describe a novel function of <em>rpz5 </em>in the development of the immune system during development. Our data indicate that <em>rpz5</em> is essential for normal erythroid, myeloid, and thrombocyte formation, as well as HSPCs. This is specific to the erythro, myeloid, and thrombocytic lineages, however, as lymphoid cells were unaffected by the loss of <em>rpz5</em>.</p><h3><strong>Materials and Methods</strong></h3><h4><strong>Zebrafish husbandry and care</strong></h4><p>Zebrafish were mated, staged, and raised as described (27) and maintained in accordance with California State University, Chico Institutional Animal Care and Use Committee (IACUC) guidelines. All procedures were approved by the IACUC before being performed. Personnel were trained in animal care by taking the online Citi Program training course entitled “Working With Zebrafish (<em>Danio rerio</em>) in Research Settings” (<a href="https://www.citiprogram.org/index.cfm?pageID=154&amp;icat=0&amp;clear=1">https://www.citiprogram.org</a>). Wildtype (AB) and the transgenic zebrafish lines <em>mpx</em>:EGFP (28), <em>itga2b</em>:EGFP (commonly referred to as <em>cd41:EGFP) </em>(29)<em>, lcr:EGFP </em>(30), and <em>lck</em>:EGFP (31)<em> </em>were used for these studies. Zebrafish were housed in a 700L recirculating zebrafish aquarium system (Aquatic Enterprises, Seattle, WA) regulated by a Profilux 3 Outdoor module that regulated salinity, pH, and temperature (GHL International, Kaiserslautern, Germany) 24-hours-a day. The facility was illuminated on a 14-hour light/ 10-hour dark cycle. Zebrafish were fed once a day with hatched brine shrimp (Brine Shrimp Direct, Ogden, UT) and Size 4 Zebrafish Research Diet (daniolab, Boston, MA).</p><h4><strong>Generation of <em>rpz5</em> mRNA</strong></h4><p><em>rpz5</em> transcript was amplified from zebrafish kidney cDNA using the following <em>rpz5</em> primers: FWD 5’-ATGAATCGGGTGGAAGAATGGG-3’ and REV 5’-CTATTCAGAGTGAATGCACAGG-3’. <em>rpz5</em> transcript was cloned into a TOPO-TA vector (Invitrogen, Carlsbad CA) and validated by Sanger sequencing. <em>rpz5</em> was then subcloned into pCS2+ and linearized with Not1. <em>rpz5 </em>mRNA was generated using a mMessage SP6 kit (Ambion, Austin, TX).</p><h4><strong><em>rpz5</em> sequence read counts</strong></h4><p>Sequenced RNA libraries generated from zebrafish stromal cell lines were processed and analyzed as previously described (21, 23).</p><h4><strong>Morpholino and <em>rpz5</em> mRNA injections</strong></h4><p><em>rpz5</em> antisense morpholino (MO) was designed against the start codon to prevent translation of <em>rpz5</em> mRNA (Gene Tools, Philomath, OR). The MO sequence is as follows: 5’-AAACCCATTCTTCCACCCGATTCAT-3’. A control MO was also used with the sequence of 5’-CCTCTTACCTCAGTTACAATTTATA-3’. For microinjection into embryos, a mix of 3 μL of 8.26 mg/mL <em>rpz5</em> MO was mixed with 1 μL of phenol red for a final concentration of 6.2 ng/nL <em>rpz5</em> MO. 1 μL of this mix was loaded into a needle made with a PM102 micropipette puller (MicroData Instrument, Plainfield, NJ). Single-cell stage embryos were collected, placed onto a 1% agarose microinjection chamber plate with troughs, and injected with 1 nL (6.2 ng) of <em>rpz5</em> MO with a PM 1000 Cell Microinjector (MicroData Instrument, Plainfield, NJ). For rescue injections, rescued embryos received 6.2 ng of <em>rpz5 </em>MO and 115 ng <em>rpz5</em> mRNA.</p><h4><strong>Microscopic visualization of the hematopoietic system</strong></h4><p>Transgenic zebrafish were visualized under a Leica M165C (Leica, Wetzlar, Germany) fluorescent dissecting microscope at time points correlated with the emergence of specific hematopoietic cell lineages. Erythrocytes were visualized at 48 hpf with <em>lcr</em>:EGFP transgenic animals. Myeloid cells were visualized under the microscope at 48 hpf with <em>mpx</em>:GFP transgenic animals. Thrombocytes were visualized with <em>cd41</em>:EGFP transgenic fish at 72 hpf. T cells were visualized at 120 hpf with <em>lck</em>:GFP transgenic fish. Zebrafish and their fluorescently labeled cells were imaged using a Leica FireCam camera (Leica, Wetzlar, Germany), scored, and enumerated. For myeloid quantitation, images were labeled by a reference number and the numbers of <em>mpx</em>:GFP+ cells were counted in each animal by several undergraduate students to ensure no bias in results. Results were validated with a machine learning program that was trained to count fluorescent cells (32). For T cell quantitation, images of <em>lck</em>:GFP embryos were analyzed with ImageJ (<a href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</a> ; 33) to determine the pixel density of each thymus relative to background.</p><h4><strong>Quantitation of HSPCs in developing zebrafish embryos</strong></h4><p>HSPC isolation and culture was performed as previously described (34–36). Samples had carp serum, GCSF, and EPO added to stimulate myeloid and erythroid differentiation (35, 37). They were incubated at 32°C and 5% CO2 for 7–10 days and imaged with an Olympus IX53 inverted microscope (Olympus, Center Valley, PA) at 20x to enumerate colony forming units (CFUs).</p><h4><strong><em>rpz5 </em>PCR</strong></h4><p>mRNA was extracted from embryos at 24 and 48 hpf using a Qiagen RNAeasy kit (Qiagen, Hilden, Germany). cDNA was then generated with the iScript cDNA synthesis kit (Biorad, Hercules, CA), and PCR was performed with JumpStart Taq DNA polymerase (MilliporeSigma, Burlington, MA). <em>ef1a </em>(38) was used as a reference gene.</p><h4><strong>Statistics</strong></h4><p>To discern statistical differences, data were analyzed using an unpaired two-tailed Student’s T test with Microsoft Excel.</p><h3><strong>Results</strong></h3><p>To identify novel transcripts likely involved in hematopoiesis, we examined the transcriptome of three hematopoietic-supportive zebrafish cell lines (ZKS, ZEST, and CHEST cells) and compared the transcripts to a non-supportive cell line (ZF4 cells) (see 21, 23). <em>rpz5</em> levels were 8.9x higher in CHEST cells, 20.2x higher in ZEST cells, and 30.7x higher in ZKS cells (<strong>Table 1</strong>) when compared to ZF4 cells. This elevated amount of <em>rpz5</em> in these cell lines indicated that the transcript was likely involved in hematopoiesis.</p><figure><img alt="Table showing that rpz5 is highly expressed in hematopoietic-supportive stromal cell lines. Each stromal cell line is derived from sites of hematopoietic emergence, expansion, and maintenance in adult and embryonic zebrafish; adult zebrafish kidney stroma (ZKS, derived from the adult kidney), zebrafish embryonic stromal trunk (ZEST, derived from the embryonic trunk), and caudal hematopoietic embryonic stromal tissue (CHEST, derived from the CHT)." src="https://cdn-images-1.medium.com/max/1024/1*gMT09yD9yK3bPuvmDrfTqw.jpeg" /><figcaption><strong>Table 1: <em>rpz5</em> is highly expressed in hematopoietic-supportive stromal cell lines. </strong>Each stromal cell line is derived from sites of hematopoietic emergence, expansion, and maintenance in adult and embryonic zebrafish; adult zebrafish kidney stroma (ZKS, derived from the adult kidney), zebrafish embryonic stromal trunk (ZEST, derived from the embryonic trunk), and caudal hematopoietic embryonic stromal tissue (CHEST, derived from the CHT). Each stromal cell line’s transcriptome was analyzed with RNA-seq and compared to a non-hematopoietic supportive stromal cell line (ZF4); transcript levels for each cell line are presented as reads per kilobase of transcript per million reads mapped (RPKM).</figcaption></figure><p>To verify that <em>rpz5</em> was expressed in developing zebrafish embryos, PCR was performed at 24 and 48 hpf. <em>rpz5</em> transcript was detectable at 48 hpf, indicating that we could modulate its activity and see the downstream effect on blood cell formation (<strong>Fig 1A</strong>). To verify if we could reduce <em>rpz5 </em>levels with a specific MO, we generated a MO that targeted the gene’s translational start site. Injection of no MO and control MO had no effect on the levels of <em>rpz5</em>, while the specific <em>rpz5</em> MO entirely prevented <em>rpz5</em> expression, likely due to mis-splicing or nonsense-mediated decay (<strong>Fig 1B</strong>).</p><figure><img alt="rpz5 is expressed in the developing zebrafish embryo and reduced by rpz5 morphilino as shown by RT-PCR and gel electrophoesis." src="https://cdn-images-1.medium.com/max/1024/1*lp02s1C_-PpSGvdDb3tGZg.jpeg" /><figcaption><strong>Fig 1: <em>rpz5</em> is expressed in the developing zebrafish embryo and reduced by <em>rpz5</em> MO. (A) </strong>10 whole zebrafish embryos were digested, RNA was extracted, cDNA generated, and subjected to RT-PCR with primers for <em>rpz5</em> (top) and <em>ef1a</em> (bottom) at 24 hpf and 48 hpf. Kidney is shown as positive control. <strong>(B)</strong> Embryos were injected at the one-cell-stage with PBS (no MO), control MO, or <em>rpz5 </em>MO. 10 whole zebrafish embryos were digested, RNA was extracted, cDNA generated, and subjected to RT-PCR with primers for <em>rpz5</em> (left) and <em>ef1a</em> (right) at 48 hpf.</figcaption></figure><p>To examine the effect of <em>rpz5</em> on morphology, <em>rpz5</em> MO was injected at the one-cell-stage and embryos were allowed to develop until 48 hpf. Most embryos were morphologically normal (<strong>Fig 2A</strong>), but a few had pericardial effusion (<strong>Fig 2B</strong>).</p><figure><img alt="rpz5 knockdown reduces erythrocytes in circulation visualized with lcr:GFP zebrafish embryos" src="https://cdn-images-1.medium.com/max/1024/1*fLXcyY3E3pN8tYEERfFuSQ.jpeg" /><figcaption><strong>Fig 2. <em>rpz5 </em>knockdown reduces erythrocytes in circulation<em>. </em></strong><em>lcr:GFP</em> zebrafish embryos were injected at the single-cell-stage with 6.2 ng <em>rpz5 </em>MO (rpz5 MO), or 6.2 ng <em>rpz5</em> MO and 115 ng of <em>rpz5</em> mRNA (Rescue); uninjected embryos served as controls (Control). 24 hpf zebrafish visualized at 50x that have normal <strong>(A)</strong>, pooled <strong>(B)</strong>, and negative GFP <strong>©</strong> blood. White arrows indicate the dorsal aorta and red arrows indicate the cardinal vein. Green brackets show the caudal hematopoietic tissue, the orange arrow indicates blood pooling of blood in the Ducts of Cuvier, and blue arrow denotes pericardial effusion. <strong>(D)</strong> Quantitation of zebrafish shown in (<strong>A-C</strong>); pooled blood (red), negative GFP (black), and normal (green) phenotypes. Numbers (n) of embryos examined are shown over the bars.</figcaption></figure><p>To observe if this loss of <em>rpz5</em> had a negative effect on blood formation, we first focused on red blood cells, one of the first blood cells produced. <em>lcr</em>:GFP fish, which have the locus control region of alpha globin that drives GFP fluorescence, allow all erythrocytes to be visualized. <em>rpz5</em> morphant zebrafish were categorized into circulation phenotypes of “normal” (<strong>Fig 2A</strong>), “pooled” (<strong>Fig 2B</strong>), or “negative” (<strong>Fig 2C</strong>). While “negative” fish had no labeled erythroid cells, “pooled” circulation refers to a buildup of erythrocytes especially in the anterior region of the embryo near the heart of the <em>lcr</em>:GFP zebrafish at 48 hpf. In this phenotype, the heart is still pumping, and liquid can be seen in the vessels of the animal. Approximately 60% of <em>rpz5</em> knockdown fish exhibited significant pooling of blood compared to none in the control group (<strong>Fig 2D</strong>). This abnormal circulation phenotype was reduced to about 20% in the rescue zebrafish. At the same time, fish with “normal” blood were reduced from approximately 60% to 10% when <em>rpz5</em> MO was added (<strong>Fig 2D</strong>). <em>rpz5</em> mRNA again rescued that phenotype, increasing numbers to almost 40%. Given these data, we suggest <em>rpz5</em> knockdown induced pooling of erythrocytes, reducing the number of cells in circulation.</p><p>Besides erythrocytes, macrophages and neutrophils are also some of the earliest blood cells produced during development. To determine the role of <em>rpz5</em> on these cell types, myeloid-specific transgenic animals (<em>mpx</em>:GFP) were injected with <em>rpz5</em> MO. At 48hpf, morphant and control zebrafish were visualized and imaged (<strong>Fig 3A</strong>). The total fluorescent myeloid cell count was determined by multiple undergraduate students and confirmed via a machine learning neutrophil counting model (32). <em>rpz5</em> morphant fish displayed a significant reduction in <em>mpx</em>:GFP cells compared to the control group (<strong>Fig 3B</strong>). Rescue experiments with <em>rpz5</em> mRNA recovered the numbers of <em>mpx</em>:GFP+ myeloid cells, confirming that <em>rpz5</em> plays an important role in myelopoiesis.</p><figure><img alt="rpz5 knockdown reduces myeloid cells visualized with mpx:GFP zebrafish embryos" src="https://cdn-images-1.medium.com/max/1024/1*9B5HkFsE2T0pg4bHpmY7CA.jpeg" /><figcaption><strong>Fig 3. <em>rpz5 </em>knockdown reduces myeloid cells<em>. </em></strong><em>mpx:GFP</em> zebrafish embryos were injected at the single-cell-stage with 6.2 ng <em>rpz5 </em>MO (rpz MO, squares), or 6.2 ng <em>rpz5</em> MO and 115 ng of <em>rpz5</em> mRNA (Rescue, triangles); uninjected embryos served as controls (Control, circles). 48 hpf zebrafish were visualized and imaged at 50x <strong>(A) </strong>Representative <em>mpx:</em>GFP embryo at 48 hpf. Every green spot denotes an individual myeloid cell. <strong>(B)</strong> Fluorescent myeloid cells were manually quantitated for each condition. Dashed line denotes median, and bars represent SD. * denotes p &lt; 0.0001, and N.S. denotes no significance.</figcaption></figure><p>Zebrafish erythrocytes and thrombocytes share a common progenitor cell called the thrombocyte erythroid progenitor (TEP). Due to the fact that circulating erythrocytes were reduced, we suspected that thrombocyte production might also be negatively impacted. To perform these studies, we utilized <em>cd41</em>:GFP transgenic animals. After injection, fish were allowed to develop for 72 hours, which is how long thrombocytes take to develop. The fish were then scored as “normal” (<strong>Fig 4A</strong>), “reduced” (<strong>Fig 4B</strong>), or “negative” (<strong>Fig 4C</strong>), depending on how many thrombocytes were visible. The “reduced” phenotype included transgenic fish with less thrombocytes in the caudal hematopoietic region; these fish also had slowed circulation. In the <em>rpz</em>5 MO KO group, 40% of fish had reduced numbers of thrombocytes, and only 25% normal amounts when compared to control (<strong>Fig 4D</strong>). Rescue with mRNA rescued this, with only 10% fish having reduced thrombocytes and normal fish increasing to 40%. Overall, <em>rpz5</em> is also required for the normal formation of thrombocytes in the developing zebrafish embryo.</p><figure><img alt="rpz5 knockdown reduces thrombocytes visualized with cd41:GFP zebrafish embryos" src="https://cdn-images-1.medium.com/max/1024/1*M8YvpaH2OzLACHxY6tPDOQ.jpeg" /><figcaption><strong>Fig 4. <em>rpz5 </em>knockdown reduces thrombocytes<em>. </em></strong><em>cd41:GFP</em> zebrafish embryos were injected at the single-cell-stage with 6.2 ng <em>rpz5 </em>MO (rpz5 MO), or 6.2 ng <em>rpz5</em> MO and 115 ng of <em>rpz5</em> mRNA (Rescue); uninjected embryos served as controls (Control). 72 hpf zebrafish visualized at 50x that have normal <strong>(A)</strong>, pooled <strong>(B)</strong>, and negative GFP <strong>©</strong> blood. Blue arrow denotes pericardial effusion. <strong>(D)</strong> Quantitation of zebrafish shown in (<strong>A-C</strong>); reduced thrombocytes (red), negative GFP (black), and normal (green) phenotypes. Numbers (n) of embryos examined is shown over the bars.</figcaption></figure><p>Lymphoid cells are another type of hematopoietic cells that are essential for the adaptive immune system. While B cell transgenic animals exist, their fluorescence is difficult to discern until later in development (39). To examine T cells, we utilized a transgenic animal where the <em>lck</em> promoter is driving GFP fluorescence. To perform these experiments, fish were injected with <em>rpz5</em> MO or control MO and allowed to develop for 5 days. At 5dpf, animals’ thymi were imaged at the same magnification and exposure settings (<strong>Fig S1A-C</strong>). Afterwards, pixel density of the thymus was quantified with ImageJ (<strong>Fig S1D</strong>). Control and morphant animals had no difference in thymic fluorescence, indicating that they had similar numbers of T cells and <em>rpz5</em> loss had no negative effects on T cell development.</p><figure><img alt="rpz5 knockdown has no effect on T cells visulaizing lck:GFP zebrafish embryos" src="https://cdn-images-1.medium.com/max/1024/1*6sEh8JC1E6kQ_B4gPVyZ1g.jpeg" /><figcaption><strong>Fig S1. <em>rpz5 </em>knockdown has no effect on T cells<em>. </em></strong><em>lck:GFP</em> zebrafish embryos were injected at the single-cell-stage with 6.2 ng <em>rpz5 </em>MO (rpz5 MO, squares); uninjected embryos served as controls (control, circles). 120 hpf zebrafish visualized at 50x that have normal <strong>(A)</strong>, low <strong>(B)</strong>, and negative GFP <strong>©</strong> thymi (red dotted circle), where T cells are formed. * denotes background fluorescence of the yolk ball. <strong>(D)</strong> Quantitation of thymic pixel density shown in (<strong>A-C</strong>) with Image J. Dashed line denotes median, and bars represent SD. N.S. denotes no significance.</figcaption></figure><p>All hematopoietic cells derive from a hematopoietic stem cell (HSC) that differentiates into more lineage-restricted hematopoietic stem and progenitor cells (HSPCs). While there are many ways to measure HSPCs in the developing embryo, we utilized a methylcellulose assay to quantitate these progenitors. To determine the impact of <em>rpz5</em> on HSPCs, pools of control and <em>rpz5</em> MO injected animals were collected at 48 hours, enzymatically digested, and plated in methylcellulose with supportive cytokines (<strong>Fig 5A</strong>). The samples were incubated for 7 days, after which the resultant colonies were visualized and counted. Colony forming units (CFUs) for <em>rpz5</em> morphant zebrafish were reduced on average by about 40% compared to the control group (<strong>Fig 5B</strong>). This reduction was completely rescued by mRNA injection (<strong>Fig 5B</strong>). These data suggest that <em>rpz5</em> is involved in the normal formation of HSPCs, which likely affects the downstream levels of erythroid, myeloid, and thrombocytic cells in the developing zebrafish.</p><figure><img alt="rpz5 knockdown reduces HPSCs measured by a methylcellulose assay" src="https://cdn-images-1.medium.com/max/1024/1*QPWBwlvyaVIPfmjGwyK52A.jpeg" /><figcaption><strong>Fig 5. <em>rpz5 </em>knockdown reduces HPSCs<em>. </em></strong>Zebrafish embryos were injected at the single-cell-stage with 6.2 ng <em>rpz5 </em>MO (rpz MO, squares), or 6.2 ng <em>rpz5</em> MO and 115 ng of <em>rpz5</em> mRNA (Rescue, triangles); uninjected embryos served as controls (Control, circles). 48 hpf zebrafish were digested and subjected to a methylcellulose assay <strong>(A)</strong>. Images created with biorender.com <strong>(B)</strong> Colony forming units (CFUs) from each condition are shown. Each point denotes 12 randomly selected animals that were digested and plated. Dashed line denotes median, and bars represent SD. * denotes p &lt; 0.02, and N.S. denotes no significance.</figcaption></figure><h3><strong>Discussion</strong></h3><p>Hematopoiesis is an extremely complex process necessary for the survival of an organism. This process begins in the early embryo, with primitive erythroid and myeloid cells arising around 24hpf. Then, definitive HSPCs and HSCs arise, which will give rise to all hematopoietic cells, including lymphoid lineages, for the remainder of the animal’s life (reviewed in 40–42). While research on hematopoiesis has occurred for decades, many of the molecular pathways responsible for the differentiation of these HSCs and HSPCs have yet to be elucidated. To address that issue, we isolated hematopoietic-supportive cell lines and interrogated their transcriptome, with the hopes that they were producing and secreting hematopoietic-supportive proteins. One of the proteins that we detected from these supportive cell lines was <em>rpz5</em>.</p><p>RPZ5 belongs to the <em>rpz</em> family, composed of <em>rpz</em>, <em>rpz2</em>, <em>rpz3</em>, and <em>rpz4</em> in zebrafish. While <em>rpz5</em> has not been detected in mammals, it is well conserved in teleosts. The zebrafish mutant <em>rapunzel</em> (a missense mutation of <em>rpz</em>) results in skeletal overgrowth (25) even though the proteins’ actual molecular function is unclear. To the best of our knowledge the other family members have not been examined, excluding <em>rpz5</em>, which is a negative regulator of RIG-I like receptor (RLR)-mediated interferon (IFN) production (26). In other words, Lu et al found that <em>rpz5</em> played an important role in the fish’s response to viral infection. There are two transcript variants of <em>rpz5</em>, and while we likely reduced both versions with our 5’ MO designed to the transcriptional start site, we saw effective rescue with the long transcript (rpz5–201 in <a href="http://www.ensembl.org),/">www.ensembl.org),</a> which codes for a 393aa protein that is ~45kDa. Our findings, that <em>rpz5</em> is involved in the early development of the immune system, fits with Lu et al.’s previous work. Proinflammatory signaling is essential in the early formation of the hematopoietic system, especially during the emergence of HSCs during development (43–45) and IFN plays an important role in the proliferation of HSCs, preserving self-renewal and multilineage differentiation capability (46 and reviewed in 47–48). The reduction of IFN signaling due to <em>rpz5</em> knockdown may directly explain why less HSCs and HSPCs are seen in morphants. Additionally, while <em>rpz</em> mutants had skeletal malformations (25), our MO resulted in no overt phenotypical skeletal issues. It appears that <em>rpz5</em>, either directly or through IFN signaling, has a novel role in the development of the hematopoietic system.</p><p>In this study we knocked down <em>rpz5</em> with a MO. MOs are excellent methods to reduce the expression of a protein, especially during development. When we knocked down <em>rpz5</em>, we saw abnormal erythroid, myeloid, and thrombocytic differentiation. Rescue with <em>rpz5</em> mRNA effectively rescued these defects, indicating that phenotypes were likely directly caused by <em>rpz5</em> reduction. While CRISPR-Cas9 mutants could be produced, there is a strong chance that one of the other four family members, if they have any functional redundancy, could be overexpressed and mask the knockout’s effect (25, 49). The effects are clearly not off-target, as T cells were not reduced. Overall, these findings further validate the use of MOs to discern important biological processes, especially during development.</p><p>As mentioned above, the fact that <em>rpz5</em> reduction has no effect on lymphoid cells is interesting. HSCs are the keystone cells of the hematopoietic system, which further differentiate into common lymphoid progenitors (CLPs; 50), and common myeloid progenitors (CMPs; 51). Further downstream of CMPs are granulocyte monocyte progenitors (GMPs; 51) and thrombocyte erythrocyte progenitors (TEPs; 52). Using a methylcellulose assay adapted for zebrafish, we saw that HSPC numbers were reduced. As we only added granulocyte colony stimulating factor (gcsf), erythropoietin (epo), and carp serum to the mix, we can only really assess CMPs and GMPs, as those cytokines are essential for those HSPCs to differentiate (35–36). Thrombopoietin could be added into the media, but it would likely have no effect, as thrombocytes were reduced in <em>rpz5</em> morphants and TEPs are downstream of CMPs and GMPs. While lymphoid cells are notoriously hard to examine <em>in vitro</em>, these studies indicate that <em>rpz5</em> likely affects downstream HSPCs like the CMP and GMP, but not necessarily HSCs; if HSCs were negatively affected, we would expect less T cells present.</p><p>Overall, these studies describe a novel role for <em>rpz5</em> in hematopoietic development, indicating that it is important for normal erythro-, thrombo-, and myelo-poiesis while appearing seemingly dispensable for T cell differentiation. While this gene is not present in mammals, it is well conserved in teleosts. Further study of this gene is needed to understand it’s role in hematopoiesis, but it is likely functioning through down-regulating IFN signaling, which affects HSPC formation and differentiation.</p><h3>Conflicts of Interest</h3><p><a href="https://www.drdavidstachura.com/">David Stachura </a>is a scientific consultant and has received compensation from <a href="https://finlessfoods.com/">Finless Foods, Inc.</a> and <a href="https://www.linkedin.com/company/xytogen-biotech-inc/">Xytogen Biotech, Inc</a>. He is the founder and CEO of <a href="https://www.nonprofitbiotech.com/">Philanthropic Pharma</a> and the Chief Scientific Officer and Chief Operating Officer of <a href="https://factorfiveskin.com/">FactorFive Skincare</a> and <a href="https://www.specbio.com/">SpecBio</a>. These consulting and employment arrangements are unrelated to this study. All other authors declare no competing interests.</p><h3><strong>References</strong></h3><p>1. Gore AV, Pillay LM, Venero Galanternik M, Weinstein BM. The zebrafish: A fintastic model for hematopoietic development and disease. Wiley Interdiscip Rev Dev Biol. 2018 May;7(3):e312. doi: 10.1002/wdev.312. Epub 2018 Feb 13. PMID: 29436122; PMCID: PMC6785202.</p><p>2. Frame JM, Lim SE, North TE. Hematopoietic stem cell development: Using the zebrafish to identify extrinsic and intrinsic mechanisms regulating hematopoiesis. Methods Cell Biol. 2017;138:165–192. doi: 10.1016/bs.mcb.2016.08.004. Epub 2016 Oct 26. PMID: 28129843.</p><p>3. Robertson AL, Avagyan S, Gansner JM, Zon LI. Understanding the regulation of vertebrate hematopoiesis and blood disorders — big lessons from a small fish. FEBS Lett. 2016 Nov;590(22):4016–4033. doi: 10.1002/1873–3468.12415. Epub 2016 Sep 25. PMID: 27616157; PMCID: PMC5483340.</p><p>4. Driever W, Fishman MC. The zebrafish: heritable disorders in transparent embryos. J Clin Invest. 1996 Apr 15;97(8):1788–94. doi: 10.1172/JCI118608. PMID: 8621761; PMCID: PMC507246.</p><p>5. Weinstein BM, Schier AF, Abdelilah S, Malicki J, Solnica-Krezel L, Stemple DL, Stainier DY, Zwartkruis F, Driever W, Fishman MC. Hematopoietic mutations in the zebrafish. Development. 1996 Dec;123:303–9. doi: 10.1242/dev.123.1.303. PMID: 9007250.</p><p>6. Ransom DG, Haffter P, Odenthal J, Brownlie A, Vogelsang E, Kelsh RN, Brand M, van Eeden FJ, Furutani-Seiki M, Granato M, Hammerschmidt M, Heisenberg CP, Jiang YJ, Kane DA, Mullins MC, Nüsslein-Volhard C. Characterization of zebrafish mutants with defects in embryonic hematopoiesis. Development. 1996 Dec;123:311–9. doi: 10.1242/dev.123.1.311. PMID: 9007251.</p><p>7. Amsterdam A, Burgess S, Golling G, Chen W, Sun Z, Townsend K, Farrington S, Haldi M, Hopkins N. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 1999 Oct 15;13(20):2713–24. doi: 10.1101/gad.13.20.2713. PMID: 10541557; PMCID: PMC317115.</p><p>8. Gaiano N, Amsterdam A, Kawakami K, Allende M, Becker T, Hopkins N. Insertional mutagenesis and rapid cloning of essential genes in zebrafish. Nature. 1996 Oct 31;383(6603):829–32. doi: 10.1038/383829a0. PMID: 8893009.</p><p>9. Kettleborough RN, Busch-Nentwich EM, Harvey SA, Dooley CM, de Bruijn E, van Eeden F, Sealy I, White RJ, Herd C, Nijman IJ, Fényes F, Mehroke S, Scahill C, Gibbons R, Wali N, Carruthers S, Hall A, Yen J, Cuppen E, Stemple DL. A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature. 2013 Apr 25;496(7446):494–7. doi: 10.1038/nature11992. Epub 2013 Apr 17. PMID: 23594742; PMCID: PMC3743023.</p><p>10. Lawson ND, Wolfe SA. Forward and reverse genetic approaches for the analysis of vertebrate development in the zebrafish. Dev Cell. 2011 Jul 19;21(1):48–64. doi: 10.1016/j.devcel.2011.06.007. PMID: 21763608.</p><p>11. Sood R, English MA, Jones M, Mullikin J, Wang DM, Anderson M, Wu D, Chandrasekharappa SC, Yu J, Zhang J, Paul Liu P. Methods for reverse genetic screening in zebrafish by resequencing and TILLING. Methods. 2006 Jul;39(3):220–7. doi: 10.1016/j.ymeth.2006.04.012. PMID: 16828311.</p><p>12. Varshney GK, Burgess SM. Mutagenesis and phenotyping resources in zebrafish for studying development and human disease. Brief Funct Genomics. 2014 Mar;13(2):82–94. doi: 10.1093/bfgp/elt042. Epub 2013 Oct 26. PMID: 24162064; PMCID: PMC3954039.</p><p>13. Varshney GK, Lu J, Gildea DE, Huang H, Pei W, Yang Z, Huang SC, Schoenfeld D, Pho NH, Casero D, Hirase T, Mosbrook-Davis D, Zhang S, Jao LE, Zhang B, Woods IG, Zimmerman S, Schier AF, Wolfsberg TG, Pellegrini M, Burgess SM, Lin S. A large-scale zebrafish gene knockout resource for the genome-wide study of gene function. Genome Res. 2013 Apr;23(4):727–35. doi: 10.1101/gr.151464.112. Epub 2013 Feb 4. PMID: 23382537; PMCID: PMC3613589.</p><p>14. Wienholds E, Schulte-Merker S, Walderich B, Plasterk RH. Target-selected inactivation of the zebrafish rag1 gene. Science. 2002 Jul 5;297(5578):99–102. doi: 10.1126/science.1071762. PMID: 12098699.</p><p>15. Wienholds E, van Eeden F, Kosters M, Mudde J, Plasterk RH, Cuppen E. Efficient target-selected mutagenesis in zebrafish. Genome Res. 2003 Dec;13(12):2700–7. doi: 10.1101/gr.1725103. Epub 2003 Nov 12. PMID: 14613981; PMCID: PMC403812.</p><p>16. Yeh JR, Munson KM, Elagib KE, Goldfarb AN, Sweetser DA, Peterson RT. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat Chem Biol. 2009 Apr;5(4):236–43. doi: 10.1038/nchembio.147. Epub 2009 Jan 26. PMID: 19172146; PMCID: PMC2658727.</p><p>17. Paik EJ, de Jong JL, Pugach E, Opara P, Zon LI. A chemical genetic screen in zebrafish for pathways interacting with cdx4 in primitive hematopoiesis. Zebrafish. 2010 Mar;7(1):61–8. doi: 10.1089/zeb.2009.0643. PMID: 20415644; PMCID: PMC2897134.</p><p>18. Ridges S, Heaton WL, Joshi D, Choi H, Eiring A, Batchelor L, Choudhry P, Manos EJ, Sofla H, Sanati A, Welborn S, Agarwal A, Spangrude GJ, Miles RR, Cox JE, Frazer JK, Deininger M, Balan K, Sigman M, Müschen M, Perova T, Johnson R, Montpellier B, Guidos CJ, Jones DA, Trede NS. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood. 2012 Jun 14;119(24):5621–31. doi: 10.1182/blood-2011–12–398818. Epub 2012 Apr 9. PMID: 22490804; PMCID: PMC3382926.</p><p>19. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, Weber GJ, Bowman TV, Jang IH, Grosser T, Fitzgerald GA, Daley GQ, Orkin SH, Zon LI. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature. 2007 Jun 21;447(7147):1007–11. doi: 10.1038/nature05883. PMID: 17581586; PMCID: PMC2775137.</p><p>20. Astuti Y, Kramer AC, Blake AL, Blazar BR, Tolar J, Taisto ME, Lund TC. A Functional Bioluminescent Zebrafish Screen for Enhancing Hematopoietic Cell Homing. Stem Cell Reports. 2017 Jan 10;8(1):177–190. doi: 10.1016/j.stemcr.2016.12.004. Epub 2016 Dec 29. PMID: 28041876; PMCID: PMC5233450.</p><p>21. Wolf A, Aggio J, Campbell C, Wright F, Marquez G, Traver D, Stachura DL. Zebrafish Caudal Haematopoietic Embryonic Stromal Tissue (CHEST) Cells Support Haematopoiesis. Sci Rep. 2017 Mar 16;7:44644. doi: 10.1038/srep44644. PMID: 28300168; PMCID: PMC5353684.</p><p>22. Berrun A, Harris E, Stachura DL. Isthmin 1 (ism1) is required for normal hematopoiesis in developing zebrafish. PLoS One. 2018 May 14;13(5):e0196872. doi: 10.1371/journal.pone.0196872. PMID: 29758043; PMCID: PMC5951578.</p><p>23. Campbell C, Su T, Lau RP, Shah A, Laurie PC, Avalos B, Aggio J, Harris E, Traver D, Stachura DL. Zebrafish embryonic stromal trunk (ZEST) cells support hematopoietic stem and progenitor cell (HSPC) proliferation, survival, and differentiation. Exp Hematol. 2015 Dec;43(12):1047–61. doi: 10.1016/j.exphem.2015.09.001. Epub 2015 Sep 21. PMID: 26391449; PMCID: PMC4666736.</p><p>24. Stachura DL, Reyes JR, Bartunek P, Paw BH, Zon LI, Traver D. Zebrafish kidney stromal cell lines support multilineage hematopoiesis. Blood. 2009 Jul 9;114(2):279–89. doi: 10.1182/blood-2009–02–203638. Epub 2009 May 11. PMID: 19433857; PMCID: PMC2714204.</p><p>25. Green J, Taylor JJ, Hindes A, Johnson SL, Goldsmith MI. A gain of function mutation causing skeletal overgrowth in the rapunzel mutant. Dev Biol. 2009 Oct 1;334(1):224–34. doi: 10.1016/j.ydbio.2009.07.025. Epub 2009 Jul 24. PMID: 19632218; PMCID: PMC2756807.</p><p>26. Lu LF, Zhou XY, Zhang C, Li ZC, Chen DD, Liu SB, Li S. Zebrafish RPZ5 Degrades Phosphorylated IRF7 To Repress Interferon Production. J Virol. 2019 Oct 15;93(21):e01272–19. doi: 10.1128/JVI.01272–19. PMID: 31413136; PMCID: PMC6803274.</p><p>27. Westerfield M. The Zebrafish Book. A guide for the laboratory use of zebrafish (<em>Danio rerio</em>). 5th ed: Univ. of Oregon Press, Eugene.; 2007.</p><p>28. Renshaw SA, Loynes CA, Trushell DM, Elworthy S, Ingham PW, Whyte MK. A transgenic zebrafish model of neutrophilic inflammation. <em>Blood</em>. 2006;108(13):3976–8. pmid:16926288</p><p>29. Lin HF, Traver D, Zhu H, Dooley K, Paw BH, Zon LI, Handin RI. Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood. 2005 Dec 1;106(12):3803–10. doi: 10.1182/blood-2005–01–0179. Epub 2005 Aug 11. PMID: 16099879; PMCID: PMC1895094.</p><p>30. Ganis JJ, Hsia N, Trompouki E, de Jong JL, DiBiase A, Lambert JS, Jia Z, Sabo PJ, Weaver M, Sandstrom R, Stamatoyannopoulos JA, Zhou Y, Zon LI. Zebrafish globin switching occurs in two developmental stages and is controlled by the LCR. Dev Biol. 2012 Jun 15;366(2):185–94. doi: 10.1016/j.ydbio.2012.03.021. Epub 2012 Apr 19. PMID: 22537494; PMCID: PMC3378398.</p><p>31. Langenau DM, Ferrando AA, Traver D, Kutok JL, Hezel JP, Kanki JP, Zon LI, Look AT, Trede NS. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc Natl Acad Sci U S A. 2004 May 11;101(19):7369–74. doi: 10.1073/pnas.0402248101. Epub 2004 May 3. PMID: 15123839; PMCID: PMC409925.</p><p>32. Thapa S, Stachura DL. Deep Learning Approach for Quantification of Fluorescently Labeled Blood Cells in <em>Danio rerio</em> (Zebrafish). Bioinform Biol Insights. 2021 Aug 7;15:11779322211037770. doi: 10.1177/11779322211037770. PMID: 34413636; PMCID: PMC8369963.</p><p>33. Abramoff, M.D., Magalhaes, P.J., Ram, S.J. “Image Processing with ImageJ”. Biophotonics International, volume 11, issue 7, pp. 36–42, 2004.</p><p>34. Berrun AC, Stachura DL. Development of an In Vitro Assay to Quantitate Hematopoietic Stem and Progenitor Cells (HSPCs) in Developing Zebrafish Embryos. J Vis Exp. 2017 Nov 30;(129):56836. doi: 10.3791/56836. PMID: 29286381; PMCID: PMC5755513.</p><p>35. Stachura DL, Svoboda O, Lau RP, Balla KM, Zon LI, Bartunek P, Traver D. Clonal analysis of hematopoietic progenitor cells in the zebrafish. Blood. 2011 Aug 4;118(5):1274–82. doi: 10.1182/blood-2011–01–331199. Epub 2011 Mar 17. PMID: 21415264; PMCID: PMC3152495.</p><p>36. Svoboda O, Stachura DL, Machonova O, Zon LI, Traver D, Bartunek P. Ex vivo tools for the clonal analysis of zebrafish hematopoiesis. Nat Protoc. 2016 May;11(5):1007–20. doi: 10.1038/nprot.2016.053. Epub 2016 Apr 28. PMID: 27123951; PMCID: PMC5560128.</p><p>37. Stachura DL, Svoboda O, Campbell CA, Espín-Palazón R, Lau RP, Zon LI, Bartunek P, Traver D. The zebrafish granulocyte colony-stimulating factors (Gcsfs): 2 paralogous cytokines and their roles in hematopoietic development and maintenance. Blood. 2013 Dec 5;122(24):3918–28. doi: 10.1182/blood-2012–12–475392. Epub 2013 Oct 15. PMID: 24128862; PMCID: PMC3854111.</p><p>38. Bertrand JY, Kim AD, Teng S, Traver D. CD41+ cmyb+ precursors colonize the zebrafish pronephros by a novel migration route to initiate adult hematopoiesis. Development. 2008 May;135(10):1853–62. doi: 10.1242/dev.015297. Epub 2008 Apr 16. PMID: 18417622; PMCID: PMC2762343.</p><p>39. Page DM, Wittamer V, Bertrand JY, Lewis KL, Pratt DN, Delgado N, Schale SE, McGue C, Jacobsen BH, Doty A, Pao Y, Yang H, Chi NC, Magor BG, Traver D. An evolutionarily conserved program of B-cell development and activation in zebrafish. Blood. 2013 Aug 22;122(8):e1–11. doi: 10.1182/blood-2012–12–471029. Epub 2013 Jul 16. PMID: 23861249; PMCID: PMC3750348.</p><p>40. Gore AV, Pillay LM, Venero Galanternik M, Weinstein BM. The zebrafish: A fintastic model for hematopoietic development and disease. Wiley Interdiscip Rev Dev Biol. 2018 May;7(3):e312. doi: 10.1002/wdev.312. Epub 2018 Feb 13. PMID: 29436122; PMCID: PMC6785202.</p><p>41. Stachura DL, Traver D. Cellular dissection of zebrafish hematopoiesis. Methods Cell Biol. 2016;133:11–53. doi: 10.1016/bs.mcb.2016.03.022. Epub 2016 Apr 11. PMID: 27263407.</p><p>42. Carroll KJ, North TE. Oceans of opportunity: exploring vertebrate hematopoiesis in zebrafish. Exp Hematol. 2014 Aug;42(8):684–96. doi: 10.1016/j.exphem.2014.05.002. Epub 2014 May 9. PMID: 24816275; PMCID: PMC4461861.</p><p>43. Espín-Palazón R, Stachura DL, Campbell CA, García-Moreno D, Del Cid N, Kim AD, Candel S, Meseguer J, Mulero V, Traver D. Proinflammatory signaling regulates hematopoietic stem cell emergence. Cell. 2014 Nov 20;159(5):1070–1085. doi: 10.1016/j.cell.2014.10.031. Epub 2014 Nov 6. PMID: 25416946; PMCID: PMC4243083.</p><p>44. He Q, Zhang C, Wang L, Zhang P, Ma D, Lv J, Liu F. Inflammatory signaling regulates hematopoietic stem and progenitor cell emergence in vertebrates. Blood. 2015 Feb 12;125(7):1098–106. doi: 10.1182/blood-2014–09–601542. Epub 2014 Dec 24. PMID: 25540193.</p><p>45. Li Y, Esain V, Teng L, Xu J, Kwan W, Frost IM, Yzaguirre AD, Cai X, Cortes M, Maijenburg MW, Tober J, Dzierzak E, Orkin SH, Tan K, North TE, Speck NA. Inflammatory signaling regulates embryonic hematopoietic stem and progenitor cell production. Genes Dev. 2014 Dec 1;28(23):2597–612. doi: 10.1101/gad.253302.114. Epub 2014 Nov 13. PMID: 25395663; PMCID: PMC4248291.</p><p>46. Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med. 2009 Jun;15(6):696–700. doi: 10.1038/nm.1973. PMID: 19483695.</p><p>47. Pietras EM. Inflammation: a key regulator of hematopoietic stem cell fate in health and disease. Blood. 2017 Oct 12;130(15):1693–1698. doi: 10.1182/blood-2017–06–780882. Epub 2017 Sep 5. PMID: 28874349; PMCID: PMC5639485.</p><p>48. Collins A, Mitchell CA, Passegué E. Inflammatory signaling regulates hematopoietic stem and progenitor cell development and homeostasis. J Exp Med. 2021 Jul 5;218(7):e20201545. doi: 10.1084/jem.20201545. Epub 2021 Jun 15. PMID: 34129018; PMCID: PMC8210624.</p><p>49. El-Brolosy MA, Kontarakis Z, Rossi A, Kuenne C, Günther S, Fukuda N, Kikhi K, Boezio GLM, Takacs CM, Lai SL, Fukuda R, Gerri C, Giraldez AJ, Stainier DYR. Genetic compensation triggered by mutant mRNA degradation. Nature. 2019 Apr;568(7751):193–197. doi: 10.1038/s41586–019–1064-z. Epub 2019 Apr 3. PMID: 30944477; PMCID: PMC6707827.</p><p>50. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997 Nov 28;91(5):661–72. doi: 10.1016/s0092–8674(00)80453–5. PMID: 9393859.</p><p>51. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000 Mar 9;404(6774):193–7. doi: 10.1038/35004599. PMID: 10724173.</p><p>52. Nakorn TN, Miyamoto T, Weissman IL. Characterization of mouse clonogenic megakaryocyte progenitors. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):205–10. doi: 10.1073/pnas.262655099. Epub 2002 Dec 18. PMID: 12490656; PMCID: PMC140928.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a2fdb683a29d" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Human adult mesenchymal stem cells (MSCs) secrete multitudes of beneficial proteins that can be…]]></title>
            <link>https://medium.com/@davidstachura/human-adult-mesenchymal-stem-cells-mscs-secrete-multitudes-of-beneficial-proteins-that-can-be-f4f1b115f1de?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/f4f1b115f1de</guid>
            <category><![CDATA[chicos]]></category>
            <category><![CDATA[mesenchymal-stem-cells]]></category>
            <category><![CDATA[stem-cells]]></category>
            <category><![CDATA[david-stachura]]></category>
            <category><![CDATA[skincare]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Mon, 16 Jun 2025 21:45:43 GMT</pubDate>
            <atom:updated>2025-07-03T23:18:36.914Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Human adult mesenchymal stem cells (MSCs) secrete multitudes of beneficial proteins that can be harnessed for skincare</strong></h3><p><a href="https://www.linkedin.com/in/davidstachura/">David L Stachura</a></p><figure><img alt="Human adult Mesenchymal Stem Cells (MSCs) derived from adipose (fat) tissue growing on tissue culture plates. Cells were derived by Dr. David Stachura, a former professor at Chico State who is now the Chief Scientific Officer at FactorFive Skincare in Chico, CA." src="https://cdn-images-1.medium.com/max/1024/1*XLHGlrk9840RgFSrjxAatg.jpeg" /><figcaption>Adipose derived mesenchymal stem cells (500x)</figcaption></figure><p>Many skincare companies utilize proteins secreted by living cells, integrating them into their products. Why? Cells actively secrete growth factors, antioxidants, extracellular matrix proteins, immunomodulatory proteins, and a host of other proteins that signal to surrounding tissue to encourage growth, healing, and rejuvenation. There are many products utilizing cell secretions on the market; some are made with various adult human stem cells, fibroblasts from human foreskin, and even cells from other animals like red deer and salmon. Additionally, multiple companies utilize stem cell proteins secreted from various species of plants.</p><h4>Why put proteins into skincare products?</h4><p>Cells “talk” to each other with proteins that they secrete. Those proteins bind to receptors on other cells and instruct them what to do (grow, secrete proteins, die, move to another location, etc.). However, human cells can only interpret proteins from closely related animal species [<a href="https://www.dermascope.com/flora-vs-fauna/">1</a>]. While plant cells secrete proteins like antioxidants that function in our bodies, they don’t secrete growth factors that human skin can interpret. And, they certainly don’t secrete useful extracellular matrix proteins like collagen or elastin. In short, the most useful cells for skincare are from the human body. They “speak” the same language, and we can respond to them [<a href="https://www.dermascope.com/flora-vs-fauna/">1</a>]. In essence, the only really useful cells for improving human skin are from humans themselves.</p><h4><strong>What kind of human cells are the best for skincare?</strong></h4><p>Mesenchymal stem cells (MSCs) are adult stem cells that can regenerate more of themselves and also differentiate into adipocytes (fat), osteocytes (bone), and chondrocytes (cartilage) [<a href="https://www.nature.com/articles/nri2395">2</a>]. They can also differentiate into fibroblasts, which are important components of your connective tissue [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9219688/">3</a>]. MSCs were first discovered in the bone marrow (BM) [<a href="https://pubmed.ncbi.nlm.nih.gov/5654088/">4</a>]; these MSCs are referred to as BM-derived MSCs (BMMSCs). MSCs are also present in the hypodermis, which is the deepest, fat-filled layer of your skin; these are called adipose-derived MSCs (ADMSCs) [<a href="https://www.liebertpub.com/doi/10.1089/107632701300062859?url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org&amp;rfr_dat=cr_pub++0pubmed">5</a>]. Yet another location of MSCs is the umbilical cord (UCMSCs) [<a href="https://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.2000.01986.x">6</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3311226/">7</a>]. Importantly, research indicates that MSCs are present in the connective tissue of every organ of the adult body [<a href="https://journals.biologists.com/jcs/article/119/11/2204/2956/Mesenchymal-stem-cells-reside-in-virtually-all">8</a>], which makes sense as humans need to replenish most cells on a daily basis.</p><p>So, why choose one cell type over another? First, it depends on what the cells will be used for. MSCs are not exactly the same- they have different roles in the body based on their location. For treating a particular issue you may want one type of cell or the other, depending on the ailment. Secondly, there is a utilitarian aspect. How easy are they to obtain, and how many can you get? Although first discovered in BM, MSCs from that location are low in frequency. Additionally, BM aspiration is a painful, invasive procedure. UCMSCs are also limited in supply, as a discarded umbilical cord is required. In contrast, the most abundant and easily isolated MSCs are present in fat. In fact, there is a 500x higher frequency of MSCs in fat than other locations of the body [<a href="https://www.liebertpub.com/doi/10.1089/scd.2011.0722?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed">9</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3117820/">10</a>], and over 1.5 million liposuction surgeries are performed globally every year [<a href="https://www.isaps.org/media/hprkl132/isaps-global-survey_2020.pdf">11</a>]. Importantly, fat removed during these procedures is regarded as waste and can be collected without additional risk to the donor. Research shows that these ADMSCs can differentiate into epidermal stem cells [<a href="https://academic.oup.com/asj/article/34/1/142/204783?login=false">12</a>] and fibroblasts [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9219688/">3</a>], indicating that they are likely the most important stem cell population for skin. For skincare, ADMSCs just make the most sense. They’re abundant and localized to the tissue we’re interested in enhancing with cosmetic skincare products.</p><h4><strong>Why use stem cell-derived proteins for skincare products?</strong></h4><p>As mentioned previously, adult stem cells “talk” to surrounding cells by secreting proteins, as well as secreting extracellular matrix proteins (ECM). ADMSCs contribute to the regeneration of skin [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4594597/">13</a>, <a href="https://www.jdsjournal.com/article/S0923-1811(07)00286-1/abstract">14</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4022592/">15</a>] and secrete ECM proteins like collagen and elastin that reduce fine lines and wrinkles [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7536557/">16</a>], as well as signaling molecules that instruct cells to grow and migrate to an injury [<a href="https://www.nature.com/articles/s41536-019-0083-6">17</a>]. Proteins produced by ADMSCs can remodel scar tissue, increase blood flow, and modulate the immune system [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3673757/">18</a>]. Additionally, they secrete antioxidants [<a href="https://www.jdsjournal.com/article/S0923-1811(07)00286-1/abstract">14</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4022592/">15</a>]. Transplantation studies indicate young ADMSCs rejuvenate aging skin [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10453478/">19</a>, <a href="https://academic.oup.com/asj/article-abstract/37/1/14/2623645?redirectedFrom=fulltext&amp;login=false">20</a>] and secrete growth factors that promote cellular homeostasis and repair [<a href="https://journals.lww.com/dermatologicsurgery/abstract/2008/10000/adipose_derived_stem_cells_and_their_secretory.3.aspx">21</a>]. Studies show that using the proteins secreted from ADMSCs helps with a multitude of skin issues, including reducing the appearance of aging [<a href="https://www.jdsjournal.com/article/S0923-1811(07)00286-1/abstract">14</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4022592/">15</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7536557/">16</a>, <a href="https://www.nature.com/articles/s41536-019-0083-6">17</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3673757/">18</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10453478/">19</a>, <a href="https://academic.oup.com/asj/article-abstract/37/1/14/2623645?redirectedFrom=fulltext&amp;login=false">20</a>, <a href="https://journals.lww.com/dermatologicsurgery/abstract/2008/10000/adipose_derived_stem_cells_and_their_secretory.3.aspx">21</a>].</p><h4>Do proteins secreted by ADMSCs promote inflammation?</h4><p>Something that I am constantly asked is: “Are ADMSCs pro-inflammatory?” The simple answer is: no! There have been numerous studies directly comparing ADMSCs and BMMSCs [<a href="https://www.sciencedirect.com/science/article/abs/pii/S0165247809001850?via%3Dihub">22</a>, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3673757/">23</a>, <a href="https://www.sciencedirect.com/science/article/abs/pii/S0008874910001541?via%3Dihub">24</a>, <a href="https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2005.05409.x">25</a>, <a href="https://www.liebertpub.com/doi/10.1089/ten.2006.0114?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed">26</a>, <a href="https://www.sciencedirect.com/science/article/abs/pii/S0008874909001154?via%3Dihub">27</a>]. Experiments showed that ADMSCs were superior at preventing the differentiation of immune cells and the expression of specific co-stimulatory molecules on their surface [<a href="https://www.sciencedirect.com/science/article/abs/pii/S0165247809001850?via%3Dihub">22</a>]. ADMSCs were also better at stimulating the secretion of interleukin 10 (IL-10), a key anti-inflammatory cytokine [<a href="https://www.sciencedirect.com/science/article/abs/pii/S0165247809001850?via%3Dihub">22</a>]. A follow-up to that study with age-matched samples showed that ADMSCs suppressed the growth of immune cells 3x better than BMMSCs [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3673757/">23</a>], reduced levels of pro-inflammatory cytokines, inhibited immune cell differentiation, and increased anti-inflammatory cytokines [<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3673757/">23</a>]. Importantly, ADMSCs have a higher metabolic activity than BMMSCs, which explains why they are making and secreting more cytokines and are more effective at preventing inflammation than BMMSCs [<a href="https://journals.lww.com/dermatologicsurgery/abstract/2008/10000/adipose_derived_stem_cells_and_their_secretory.3.aspx">21</a>]. The data is compelling; in a head-to-head comparison, ADMSCs are less inflammatory than BMMSCs. Interested in a summary of that research? Check out this brief <a href="https://www.youtube.com/shorts/l-U5_F0au3Y">YouTube video</a> I made about the subject.</p><p>Overall, it’s clear from the scientific literature that when it comes to cells for skincare, you need to be using human cells. And when it comes to human cells, ADMSCs are clearly the best source- they grow fast, are easy to isolate, and give rise to other cells in the skin like fibroblasts. They are ethically obtained from consenting adults, and would normally just be thrown away as medical waste. Add to that the fact that they’re the least inflammatory stem cells, it’s clear why ADMSCs are the obvious choice to use for skincare products.</p><h4><strong>Works Cited</strong></h4><ol><li><a href="https://www.dermascope.com/flora-vs-fauna/">Stachura D. 2022. Flora vs. Fauna. <em>Dermascope</em>. 2022 Dec 20; 9:13.</a></li><li><a href="https://www.nature.com/articles/nri2395">Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. <em>Nat Rev Immunol</em>. 2008 Sep;8(9):726–36.</a></li><li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9219688/">X. Tanaka K, Ogino R, Yamakawa S, Suda S, Hayashida K. Role and Function of Mesenchymal Stem Cells on Fibroblast in Cutaneous Wound Healing. <em>Biomedicines</em>. 2022 Jun 12;10(6):1391.</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/5654088/">Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. <em>Transplantation</em>. 1968 Mar;6(2):230–47.</a></li><li><a href="https://www.liebertpub.com/doi/10.1089/107632701300062859?url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org&amp;rfr_dat=cr_pub++0pubmed">Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. <em>Tissue Eng</em>. 2001 Apr;7(2):211–28.</a></li><li><a href="https://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.2000.01986.x">Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. <em>Br J Haematol</em>. 2000 Apr;109(1):235–42.</a></li><li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3311226/">Troyer DL, Weiss ML. Wharton’s jelly-derived cells are a primitive stromal cell population. <em>Stem Cells</em>. 2008 Mar;26(3):591–9.</a></li><li><a href="https://journals.biologists.com/jcs/article/119/11/2204/2956/Mesenchymal-stem-cells-reside-in-virtually-all">da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. <em>J Cell Sci</em>. 2006 Jun 1;119(Pt 11):2204–13.</a></li><li><a href="https://www.liebertpub.com/doi/10.1089/scd.2011.0722?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed">Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. <em>Stem Cells Dev</em>. 2012 Sep 20;21(14):2724–52.</a></li><li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3117820/">Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. <em>Cell Commun Signal</em>. 2011 May 14;9:12.</a></li><li><a href="https://www.isaps.org/media/hprkl132/isaps-global-survey_2020.pdf">International Society of Aesthetic Plastic Surgery International Survey on Aesthetic/Cosmetic Procedures in 2020.</a></li><li><a href="https://academic.oup.com/asj/article/34/1/142/204783?login=false">Derby BM, Dai H, Reichensperger J, Cox L, Harrison C, Cosenza N, Yang M, Bueno RA, Neumeister MW. Adipose-derived stem cell to epithelial stem cell transdifferentiation: a mechanism to potentially improve understanding of fat grafting’s impact on skin rejuvenation. <em>Aesthet Surg J</em>. 2014 Jan 1;34(1):142–53.</a></li><li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4594597/">Lynch K, Pei M. Age associated communication between cells and matrix: a potential impact on stem cell-based tissue regeneration strategies. <em>Organogenesis</em>. 2014;10(3):289–98.</a></li><li><a href="https://www.jdsjournal.com/article/S0923-1811(07)00286-1/abstract">Kim WS, Park BS, Kim HK, Park JS, Kim KJ, Choi JS, Chung SJ, Kim DD, Sung JH. Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. <em>J Dermatol Sci</em>. 2008 Feb;49(2):133–42.</a></li><li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4022592/">Zhang S, Dong Z, Peng Z, Lu F. Anti-aging effect of adipose-derived stem cells in a mouse model of skin aging induced by D-galactose. <em>PLoS One</em>. 2014 May 15;9(5):e97573.</a></li><li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7536557/">Novoseletskaya E, Grigorieva O, Nimiritsky P, Basalova N, Eremichev R, Milovskaya I, Kulebyakin K, Kulebyakina M, Rodionov S, Omelyanenko N, Efimenko A. Mesenchymal Stromal Cell-Produced Components of Extracellular Matrix Potentiate Multipotent Stem Cell Response to Differentiation Stimuli. <em>Front Cell Dev Biol</em>. 2020 Sep 22;8:555378.</a></li><li><a href="https://www.nature.com/articles/s41536-019-0083-6">Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. <em>NPJ Regen Med</em>. 2019 Dec 2;4:22.</a></li><li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3673757/">Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. <em>Stem Cells Transl Med</em>. 2013 Jun;2(6):455–63.</a></li><li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10453478/">Bernardini FP, Gennai A, Izzo L, Zambelli A, Repaci E, Baldelli I, Fraternali-Orcioni G, Hartstein ME, Santi PL, Quarto R. Superficial Enhanced Fluid Fat Injection (SEFFI) to Correct Volume Defects and Skin Aging of the Face and Periocular Region. <em>Aesthet Surg J</em>. 2015 Jul;35(5):504–15.</a></li><li><a href="https://academic.oup.com/asj/article-abstract/37/1/14/2623645?redirectedFrom=fulltext&amp;login=false">Gennai A, Zambelli A, Repaci E, Quarto R, Baldelli I, Fraternali G, Bernardini FP. Skin Rejuvenation and Volume Enhancement with the Micro Superficial Enhanced Fluid Fat Injection (M-SEFFI) for Skin Aging of the Periocular and Perioral Regions. <em>Aesthet Surg J</em>. 2017 Jan;37(1):14–23.</a></li><li><a href="https://journals.lww.com/dermatologicsurgery/abstract/2008/10000/adipose_derived_stem_cells_and_their_secretory.3.aspx">Park BS, Jang KA, Sung JH, Park JS, Kwon YH, Kim KJ, Kim WS. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. <em>Dermatol Surg</em>. 2008 Oct;34(10):1323–6.</a></li><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0165247809001850?via%3Dihub">Ivanova-Todorova E, Bochev I, Mourdjeva M, Dimitrov R, Bukarev D, Kyurkchiev S, Tivchev P, Altunkova I, Kyurkchiev DS. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. <em>Immunol Lett</em>. 2009 Sep 22;126(1–2):37–42.</a></li><li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3673757/">Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. <em>Stem Cells Transl Med</em>. 2013 Jun;2(6):455–63.</a></li><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0008874910001541?via%3Dihub">Najar M, Raicevic G, Boufker HI, Fayyad Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton’s Jelly and bone marrow sources. <em>Cell Immunol</em>. 2010;264(2):171–9.</a></li><li><a href="https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2005.05409.x">Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud L, Casteilla L, Blancher A. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. <em>Br J Haematol</em>. 2005 Apr;129(1):118–29.</a></li><li><a href="https://www.liebertpub.com/doi/10.1089/ten.2006.0114?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed">Niemeyer P, Kornacker M, Mehlhorn A, Seckinger A, Vohrer J, Schmal H, Kasten P, Eckstein V, Südkamp NP, Krause U. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. <em>Tissue Eng</em>. 2007 Jan;13(1):111–21.</a></li><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0008874909001154?via%3Dihub">Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, Lee JE, Kim YJ, Yang SK, Jung HL, Sung KW, Kim CW, Koo HH. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. <em>Cell Immunol</em>. 2009;259(2):150–6.</a></li></ol><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f4f1b115f1de" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Demystifying retinoids for skincare]]></title>
            <link>https://medium.com/@davidstachura/demystifying-retinoids-for-skincare-5d9b29436145?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/5d9b29436145</guid>
            <category><![CDATA[retinol]]></category>
            <category><![CDATA[skincare]]></category>
            <category><![CDATA[chico-state]]></category>
            <category><![CDATA[anti-aging]]></category>
            <category><![CDATA[david-stachura]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Tue, 08 Oct 2024 00:52:06 GMT</pubDate>
            <atom:updated>2024-10-08T00:52:06.925Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Demystifying retinoids for skincare: Retinol? Retinal? Retinoic Acid? Retinoids? What’s the difference, and what should I use in my skincare?</strong></h3><p><a href="https://www.linkedin.com/in/davidstachura/">David L Stachura</a> and <a href="https://www.linkedin.com/in/kristen-rueb-ba4557202/">Kristen F Rueb</a></p><p>Like most consumers who care about skin health, you probably see products advertised as containing “retinol.” Most people have at least an inkling that these products are part of a normal skincare routine, but it is hard for most consumers to sort through all the different “versions” of retinoids that companies advertise. Few people understand the differences between these molecules, but fret not! You don’t need to be a biochemist to understand what retinol is and why you should incorporate it into your skincare routine.</p><h3><strong>The science behind retinoids and vitamin A</strong></h3><p>First, some nomenclature discussion. It’s more accurate to refer to “retinoids,” which is a fancy way of saying a chemical compound that is either a natural derivative of vitamin A or chemically related to it. In other words, “retinoid” is a catch-all term that refers to anything related to vitamin A. Some people use the term “vitamin A” in a similar way- to include all versions of these compounds, but “retinoid” is more accurate.</p><p>What is vitamin A? Vitamin A is an essential, fat-soluble vitamin that your body needs to function (reviewed in <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157347/">[1</a>]). That’s right- the human body can’t make vitamin A- you need to get it from somewhere else (hence the term “essential”). It is necessary for the immune system, reproduction, organ function, and growth and development. It’s also important for your vision. Fun fact? Retinol’s name is derived from “retina,” due to its role in your eye. We’ll talk more about the different versions of retinoids later on.</p><p>How do most people get vitamin A? Mostly it is obtained from the diet. You can get vitamin A from animal-based foods like dairy products, meat, eggs, and fish. You also get vitamin A in the form of retinoid precursors (like beta carotene) from fruits and vegetables- these substances are converted to retinoids in your body by special enzymes. Want to make sure you are getting plenty of vitamin A in your diet? Think about this- vitamin A is stored in fat, so the amount of fat in your milk or dairy product directly translates to its vitamin A content. Additionally, it’s better to eat meat from animals that have been fed a higher concentration of feed with beta carotene- they are richer in vitamin A due to their bodies metabolizing the compound before you consume it. In terms of vegetables and plants? Beta carotene is the main source of vitamin A precursor in the human diet, and that is easily obtained from eating red and orange vegetables and fruit. Carrots, tomatoes, and spinach (one of the green vegetables with high concentration of vitamin A precursor) are the main contributors in the human diet, although citrus fruit and juice also contain large amounts. These retinoids are absorbed by your body and accumulate in the liver and in adipose tissue (fat). We’ll describe a little bit more of the chemistry involved in these processes below, but in essence, you take retinoids into your body as either retinyl esters and retinol (from animal products) or as vitamin A precursor (from vegetables). They are converted to other substances in your body by a multitude of enzymes. The main active retinoid molecules are retinal and retinoic acid (RA).</p><p>Ok. Already it’s getting confusing. So, let’s look at <strong>Figure 1</strong>, which shows all the retinoids we’re talking about here (modified from [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679378/">2</a>]). I’ve drawn arrows in between the versions of retinoids to show you what can be converted into different versions of vitamin A. Let’s say you eat some meat, and ingest some retinyl esters (like retinyl linoleate). That substance can be converted into retinol. That retinol can either be used by your body, or converted to retinal. That retinal can either be used by your body or converted into RA. Note that all of the arrows go both ways, except for the one that points to RA. That means that, depending on the need, you can convert the retinoids back and forth (using different enzymes). For example, you can convert retinol into retinal, and then back again into retinol. There’s a lot of metabolism and chemistry involved here, but the simplest way to think about it is this: the main retinoid your body uses is RA. That comes from retinal. And retinal comes from retinol. And retinol comes from retinyl lineolate. So, retinyl lineolate is three steps away from being the most potent retinoid, RA.</p><figure><img alt="Visual representation of retinoids from strongest at top of image (retinoic acid, a prescription drug) to weakest at bottom of image (retinyl esters, the fat-bound version of retinol). The common names of the retinoids are listed, as well as their chemical structure. Arrows show that retinyl esters can be converted to retinol, which can be converted to retinal, which is converted to all-trans retinoic acid or 13-cis-retinoic acid." src="https://cdn-images-1.medium.com/max/720/1*igKv8bZman6d1Fjgiigk4Q.jpeg" /><figcaption><strong>Figure 1: Common retinoids for skincare and their relative strength.</strong> The strongest retinoids (retinoic acid isomers all-trans-retinoic acid and 13-cis-retinoic acid) are listed at the top, and the weakest are at the bottom, which inversely correlates with how mild they are for skincare applications. Structure diagrams used and modified from [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679378/">2</a>]. Arrows in between the retinoids show what chemical structure can be converted into what other structure (i.e. retinol can be converted into retinal and into retinyl esters, although different enzymes are involved); see text for a full explanation.</figcaption></figure><p>In the above example, I highlighted an animal product with a retinyl ester. If you do the same exercise with vegetables, you start off at a different step in the process. Beta carotene is converted to retinal. Then your body has the option to store it as retinol (and further down the storage path as a retinyl ester), use it at retinal, or make more RA. It’s the same idea, just a different step in the process.</p><h3><strong>Skincare and retinoids</strong></h3><p>As mentioned above, vitamin A is essential for a multitude of different processes in the body, due to the fact that it has several biologically active forms (retinol, retinal, and RA). As you probably guessed, vitamin A is also important for your skin (reviewed in [<a href="https://academic.oup.com/bjd/article/189/Supplement_1/i17/7333865?login=false">3</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791161/?_ga=2.10133109.1153138095.1727112045-220736323.1727112044">4</a>,<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618501/">5</a>]). In fact, retinoids are widely used in dermatology due to the fact that there is solid clinical evidence that they induce skin repair. Tretinoin, which is the prescription form of RA, has been widely studied and is a treatment for acne vulgaris (the common form of acne). Importantly, it is the “gold standard” for skin rejuvenation due to its effect of reducing fine lines, deep wrinkles, and hyperpigmentation. It also improves skin texture and is used to treat photoaging. Importantly, these aren’t just cosmetic claims- tretinoin is a prescription drug that has years of clinical trial data to support these statements.</p><p>As a brief review, your skin is composed of three major layers; the outer epidermis, the middle dermis, and the lower hypodermis (<strong>Figure 2</strong>). On the surface of the epidermis are actually dead epithelial cells known as the stratum corneum. The cells present in these layers are held together by lots of proteins known collectively as the extracellular matrix (ECM). The ECM is mostly made of collagen and elastin, which help give your skin shape, structure, and elasticity. It’s important to note that you are constantly producing more skin cells- there are adult stem cells located in the hypodermis and dermis that make more cells and push the old one’s further towards the surface, where they are eventually sloughed off. On average, you replace the epidermis of your skin every month. Vitamin A is a huge component of how your skin performs this process.</p><figure><img alt="Cross section diagram of healthy skin (on the left) and older skin (on the right) showing the epidermis (top), dermis (middle), and hypodermis (lower) layers of the skin. Hair follicles, sweat glands, blood vessels, and stem cells are shown." src="https://cdn-images-1.medium.com/max/720/1*9nqeBctU8faS6KGBkHs9LQ.jpeg" /><figcaption><strong>Figure 2</strong>: Retinoids can reverse the aging process that naturally occurs in skin. Healthy skin (left) has thicker epidermis, dermis, and hypodermis due to more healthy cell turnover and ECM production. Older skin (right) begins to thin and becomes less elastic over time. Additionally, inappropriate pigmentation occurs, blood flow is reduced to these tissues, and the production of cells and their ECM is reduced. Adding retinoids to older skin can’t reverse all the issues that come along with aging, but it promotes sloughing off of the stratum corneum (the upper layer of the epidermis), epidermal cell turnover, and ECM production to thicken the skin and reduce wrinkles. Image modified from <a href="https://kristinecordy.com/">Kristine Cordy</a></figcaption></figure><p>Tretinoin stimulates epidermal cells to proliferate and grow and also remodels ECM proteins in the dermis. ECM protein homeostasis is super important for how your skin ages- the balance of collagen production, destruction, and rearrangement is essential for the skin’s tone and elasticity. In essence, tretinoin stimulates the production of more collagen, while reducing the activity of enzymes that break down collagen called matrix metalloproteinases (MMPs). It also stimulates tissue inhibitors of MMPs (called TIMPs), which again help maintain healthy ECM homeostasis. Although this is a very simplified description, vitamin A is an important molecule that regulates cell growth and proper ECM homeostasis. In essence, RA helps reverse the negative effects of aging that make aging skin thin and less elastic.</p><h3><strong>What is the strongest retinoid?</strong></h3><p>Great question! Let’s order the common retinoids starting with the strongest version. Basically every step down in strength is a different modified form of vitamin A. Although it may be too much chemistry for some, I’ve adapted an image from [<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679378/">2</a>] that helps explain the difference in these molecules (<strong>Figure 1</strong>).</p><p>Basically, in chemical terms, there are four core versions of retinoids. All of them are very similar; they vary in their terminal polar end group (in <strong>Figure 1</strong>, look at the right side of the chemical molecules- note that they are all slightly different).</p><h4><strong>1. Retinoic Acid (RA)</strong></h4><p>The strongest retinoid is RA. This is the most biologically active retinoid and a powerful signaling molecule. All forms of retinoids can be converted to this metabolite, which exerts its effects by binding to a specific receptor in cells called, conveniently, the retinoic acid receptor (RAR). RAR is essential for either turning on or turning off specific gene sequences. Without getting into too much biology, you can think of RA directly affecting the expression of genes and therefore production of proteins in your body. As mentioned before, RA is essential for lots of processes in your body. It’s even required for the patterning of the anterior/posterior axis (how your body is arranged head-to-toe) in early embryonic development.</p><p>RA basically comes in two versions, which are all-trans-retinoic acid and 13-cis-retinoic acid (there is another version called 9-cis-retinoic acid that I have omitted due to it not being super popular for skincare applications). These are two isomers of each other, which is a fancy way of saying that their atoms are arranged in a slightly different way (see <strong>Figure 1</strong>). Effectively they do the same thing biologically, though. You probably know all-trans-retinoic acid as tretinoin, and 13-cis-retinoic acid as isotretinoin. Or, you’ve heard of their more popular prescription drug names, Retin-A and Accutane, respectively. These are prescription drugs, and you need to have a doctor evaluate your skin condition and write a prescription for them. They are primarily used to treat severe acne, but also are useful for treating photoaging of the skin, significantly reducing fine lines and hyperpigmentation. If you’ve ever used RA, you know that it sometimes has pretty visible side effects, such as skin redness, irritation, peeling, and sun sensitivity. This is due to the remodeling and rejuvenation of the skin that it induces. And although it eventually causes thickening of the skin, at first the effect is to clear dead skin cells from the epidermis, causing the skin to be more sensitive to UV radiation from the sun. If you use RA on a daily basis, you need a good SPF to protect yourself. Another important issue to consider is that RA is a powerful signaling molecule that is essential for patterning the early embryo. That means you cannot use RA when you are pregnant. In fact, most doctors will want female patients to be on at least two forms of birth control if they are using RA; it’s that powerful and the detrimental effects to a developing fetus would be catastrophic.</p><h4><strong>2. Retinaldehyde (retinal)</strong></h4><p>Second in line is retinal, also called retinaldehyde. It’s one enzymatic reaction away from RA, and can also be converted into retinol. When you eat beta carotene from vegetables, that molecule actually gets enzymatically converted into retinal. Retinal is also a signaling molecule in your body and is the basis of vertebrate sight. When bound to opsins, retinal forms the chemical basis for light detection in your eyes (it triggers a chemical signaling cascade in the retina, which is interpreted by the brain).</p><p>Retinal is the strongest of the over-the-counter (OTC) retinoids but it is still gentler than RA itself. When formulated in skincare products, retinal promotes cell turnover to even skin tone and texture, and smooths wrinkles and fine lines. It also helps with acne. Some people will still experience irritation and dryness when using retinal, but less so than pure RA. Retinal isn’t super common in skincare formulations, though. In general, it is pretty unstable, and is easily oxidized. Although it converts quickly to RA and is fairly efficacious in skincare, to make a stable product with retinal is difficult, so the products are relatively expensive.</p><h4><strong>3. Retinol</strong></h4><p>Next in line strength-wise is retinol, which is more common in skincare products. It is two enzymatic steps away from pure RA, and so is more mild than retinal or RA. Most retinol is obtained from your diet by consuming foods from animal sources, including dairy products, eggs, fish, and organ meats. Once in your body, it can be converted to retinal or retinyl esters (which is the form of most of your body’s retinoid storage).</p><p>Retinol, like its other retinoid relatives, regulates cell turnover, promotes effective exfoliation, prevents acne, helps with hyperpigmentation, smooths fine lines and wrinkles, increases hyaluronic acid production, produces collagen, and helps to reduce oil production and unclog pores. Like its relatives, it also can cause irritation, drying, and peeling. However, its effects are much more mild than retinal or RA. Retinol is more stable than retinal, but it isn’t always the easiest to formulate skincare products with. Retinol is sensitive to light, heat, and oxygen, and studies indicate that many cosmetic products containing retinol are extremely unstable [<a href="https://pubmed.ncbi.nlm.nih.gov/33206444/">6</a>]. In fact, long-term stability testing of retinol-containing products indicates that most products have less retinol than they claim, likely due to degradation of the molecule [<a href="https://pubmed.ncbi.nlm.nih.gov/32813932/">7</a>].</p><h4><strong>4. Retinyl esters</strong></h4><p>Finally, you have retinyl esters, which are the oil-soluble versions of Vitamin A. They are the furthest removed from RA and take three enzymatic steps to be converted into it. Hence, retinyl esters are the most mild of the retinoids. Like retinol, retinyl esters are mainly obtained by eating animal products, and most of the body’s vitamin A is stored in the liver in the form of retinyl esters.</p><p>There are a few retinyl esters used in skincare, including retinyl palmitate, retinyl propionate, retinyl acetate, and retinyl linoleate. These are all ester forms of retinoids, which is a fancy way of saying that the retinol molecule is bound to something that makes it “fatty” and oil-soluble (hence the reason vitamin A is fat soluble). Take a peek at <strong>Figure 1</strong>, and you’ll see the “R” groups at the right end of the molecules. Each different retinyl ester has a different one attached. Retinyl linoleate is retinol plus linoleic acid (also called vitamin F), retinyl palmitate is retinol + palmitic acid, retinyl propionate is retinol bound to propionic acid, and retinyl acetate is retinol + acetic acid. So, when you apply these versions of retinoids to the skin, they de-esterify, turning into retinol and whatever R group is attached. One of the main benefits of the retinyl esters in skincare is their stability. Because they are linked to other molecules, they are generally more stable and easy to formulate with.</p><p>Let’s look at retinyl linoleate first. This retinyl ester is very stable and de-esterifies in the skin to retinol and linoleic acid, generating two active ingredients, retinol and vitamin F. Retinol, as we’ve discussed previously, is great for skin turnover and antiaging. Vitamin F is an essential omega-6 fatty acid that is hydrating and helps protect the skin’s barrier, retaining moisture. It’s also useful for brightening the skin. Therefore, it counteracts the negative effects of retinol when used on its own. It also increases hyaluronic acid synthesis (another essential ECM component that moisturizes your skin) and reduces inflammation. Overall, it’s a milder retinoid, but that aids its positive effects on the skin.</p><p>Retinyl palmitate is the most abundant endogenous retinyl ester found in the skin, and it is more stable than retinol alone. It is popular in skincare formulations, and separates into retinol and palmitic acid when applied to the skin. Palmitic acid is a fatty acid present in the skin, and it has emollient properties that soften the skin and hydrate it. As such, it is useful to counteract some of the negative properties associated with retinol use.</p><p>Retinyl propionate separates into retinol and propionic acid and has stronger retinoid activity than retinyl palmitate [<a href="https://pubmed.ncbi.nlm.nih.gov/33098193/">8</a>]. It has the same antiaging effects as the other retinoids, and seems to work best when combined with other ingredients such as niacinamide (vitamin B3) for reversing the negative effects of aging on skin.</p><p>Retinyl acetate is a popular retinyl ester used as a commercial cosmetic ingredient in antiaging products. However, clinical studies have not evaluated the antiaging efficacy of retinyl acetate as a single active ingredient in a topical formulation. Instead, it is usually combined with other retinoids in skin formulations.</p><p>So, I think the best way to think about this is that RA is the strongest, followed closely by retinal. Retinol is weaker, and retinyl esters are the weakest. If you think about it, your body needs to undergo three enzymatic reactions to make a retinyl ester into RA, while it needs two reactions to convert retinol, and only one to convert retinal. And that is exactly what happens when you add these compounds to your skin- your body converts them to pure RA to affect skin changes. So, the compounds further removed from RA will be weaker, but also less irritating because they need time to convert to RA. They also tend to be more stable, which is important when you formulate a skincare product.</p><h3><strong>How do I know what retinoid is in a product?</strong></h3><p>Great question! You need to read the label and interpret this information. See <a href="https://medium.com/@davidstachura/whats-in-my-skincare-product-cosmetic-inci-ingredient-lists-explained-for-the-consumer-50c0a0ef8f19">this article</a> that we wrote previously for a great explanation of how to read cosmetic labels and decipher what is in your favorite (or prospective) product.</p><h3><strong>What retinoid should I use in my skincare regimen?</strong></h3><p>This is what most people actually want to know, and like most issues, the answer is a little nuanced. Really, it depends on the situation you’re trying to address, your age, and your skin’s sensitivity.</p><p>Try not to think about how powerful something is in terms of its efficacy. Think about it like this: a muscle car has a lot of horsepower and is great at going fast in a straight line. But if you are racing on a curvy racetrack, you’ll likely be better off with a more agile car with better handling and less power. It’s good to think about the whole package, and not just “strength.”</p><p>If you have severe acne issues, you’ll likely see a doctor and be prescribed the strongest version of retinoid: tretinoin or isotretinoin. But remember- these products are prescription only and are pretty irritating to the skin; you’ll want to pay close attention to using SPF and staying out of the sun (although, everyone should use SPF to protect their skin from UV radiation). If you have sensitive skin and are new to retinoids? Most skincare professionals would probably suggest that you start off with a “weaker” retinoid like a retinyl ester or retinol. Start off slowly, applying every other day, using SPF, and see how your skin reacts. You can always go up in strength, but you can’t easily reduce the strength of your product.</p><p>And remember that not all skincare products are created equally. Retin-A and Accutane have other ingredients, but mainly those creams are drugs designed to get RA into your skin as fast as possible. Most commercially available skincare creams have other ingredients that are beneficial for other aspects of your skin. So try and pick a good skincare product that has other high quality ingredients. Peptides, niacinamide, antioxidants, hyaluronic acid, quality emollients, and other ingredients can make a product creamy, luxurious, and more versatile for your skin. You really want something well balanced that makes your skin feel hydrated and look great as opposed to something with the highest amount of retinoids someone can pack into a product. When in doubt, consult a trusted skincare expert for guidance. They have lots of experience with retinoids and should be able to help you get the clear, healthy skin you’ve always wanted.</p><h3><strong>References</strong></h3><ol><li>Carazo A, Macáková K, Matoušová K, Krčmová LK, Protti M, Mladěnka P. Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity. Nutrients. 2021 May 18;13(5):1703.</li><li>O’Byrne, Sheila M. Retinol and retinyl esters: biochemistry and physiology. Journal of Lipid Research, Volume 54, Issue 7, 1731–1743</li><li>Griffiths TW, Watson REB, Langton AK. Skin ageing and topical rejuvenation strategies. Br J Dermatol. 2023 Oct 30;189(Suppl 1):i17-i23.</li><li>Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Postepy Dermatol Alergol. 2019 Aug;36(4):392–397.</li><li>Milosheska D, Roškar R. Use of Retinoids in Topical Antiaging Treatments: A Focused Review of Clinical Evidence for Conventional and Nanoformulations. Adv Ther. 2022 Dec;39(12):5351–5375.</li><li>Temova Rakuša Ž, Škufca P, Kristl A, Roškar R. Retinoid stability and degradation kinetics in commercial cosmetic products. J Cosmet Dermatol. 2021 Jul;20(7):2350–2358.</li><li>Temova Rakuša Ž, Škufca P, Kristl A, Roškar R. Quality control of retinoids in commercial cosmetic products. J Cosmet Dermatol. 2021 Apr;20(4):1166–1175.</li><li>Bjerke DL, Li R, Price JM, Dobson RLM, Rodrigues M, Tey C, Vires L, Adams RL, Sherrill JD, Styczynski PB, Goncalves K, Maltman V, Przyborski S, Oblong JE. The vitamin A ester retinyl propionate has a unique metabolic profile and higher retinoid-related bioactivity over retinol and retinyl palmitate in human skin models. Exp Dermatol. 2021 Feb;30(2):226–236.</li></ol><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5d9b29436145" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What’s in my skincare product? Cosmetic INCI ingredient lists explained for the consumer.]]></title>
            <link>https://medium.com/@davidstachura/whats-in-my-skincare-product-cosmetic-inci-ingredient-lists-explained-for-the-consumer-50c0a0ef8f19?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/50c0a0ef8f19</guid>
            <category><![CDATA[mocra]]></category>
            <category><![CDATA[cosmetics]]></category>
            <category><![CDATA[david-stachura]]></category>
            <category><![CDATA[chico-state]]></category>
            <category><![CDATA[skincare]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Thu, 13 Jun 2024 22:51:32 GMT</pubDate>
            <atom:updated>2024-06-13T22:51:32.476Z</atom:updated>
            <content:encoded><![CDATA[<p><a href="http://www.linkedin.com/in/davidstachura">David L Stachura</a> and <a href="https://www.linkedin.com/in/kristen-rueb-ba4557202/">Kristen Rueb</a></p><p>A common question many consumers have is: “how much of ______ chemical is in my skincare product?” I also hear “what is ______, anyway?” And, “is ______ safe?” The amount and identity of chemicals used in skincare is easily assessed, and you don’t need to be an organic chemist to figure out what is in a cosmetic product that you may use. The safety issue is a bit tricky, but read on.</p><figure><img alt="Pallete of cosmetic products" src="https://cdn-images-1.medium.com/max/1024/0*lfQOlobIYKIUb_q5" /><figcaption>Photo by <a href="https://unsplash.com/@jazminantoinette?utm_source=medium&amp;utm_medium=referral">Jazmin Quaynor</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><h3><strong>Cosmetic products versus drug products</strong></h3><p>First, we need to define what a cosmetic product is, and how they are regulated in the United States. A cosmetic product is defined by the <a href="https://www.fda.gov/">US Food and Drug Administration (FDA) </a>as something “intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body…for cleansing, beautifying, promoting attractiveness, or altering the appearance” (<a href="https://www.govinfo.gov/content/pkg/COMPS-973/pdf/COMPS-973.pdf">FD&amp;C Act, sec. 201(i)</a>). In essence, it is to clean you and make you look better temporarily. Makeup, perfume, lipstick, skin moisturizers, skin cream, hair color, etc. fall into this category.</p><p>So, what exactly is a drug? Well, the FDA defines drug products as “articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease” and “articles (other than food) intended to affect the structure or any function of the body of man or other animals” (<a href="https://www.govinfo.gov/content/pkg/COMPS-973/pdf/COMPS-973.pdf">FD&amp;C Act, sec. 201(g)(1)</a>). In other words, a drug is intended to alter the body’s physiology and fix a problem. Most of us could easily think of a bunch of well-known drug products that we use regularly, whether they are prescribed by a doctor or over-the-counter (OTC).</p><p>It gets a little tricky when we start to think about things that are classified as cosmetics and drugs. A great example would be anti-perspirant. While deodorant is a “cosmetic” (it just makes you smell better), an anti-perspirant is a drug (because it alters the physiological process of sweating). Another example? Anti-dandruff shampoo; it both cleans your hair (its cosmetic use), but also treats a medical condition (dandruff). Sunscreen is another good example, as it moisturizes your skin, but also has a sun-protective quality that protects the skin from UV radiation. All of these products are regulated by the laws that govern cosmetics and drug products.</p><p>In general, cosmetic products can’t really make “claims” as to what they do, because they aren’t supposed to alter the body or treat a medical condition. Cosmetics can “reduce the appearance” of wrinkles. But if they “treat” wrinkles? Then they are classified as a drug.</p><h3><strong>Who regulates all of this?</strong></h3><p>In essence, the FDA regulates drugs (obviously this is only in the United States, although lots of countries follow the rules and regulations set forth by the FDA). Drugs need to go through an approval process before they go on the market. Briefly, drugs need to go through a new drug application (NDA) process or conform to a pre-existing monograph to be approved as an OTC drug. Let’s say you’re a company that wants to sell a drug to treat cancer or hypertension. You would need to file an NDA, show the FDA relevant tests and data, and then they would approve your drug for sale on the market. In other words, you’d have to prove that the drug did what you said it would and that it was safe. If you want to sell an OTC drug, you could use an approved monograph. The FDA basically has a list of pre-approved chemicals that are safe and effective for specific purposes. If you follow the monograph (really just a rule book of what chemicals you can use and how you can use them), you can sell an OTC without it being tested by the FDA. For example, if you wanted to sell a sunscreen (remember- this is an OTC drug), you simply need to follow the FDA monograph for that product, which tells you what chemicals would work, what percentage they need to be, and what tests you need to follow to make sure you’re in compliance with their rules. If your OTC drug doesn’t conform to a monograph, then it needs to go through the NDA process (if you want to sell a sunscreen with a chemical that the FDA hasn’t approved yet but you believe blocks UV rays in a similar manner). In other words- if it’s a drug? It’s regulated by the FDA.</p><p>But who regulates cosmetics? Cosmetics live in a strange regulatory space. In general, the FDA cares most about preventing the adulteration or mislabeling of cosmetics. In other words, the FDA gets involved if someone is making unfounded claims about a cosmetic product or if that product is mislabeled or dangerous. Only recently has the United States come up with rules for cosmetics called the <a href="https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra">Modernization of Cosmetics Regulation Act of 2022</a> (MoCRA) that now requires producers to use good manufacturing practice (GMP) requirements in their facilities. This law is the most significant expansion of FDA’s authority to regulate cosmetics since the 1930’s, and makes sure that companies are licensed and approved before they can make cosmetics. It’s a way to make cosmetic companies more responsible for the products they produce. While MoCRA gives the FDA more “teeth” to enforce rules that govern cosmetics, it is not the same type of requirement that the FDA has for bona fide drugs; those rules and regulations are much stricter.</p><h3><strong>How do I know what is in my cosmetic product?</strong></h3><p>The good news for consumers is that MoCRA is instituting rules and regulations on the labeling of cosmetic products here in the United States. So, the FDA <strong>will be</strong> regulating cosmetics, at least on some level. However, most responsible cosmetic companies have already been labeling their product ingredients by listing them out in what is known as the International Nomenclature Cosmetic Ingredient list (INCI). INCI is a uniform labeling system, established in the 1970’s, of listing names for cosmetic ingredients that consumers, producers, and regulators can understand.</p><p>Why do we need this type of labeling system? In essence, it’s so that everyone knows what is in a particular product and when you pick up a cosmetic product and read the list of ingredients you can easily tell what is in it. And, fun fact? It also gives you the relative abundance of that ingredient in the mix (not the exact concentration- those are usually trade secrets 🙂).</p><p>So, now that you know there is a uniform listing system, let’s discuss how to read the list and determine what is in your cosmetic product.</p><p>The first thing to do is locate the list. Due to MoCRA regulations, this needs to be on the product and has to be prominently marked. Lot’s of companies list the INCI on their website, as well. Let’s use a FACTORFIVE Skincare product (<a href="https://factorfiveskin.com/collections/full-sizes/products/gentle-gel-facial-cleanser">Gentle Gel Cleanser</a>) as an example.</p><figure><img alt="FACTORFIVE Gentle Gel Cleanser box and bottle" src="https://cdn-images-1.medium.com/max/1024/0*yOVz2YVo-mmccSjq" /></figure><p>The INCI is on the box, and lists the following ingredients:</p><figure><img alt="INCI list of FACTORFIVE Skincare Gentle Gel Cleanser" src="https://cdn-images-1.medium.com/max/511/0*aoBFcoR7qUZDuMB1" /></figure><p>Here’s the important part- the chemicals are listed <strong>in the order of concentration</strong>, from highest to lowest. Convenient, right? So, in our example, we have water as the number one ingredient (that’s common in most water-based cosmetic creams and cleansers). And, you guessed it, Disodium EDTA (a chelating agent) is the least concentrated chemical in this product. There is a caveat: this is how the system should work- some companies simply list ingredients in alphabetical order, which is definitely not the way the list should be compiled on the package. If it’s in alphabetical order, then don’t use the list to gauge the amount.</p><p>But what are these chemicals? Some will look familiar to most people, like water. Skincare aficionados might recognize tocopherol (the chemical name of Vitamin E, an antioxidant) and sodium hyaluronate (the sodium form of hyaluronic acid that is a critical component of the skins’ extracellular matrix). But the other chemicals are likely a little esoteric to most consumers.</p><p>How can you figure it out? Well, there are lots of great websites like <a href="https://incidecoder.com/">INCI decoder</a> that have a useful searchable format- just put in the chemical name and click on “ingredients,” and the website will show you the chemical structure (and/or chemical nomenclature), give you the official INCI name, and a little information on the ingredient’s function. It will also give you its chemical abstracts services (CAS) number. If you want to go deep into a chemical’s information, this number is key.</p><p>Let’s use cocamidopropyl hydroxysultaine as an example; this is probably not a common chemical to most consumers. If you <a href="https://incidecoder.com/ingredients/cocamidopropyl-hydroxysultaine">search for that</a>, you’ll find the function of the chemical to be: “antistatic, cleansing, foam boosting, hair conditioning, skin conditioning, surfactant, (and) viscosity controlling.” In plain language: it’s the “soap” part of the cleanser (that’s what a “surfactant” is). If you don’t know the function terms, just do a <a href="http://www.google.com/">Google search</a>. Conveniently, this entry has a description describing this as “mild,” “gentle,” biodegradable,” and made from coconuts. So, it’s a soap made from coconuts. Pretty easy.</p><p>The system isn’t perfect, though. Some things actually have the same INCI, but are slightly different compounds. One great example of this would be “green tea,” which is an antioxidant added to many skincare products. The INCI listing for this ingredient is “<a href="https://incidecoder.com/ingredients/camellia-sinensis-leaf-extract">Camellia Sinensis Leaf Extract</a>” because it is extracted from the <em>Camellia sinensis</em> tea plant. But, all true teas (white, yellow, green, oolong, and black tea) are made from this plant. To indicate the difference, most products, like the one shown above, denote this by placing terms in parentheses. Basically, it’s trying to help the consumer decipher the “common” name of the chemical. The difference between these tea extracts is simply their oxidation state- white tea is the least oxidized, and black tea is the most. They have different roles and effects in skincare products.</p><p>If you’re approaching this as someone that formulates skincare, the INCI listing can also be a little problematic. A great example would be the INCI listing “<a href="https://incidecoder.com/ingredients/sodium-polyacrylate">sodium polyacrylate</a>,” which is a common thickener. However, you can have very different versions of the same chemical (with the same INCI name). One is linear sodium polyacrylate (really just a string of the chemical repeated over and over), which is stringy and good for making more liquid-like products. Additionally, you can get cross-linked sodium polyacrylate (so the chemical is linked together with others in a non-linear way), which creates a richer, thicker gel. Think about it like a piece of yarn laid out in a straight line (linear version) versus taking that string, balling it up, and gluing it together in a clump (the crosslinked version). The result for a skincare product would be something that is runny (like a serum) versus something that is firmer and gel-like that is more solid and firm. You get a very different feel from the product with these different chemicals. But, their INCI is the same.</p><h3><strong>If it’s on an INCI list, is it safe?</strong></h3><p>This is the question that everyone wants to know, and it is tricky. The important thing you should know as a consumer: the presence of a chemical on the INCI list doesn’t necessarily mean it is safe or approved for use in cosmetics. The onus for showing safety and efficacy for a product lies on the manufacturer. Remember, the FDA doesn’t currently regulate cosmetics- they only regulate if the cosmetic is adulterated or is making specific claims that cannot be substantiated. However, the FDA has already banned some specific <a href="https://www.fda.gov/cosmetics/cosmetics-laws-regulations/prohibited-restricted-ingredients-cosmetics">dangerous substances</a> such as mercury compounds and chloroform. The recent MoCRA law will also allow the FDA to investigate ingredients like <a href="https://www.fda.gov/cosmetics/cosmetic-ingredients/and-polyfluoroalkyl-substances-pfas-cosmetics">per- and poly-fluoroalkyl substances (PFAS)</a> and their safety in cosmetics as well as establishing and requiring standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products. Importantly, cosmetics may contain a wide range of fragrances, which are natural or synthetic compounds added to impart a characteristic and pleasant smell. The problem is, certain fragrances may also cause allergic reactions. So, MoCRA will institute that each fragrance allergen included in the product must be identified on the label. MoCRA will also require cosmetic manufacturers to have a system in place to record and deal with adverse reactions and report these issues to the FDA. Additionally, the FDA will have the ability to go through records for the products and order mandatory recalls, if necessary. Interestingly, while the FDA won’t tell a manufacturer how to do safety testing of their product, they are demanding that the product be safety tested on some level. Certainly those regulations will evolve over time, especially since many of these regulations are reactive, versus proactive. In conclusion? The manufacturer of a cosmetic product is responsible for its safety; the FDA doesn’t regulate cosmetic products or ingredients for safety at this time.</p><h3><strong>So, how do I investigate if a chemical in the INCI list is safe?</strong></h3><p>This is tough, because you need to do some sleuthing on your own. The first place to start is the INCI list. Go to the <a href="https://incidecoder.com/">INCI decoder</a> to start your search. A lot of times they’ll have descriptions of where to go and some references if you’d like to dig deeper. And remember the CAS number? That’s your second step for investigation. Type that number into google or a chemical supplier website like <a href="http://guidechem.com/">guidechem</a> or <a href="http://chemicalbook.com/">chemicalbook</a> and you’ll get all the information you’d ever want on a chemical. Basically, what you want to look at is the material data safety sheet (MSDS). That is a standardized collection of everything known about the chemical in question- its toxicity, how to handle the chemical safely, its physical characteristics, its disposal, what to do if it’s ingested, etc. But I have to caution you here- to paraphrase Paracelsus, “the dose makes the poison.” Remember, high concentrations of a surfactant will be irritating and cause harm to wildlife if dumped in your local creek. But it doesn’t mean that it is dangerous in low concentrations in your gel cleanser. And beware of the idea that organic ingredients are somehow better than synthetic chemicals. Lots of things from nature are dangerous and can cause harm (and allergic reactions).</p><p>In essence, it’s really hard to know what is “safe” and what isn’t. A great example is octinoxate, a UV blocking chemical common in chemical sunscreens (and remember- the FDA considers sunscreens OTC drugs). In a <a href="https://jamanetwork.com/journals/jama/fullarticle/2759002?guestAccessKey=81a4a1e1-66d2-4f85-8d80-8d4d1aa1c56e&amp;utm_source=For_The_Media&amp;utm_medium=referral&amp;utm_campaign=ftm_links&amp;utm_content=tfl&amp;utm_term=012120">2020 manuscript </a>in the Journal of the American Medical Association (JAMA), researchers showed that octinoxate and six other chemicals commonly found in sunscreens were absorbed into the bloodstream at levels that exceed FDA safety thresholds (read the CNN synopsis of the study <a href="https://www.cnn.com/2020/01/21/health/sunscreen-dangers-chemicals-bloodstream-wellness/index.html">here</a>). In fact, octinoxate was detected at high levels in plasma <strong>21 days</strong> after only one application! The reason people are concerned about this is that a lot of these chemicals have incomplete safety studies. Many of them, including octinoxate, are endocrine disruptors and may affect hormone signaling. So, is it “safe?” Well, these chemicals do prevent UV damage to the skin, so they are helpful in preventing skin cancer. But the jury’s still out on if these should be banned due to their possible effects on the endocrine system. They are still in common chemical sunscreens; <a href="https://www.cnn.com/2024/05/01/health/2024-safest-sunscreens-wellness/index.html">they have not been banned by the FDA</a>. My advice (and the advice of most dermatologists)? Avoid them and just <a href="https://www.ewg.org/sunscreen/report/executive-summary/">use a mineral sunscreen</a> with zinc oxide or titanium dioxide, which work as a physical barrier that reflects UV rays versus getting absorbed into the skin. The SPF test is the same for all those products (and regulated by the FDA’s monograph rules), so why not use a potentially less toxic version of an SPF 30 sunscreen if you have a choice? Bonus? It’s better for reefs if you’re out in the water. In fact, many locations like Hawaii have banned these chemicals for their potential environmental hazards in the ocean.</p><h3><strong>So how does the INCI listing help me?</strong></h3><p>In conclusion, it’s hard to say <strong>exactly</strong> what’s in your cosmetic product. But, the INCI is the best place to start. It tells you <strong>what</strong> is in the cosmetic product, and <strong>relative abundance</strong> in comparison to other things in the mix, allowing you to at least gauge your comfort with the amount of something you may find suspect (like a fragrance, for instance). The rest is really up to you as the consumer- if you’re interested, go to the INCI and chemical websites and dig deeper for information about chemicals you may be interested in. Remember- the FDA doesn’t really regulate this- it’s up to the consumer. I advise you to stick with brands that you trust are doing their due diligence to research the safety and efficacy of the chemicals they use in their products. As the Russian proverb says, “trust, but verify.” Ultimately it’s your skin and health. So start with the INCI, but don’t be afraid to investigate further.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=50c0a0ef8f19" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Impact of Using Danio rerio (Zebrafish) in the Middle School Classroom to Engage Students in…]]></title>
            <link>https://medium.com/@davidstachura/impact-of-using-danio-rerio-zebrafish-in-the-middle-school-classroom-to-engage-students-in-250f9902fbe0?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/250f9902fbe0</guid>
            <category><![CDATA[draw-a-scientist]]></category>
            <category><![CDATA[zebrafish]]></category>
            <category><![CDATA[chico-state]]></category>
            <category><![CDATA[inquiry-based-learning]]></category>
            <category><![CDATA[david-stachura]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Wed, 22 May 2024 00:02:09 GMT</pubDate>
            <atom:updated>2024-05-22T21:07:19.513Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Impact of Using Danio rerio (Zebrafish) in the Middle School Classroom to Engage Students in Authentic Novel Scientific Research Investigating Unknown Effects of E-Cigarettes</strong></h3><p><a href="https://www.linkedin.com/in/hannah-metzger-122360267/">Hannah Metzger</a>, <a href="https://www.linkedin.com/in/samrat-t-6564131a5/">Samrat Thapa</a>, and <a href="http://www.linkedin.com/in/davidstachura">David L Stachura</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*E8bSJhkc7HtLBBVfCf-VpA.png" /></figure><p>A teaching method that has regained recent attention is inquiry-based instruction, which differs from traditional dialectic instruction in being discovery-based rather than instructor-directed. To integrate this type of hands-on, impactful method into the science classroom, we picked a topic of interest to middle school children and allowed them to perform novel research. Due to the fact that there has been a dramatic increase in sales of electronic cigarettes (e-cigarettes) coupled with companies intentionally targeting the youth market with fruit- and candy-flavored e-cigarette fluid (ECF) options, we hypothesized young people would be interested in examining the effects of e-cigarettes on their health. To perform these studies, we had 7th grade middle school students observe <em>Danio rerio</em> (zebrafish)<em> </em>embryos to examine vertebrate development and how it was affected by different nicotine-free ECF flavors. The purpose of this research was twofold. First, it was to determine the impact of using zebrafish in the classroom to engage students in real scientific research, to elucidate if it improved learning outcomes and attitudes toward science. Secondly, it was to determine the effects of ECF fluid on early embryonic development. Our results showed that these experiments led to a significant increase in learning outcomes and attitudes toward science among all students.</p><h3><strong>Introduction</strong></h3><h4>Why Zebrafish are Used in the Classroom</h4><p>A teaching method that has regained recent attention is inquiry-based instruction, which differs from traditional dialectic instruction in being discovery-based rather than instructor-directed (National Research Council, 2012). Essentially, it is a way of guiding students through an investigative process to arrive at an answer on their own. Even though this method has recently gained popularity, it is not a new idea; it is a culmination of centuries of educational theories to describe the process of learning dating as far back as Socrates. Two of the most notable theories behind inquiry-based instruction were described in the educational philosophies of Jean Piaget (Kolb, 1984) and of John Dewey (Dewey, 1938).</p><p>The first is that more effective learning takes place if students can find relevance in what they are learning and connect it to something that is familiar to them (Kolb, 1984).<strong> </strong>Indeed, studies have shown that students are more engaged in learning when they have buy-in, either by connecting the relevance of the topic to their personal lives, or by understanding that what they’re learning can be used to directly and positively impact the greater world (Rana et al., 2010, Tomasiewicz et al., 2014).</p><p>The second important theory behind inquiry-based instruction is that more effective learning takes place if students can observe tangible evidence of what they are being taught (Kolb, 1984). Zebrafish are particularly useful for showing students evidence of scientific concepts being taught by allowing students to observe directly physiological responses under a variety of circumstances, ultimately providing a way of visualizing possible impacts on human health.</p><h4>How Zebrafish are Used in the Classroom</h4><p><em>Danio rerio</em> (zebrafish) are an excellent model organism for observing developmental processes. They grow quickly, reproduce frequently, and their development is easily visualized under a microscope in real-time. Their organogenesis and development are similar to other vertebrates, informing about perturbations that affect humans.</p><p>Zebrafish are also very useful for teaching scientific concepts and skills in the classroom. Examples of some curricular topics that zebrafish are excellent at addressing include developmental biology (Fields et al., 2009; Guerra-Varela et al., 2016; Pierret et al., 2012; Shunda et al., 2016; Tomasiewicz et al., 2014; Wilk et al, 2018), disease mechanisms and human health (Gos et al., 2016; Pierret et al., 2012; Rana et al., 2010; Tomasiewicz et al., 2014), genetics (Fields et al., 2009; Guerra-Varela et al., 2016; Lindemann et al., 2011; Pierret et al., 2012; Shunda et al., 2016; Wilk et al, 2018), evolutionary biology (Lindemann et al., 2011), and environmental science (Pierret et al., 2012; Tomasiewicz et al., 2014). Many of the educational programs that implement these curricula are arranged into modules that range in complexity, making them suitable for students of all ages.</p><h4>Electronic Cigarettes (e-cigarettes)</h4><p>E-cigarettes were first developed and marketed to consumers as a safer alternative to traditional cigarettes (Scheffler et al., 2015).<strong> </strong>Over the past few years, there has been a dramatic increase in production and supply of e-cigarettes (McKay et al, 2018).<strong> </strong>Consequently, the World Health Organization (WHO) and the FDA have been unable to regulate effectively the use and distribution of ECF flavors that continue to arise in the US (McKay et al, 2018). In recent years, tobacco companies have intentionally targeted the youth market with fruit- and candy-flavored ECF options<strong> </strong>and trendy designs (Tolentino, 2018). E-cigarettes have been gaining popularity among middle and high school students, with a surge in youth e-cigarette use from 2017 to 2018, with a 48% increase among middle school students and a 78% increase among high school students (Cullen et al., 2018).</p><p>Importantly, 66% of teen e-cigarette users surveyed in 2017 chose e-cigarettes that had no tobacco or nicotine (www.drugabuse.gov). The marketing of flavored, nicotine-free products presents a potential problem for two reasons: First, the advertising as nicotine free is misleading, since most ECF products actually do contain trace amounts of nicotine (Davis et al., 2014). Secondly, there is a lack of chemical analysis of flavoring components prior to their distribution, potentially leading to harmful effects (Varlet et al., 2015; Behar et al., 2014).</p><h3>Project Aim</h3><p>Our project’s aim was to determine if conducting novel, real-world experiments on the safety of ECF in the classroom using zebrafish would positively impact the learning outcomes and attitudes toward science of middle school students.</p><p>Previous studies using laboratory programs in the middle school classroom have teamed schools with programs such as <a href="https://www.bioeyes.org/">Project BioEYES</a> (Shuda et al., 2009; Shuda et al., 2016) and <a href="https://insciedout.org/">InSciEdOut</a> (Pierret et al., 2012; Yang et al., 2016) to deliver laboratory experiments with predetermined results, such as using known genetic modifiers. Similar types of experiments have also been done by other educational programs outside these larger organizations (Fields et al., 2009; Wilk et al, 2018). Predetermined results are similar to the traditional validation laboratory studies common in science curricula. Notably, some of the 6–8 grade level modules developed by InSciEdOut involve students designing novel experiments to test new, unknown outcomes of chemicals such as caffeine, nicotine, and alcohol, in which they aim to expand upon the substantial amount of previous scientific research that has been done on their adverse health effects (Yang et al., 2016).</p><p>This project was unique in that it undertook an experiment to discover an unknown impact of ECF on developmental processes. By participating in this experiment, students were involved in novel scientific research to investigate products with chemical compositions that were unregulated and potentially had adverse health impacts . Under these circumstances, it was important to determine if involvement in such a discovery would result in a change in learning outcomes and attitudes toward science if students collected actual data that could contribute to impactful, real-world findings.</p><p>Overall, our hypothesis was that we would observe increased learning outcomes and attitudes towards science after involving students in these timely, topical, real-world studies.</p><h3><strong>Methods and Materials</strong></h3><h4>E-Cigarette Fluids</h4><p>The following four different flavors and brands of E-Cigarette Fluid (ECF) were acquired from a local vape shop in <a href="https://chico.ca.us/">Chico, CA</a> and used in this study: Zues (Liquid Clouds); Nopales Lictor (Netvapes); Midnight (Sutter Buttes Reserve); and Danish (Basics). All four ECFs used for this study were verified by mass spectroscopy to contain 0 mg tobacco and 0 mg nicotine.</p><h4>Participants</h4><p>There were a total of 57 7th grade students that participated in this module. Of these, 31 participants were female and 26 were male. Additionally, the following racial and ethnic demographics were represented within the group of participants: Caucasian (34 students); Hispanic or Latino (16 students); Black or African American (4 students); Asian or Pacific Islander (3 students); Native American (1 student). All participants attended a Junior High School in Chico, California, where the module was implemented.</p><p>Institutional review board (IRB) and Institutional Animal Care and Use Committee (IACUC) approval was obtained for this study from <a href="https://www.csuchico.edu/">Chico State University</a> before experiments were performed. All students were given instruction on the ethical and humane treatment of vertebrate animals before performing these studies. The laboratory manual, <em>Developmental Biology, A Guide for Experimental Study, </em>was used as a direct guide for delivering this instruction (Tyler, 2010).</p><h4>Module Development</h4><p><strong>Figure 1</strong> illustrates the framework that was developed specifically for this project and used to carry out the classroom module at the middle school level. In this module, two Disciplinary Core Ideas (DCIs) were taught by integrating selected crosscutting concepts and Science and Engineering Practices (SEPs). The DCIs taught were: <em>Biological Evolution: Unity and Diversity; </em>and <em>Growth and Development of Organisms.</em></p><figure><img alt="Figure 1. The educational framework developed for the zebrafish and ECF classroom module. Two DCIs (arrows) are introduced in this module through three crosscutting concepts (circles), all of which tie into each other. Together, the DCIs and crosscutting concepts are anchored by five SEPs (center text)." src="https://cdn-images-1.medium.com/max/1024/1*KCFeAuSyzdEZscVp7GpTGA.jpeg" /><figcaption><strong>Figure 1. The educational framework developed for the zebrafish and ECF classroom module. </strong>Two DCIs (arrows) are introduced in this module through three crosscutting concepts (circles), all of which tie into each other. Together, the DCIs and crosscutting concepts are anchored by five SEPs (center text).</figcaption></figure><p>For DCIs, we focused on one middle school Performance Expectation (PE); for the first DCI the PE was: “Analyze displays of pictorial data to compare patterns of similarities in the embryological development across multiple species to identify relationships not evident in the fully formed anatomy.” For the second DCI<em>, </em>the PE was: “Construct a scientific explanation based on evidence for how environmental and genetic factors influence the growth of organisms.”</p><h4>Module Implementation</h4><p>First, students made a<em> </em>“stages of development” poster. They were given randomly shuffled cards, each with a photograph of a zebrafish embryo in a different stage of development. Students were then asked to arrange the cards, in the correct order, onto a large piece of poster paper. Finally, they were challenged to use the development cards they arranged to identify on their poster the specific points at which four major stages of development occur.</p><p>Students were then asked to form a hypothesis<em>; </em>they collaborated with their peers as they formed hypotheses about what the impact of different ECF flavors would have on various stages of zebrafish development.</p><p>Next, students investigated and collected data. They conducted their investigation over three days of 50-minute class periods. Each day they spent time recording observations about zebrafish embryos that had been exposed to various flavors and amounts of ECFs during different times of development: 24 hours post fertilization (hpf), 48 hpf, and 72 hpf. Participants focused their observations on two components: survival rate and heart morphology after ECF exposure. They were also encouraged to record observations about additional abnormalities they noticed. In this way, students collected real data that was contributing to an actual scientific study.</p><p>Prior to the investigation, students were given images of zebrafish hearts that were both normal and abnormal, which they used as a reference while making observations. As another reference, students were presented with a series of images that would help them determine if the embryo was alive or dead.</p><p>Each day, groups of students rotated through nine stations set up around the classroom and recorded their observations. At each station, there was a dissecting microscope with embryos. All nine prepared embryo setups consisted of a petri dish with embryos in 30 ml of water. The differences in the setups were the flavor and dosage of ECF exposures: there was a high dose (300 uL) and low dose (30 uL) for each of the four flavors used in this study, plus one control without any ECF. On each successive student investigation day, they observed embryos that had been exposed at different stages of development.</p><p>Finally, students formed conclusions. Following the three-day investigation, students discussed the data with their groups and revisited their hypotheses as they made conclusions with regard to their investigation question.</p><h4>Measuring the Impact of Student Learning Outcomes and Attitudes Toward Science</h4><p>The impact on student learning and attitudes toward science as a result of this module were quantitatively measured using three specific instruments: The first was a pre- and post-module assessment. This diagnostic assessment was first given to students before participating in the module, and then again directly after participation.</p><p>The second was the Draw a Scientist Test (DAST). Both before and after the module, students were given a blank sheet of paper with their only instructions being: “draw a scientist.” Results from their pre- and post-module DAST were comparatively analyzed and scored using an adapted version of the official DAST-C tool (Finson et al., 1995), with one alteration from its original form: we substituted “Caucasian” for “crazy/messy hair.”</p><p>The last technique served as a summative assessment of student learning. For this part, students made tri-fold informational brochures according to specific criteria that were developed to provide a way for students to demonstrate their learning outcomes.</p><h3><strong>Results</strong></h3><h4>Learning Outcomes</h4><p>Student learning outcomes were measured by administering an assessment to students prior to participation and then, again, after having completed the module.<strong> </strong>The assessment used in this study consisted of a series of statements, to which students were asked to respond as either “strongly disagree”; “somewhat disagree”; “neutral”; “somewhat agree”; or “strongly agree.”</p><p>Statement 1 was: “science experiments that use other living things show us how exposure to harmful substances affects a human being” (<strong>Figure 2A</strong>). Pre-assessment, the majority of students were neutral about this. Most of the other pre-assessment responses were largely divided between “somewhat agree” and “somewhat disagree.” Fewer than 15% of students claimed to strongly agree or strongly disagree with this statement. Comparing this to the post-assessment responses, strong evidence of improved learning was indicated. First, there was a drop in the percentage of students that initially responded as “neutral,” and a large shift toward “strongly agree.”</p><figure><img alt="Figure 2. Students demonstrate improved learning outcomes after participating in the module. Students took a pre-assessment before participating in the module and an identical post-assessment after participating in it. This consisted of 5 statements, to which they had to respond either “strongly disagree”; “somewhat disagree”; “neutral”; “somewhat agree”; or “strongly agree.”" src="https://cdn-images-1.medium.com/max/1024/1*NNqn4Vk0Po0bldQ_DTGjXg.jpeg" /><figcaption><strong>Figure 2. Students demonstrate improved learning outcomes after participating in the module. </strong>Students took a pre-assessment before participating in the module and an identical post-assessment after participating in it. This consisted of 5 statements, to which they had to respond either “strongly disagree”; “somewhat disagree”; “neutral”; “somewhat agree”; or “strongly agree.” Student responses from each category were added up, separated as pre-assessment or post-assessment, then calculated as a percentage: n=57 for each assessment. The strongest evidence of improved learning outcome is seen from Statement 1.</figcaption></figure><p>Statement 2 was: “the way an experiment is set up affects observation and results.” On both the pre- and post-assessments, the majority of students said that they strongly agreed with this statement (<strong>Figure 2B</strong>). The percentage that strongly agreed on the post-assessment was slightly higher. These results also show a small but unexpected increase in students that somewhat disagreed with this statement post-assessment.</p><p>Statement 3 was: “what happens in my science class does not relate to what happens in the outside world” (<strong>Figure 2C</strong>). Results from this statement indicated a shift towards “strongly disagree” from pre- to post-assessment. Additionally, there was a significant increase in the percentage of students who responded as “neutral” post-assessment. This could have been due to students getting confused by the indirect phrasing of the statement.</p><p>Another way student learning outcomes were assessed was by having students make informational brochures about their research, which were evaluated based on six specific learning targets. <strong>Table 1</strong> illustrates these learning targets and the percentage of students whose work met each. Also included in <strong>Table 1</strong> are work samples from different students, which demonstrate specific examples of how the learning targets were met.</p><figure><img alt="Table 1: Summative assessment results evaluated by learning targets. Learning targets are listed below SEPs. The arrangement of SEPs illustrates how they align with each learning target. Percentage values represent the number of students whose work met each learning target: n=44. Samples from student work are shown below to provide an example of some of the ways each learning target was met." src="https://cdn-images-1.medium.com/max/1024/1*i7a5s15judUZrvVyvvBCoQ.jpeg" /><figcaption><strong>Table 1: Summative assessment results evaluated by learning targets. </strong>Learning targets are listed below SEPs. The arrangement of SEPs illustrates how they align with each learning target. Percentage values represent the number of students whose work met each learning target: n=44. Samples from student work are shown below to provide an example of some of the ways each learning target was met.</figcaption></figure><p>Importantly, 93% of students were able to use the target vocabulary correctly. Furthermore, 91% of students were able to articulate not only <em>how</em> model organisms are used in science, but also <em>why</em> zebrafish are model organisms.</p><p>Students’ ability to outline the experimental procedure was evaluated based on their inclusion of what processes were being observed, by demonstrating an understanding of the use of three specific time treatments as variables, and by demonstrating an understanding of the use of the other two variables, ECF flavor and dosage. An impressive 80% of students were able to meet the experimental procedure learning target. A number of these students even included additional details (<strong>Table 1)</strong>. 77% of students were able to explain the significance of the research. The low percentage of students meeting the learning target of asking questions for further research was mostly due to a lack of an answer rather than an incorrect answer. However, the 27% of students that did answer this developed testable questions based on this module.</p><p>Overall, these results showed that student learning outcomes significantly improved after having participated in this module.</p><h4>Attitudes Toward Science</h4><p>The first way<strong> </strong>of measuring the impact of this module on student attitudes toward science was with pre- and post-assessment statements (<strong>Figure 3</strong>). One of these was Statement 4: “I can imagine myself as a scientist” (<strong>Figure 3A</strong>). Student responses to this showed a shift from “strongly disagree” to “somewhat disagree,” with 32% of students that strongly disagreed dropping to 0% on the post-assessment. These data indicated that students were more open to the idea of seeing themselves as scientists after participating in the zebrafish module.</p><figure><img alt="Figure 3. Students demonstrate improved attitudes toward science after participating in the module. Students took a pre-assessment before participating in the module and an identical post-assessment after participation. This consisted of 5 statements, to which they had to respond either “strongly disagree”; “somewhat disagree”; “neutral”; “somewhat agree”; or “strongly agree.”" src="https://cdn-images-1.medium.com/max/1024/1*BoLopXpZdhOKQNvSMYRzAg.jpeg" /><figcaption><strong>Figure 3. Students demonstrate improved attitudes toward science after participating in the module. </strong>Students took a pre-assessment before participating in the module and an identical post-assessment after participation. This consisted of 5 statements, to which they had to respond either “strongly disagree”; “somewhat disagree”; “neutral”; “somewhat agree”; or “strongly agree.” Student responses from each category were added up, separated as pre-assessment or post-assessment, then calculated as a percentage: n=57 for each assessment. The strongest evidence of improved attitudes toward science is seen from Statement 5.</figcaption></figure><p>Statement 5: “the science I do can help make a difference in real scientific research” (<strong>Figure 3B</strong>) also evaluated students’ attitudes toward science. The results indicated that pre-assessment the majority of students felt neutral about this (<strong>Figure 3B</strong>). Post-assessment, the number of students that initially responded as “neutral” dropped, correlating to a major shift toward “agree.” Furthermore, post-assessment showed that only 2% of students still somewhat disagreed, and none remained in strong disagreement.</p><p>Secondly, we utilized DAST, an established method used to quantify young peoples’ stereotypes of scientists. A modified version, the DAST-C, was published in 1995 by Finson et al., to include a full checklist of other relevant stereotypes. Both versions are scored by adding up the number of features from the checklist that are present in the subject’s drawing: A higher score indicates a more stereotypical perception of a scientist, while a lower score indicates less.</p><p>In this study, students were asked to draw a scientist before participating in the module, and then again afterwards with no prompts or instruction. The results indicated that 59% of students had a higher DAST score on their pre-module drawings, supporting the idea that their perceptions of scientists were less stereotypical by the end of the module (<strong>Figure 4</strong>).</p><figure><img alt="Figure 4. Draw a Scientist Test (DAST) images display fewer stereotypes of scientists after participation in the module. Using the DAST technique, students drew a scientist before and after the module. Each drawing was scored individually by adding up the number of stereotypes present from the adapted DAST-C tool. A higher DAST-C score indicates a more stereotypical image. Each student’s pre-module DAST-C score was compared to their post-module DAST-C score, which is reflected in this graph." src="https://cdn-images-1.medium.com/max/1024/1*kcmf7zDg2wgUsi0ppcT1qg.jpeg" /><figcaption><strong>Figure 4. Draw a Scientist Test (DAST) images display fewer stereotypes of scientists after participation in the module. </strong>Using the DAST technique, students drew a scientist before and after the module. Each drawing was scored individually by adding up the number of stereotypes present from the adapted DAST-C tool. A higher DAST-C score indicates a more stereotypical image. Each student’s pre-module DAST-C score was compared to their post-module DAST-C score, which is reflected in this graph: Each column represents an individual student (n=49). The lower post-module scores demonstrated by the majority of students is indicative of a less stereotypical image of scientists by the end of the module. NOTE: “Caucasian” was substituted for “crazy/messy hair,” since the ethnicity was hard to determine in many drawings.</figcaption></figure><p><strong>Figure 5</strong> shows examples of drawings from 4 different students before and after participation in the module. These drawings are representative of some of the common patterns which occurred. Students 1 and 2 were among the majority of students with a higher DAST score on their pre-module drawings, indicating a less stereotypical view of scientists after participating in the module. 31% of students had the same DAST score on both their pre- and post-module drawings. Of these, about half drew essentially the same thing both times. Importantly, closer examination of the rest of these drawings revealed that what accounted for higher scores on most of the post-module drawings were things like the addition of detail to the background or of captions. While these elements artificially raised the DAST score, their presence in the post-module drawings did not reflect any obvious stereotypes. In fact, qualitative analysis of many post-module drawings suggests an increased confidence and familiarity with science. The remaining 10% of students showed a higher score on their post-module drawings. In almost all of these cases it was because more detail was added in the post-module drawing, contributing to a higher score, though not necessarily indicating a negative impact on these students’ impressions of science or scientists.</p><figure><img alt="Figure 5. Draw a Scientist Test (DAST) images reveal a variety of ways in which stereotypes of scientists were broken down as a result of this module. Individual drawings were qualitatively analyzed by looking at the specific ways that different features from the DAST tool changed from pre-module DAST images to post-module DAST images. This is a representative sample of DAST results from 4 individual students out of the 49 analyzed." src="https://cdn-images-1.medium.com/max/689/1*L26RggGTZSAaTQmDFSQJeA.jpeg" /><figcaption><strong>Figure 5. Draw a Scientist Test (DAST) images reveal a variety of ways in which stereotypes of scientists were broken down as a result of this module. </strong>Individual drawings were qualitatively analyzed by looking at the specific ways that different features from the DAST tool changed from pre-module DAST images to post-module DAST images. This is a representative sample of DAST results from 4 individual students out of the 49 analyzed.</figcaption></figure><p>In addition to using the DAST tool, student drawings were also analyzed to identify trends in their drawings. To do this, we focused on three distinct categories based on common patterns that were observed: gender, facial expression, and general characterization of the scientist. Student drawings were tallied according to which sub categorical features they exhibited within each category (<strong>Figure 6</strong>). The purpose of this was to take the DAST data further, by quantifying not just <em>if </em>students’ perceptions of scientists had shifted, but <em>how</em> they had shifted.</p><figure><img alt="Figure 6. Following this module, more Draw a Scientist Test (DAST) images portray scientists as being females and students with positive facial expressions. The three categories (gender, facial expression, and general characterization), and sub categorical features for each were selected to identify trends based on common themes we noticed from our qualitative analysis and use of the DAST tool." src="https://cdn-images-1.medium.com/max/1024/1*gadTmYscSWseHzoTuVRPdw.jpeg" /><figcaption><strong>Figure 6. Following this module, more Draw a Scientist Test (DAST) images portray scientists as being females and students with positive facial expressions. </strong>The three categories (gender, facial expression, and general characterization), and sub categorical features for each were selected to identify trends based on common themes we noticed from our qualitative analysis and use of the DAST tool. Student drawings were classified according to the sub categorical features and the number of drawings that exhibited each one from the pre-module and post-module groups, respectively. Totals within each category were calculated as a percentage: n=49 for all drawings.</figcaption></figure><p>Interestingly, more students drew a female scientist in their post- versus pre-module drawings (<strong>Figure 6A</strong>). All of the students that initially drew male scientists before but then drew a female after the module were female themselves, strongly suggesting an increase in confidence in their personal scientific ability. Another indication of increased confidence was the shift in the facial expressions from angry/mean or worried/scared expressions to more smiling/happy expressions (<strong>Figure 6B</strong>).</p><p>Considering the general characterization of the scientists drawn, the percentage of students who drew a “mad scientist” figure dropped nearly 3-fold. A proportional increase was observed in those who drew their scientist as a student or young person after the module (<strong>Figure 6C</strong>). Additionally, there was a noticeable increase in the percentage of students who drew their post-module scientists as normal people (<strong>Figure 6C</strong>).</p><p>It is evident from these data that multiple stereotypes about science and scientists were broken down after the module, indicating improved attitudes toward science.</p><p>At the end of the school year, students were given a poll to determine their overall opinions of the zebrafish module in relation to everything else the class covered. On the poll, students were provided with a list of the 8 major subjects or modules from the class, and asked, “What was the most memorable thing we did in class this year?” Based on the results from this poll, 60% of students said the zebrafish module was the most memorable for them.</p><h3><strong>Discussion</strong></h3><p>This study indicated that using zebrafish in the classroom to engage students in authentic scientific research led to both improved learning outcomes and improved student attitudes toward science. Importantly, the module improved student attitudes toward science in terms of confidence in ability and appreciation for the relevance and importance of science in everyday life.</p><p>In addition to gains seen in the questions posited to students pre- and post- module, students created detailed informational brochures to summarize their research. In that summative assessment, specific learning targets served as criteria by which to evaluate learning outcomes. The majority of student work (77%-93%) successfully met these learning targets. Only 27% of student work met the learning target: “asks observation-based questions for further research;” this was due to the high percentage of students whose work, for one reason or another, did not address this learning target at all, as opposed to showing a subpar understanding of it. Further studies should be performed to address this issue, as it is an important part of the scientific process.</p><p>Finally, it was clear from DAST that more students had less stereotypical perceptions of scientists after the module. Following the module, more students drew scientists as being female, having positive facial expressions, and as being students or young people. Taken together, these data showed an overall transition to a more humanized perception of scientists.</p><p>There are several limitations to this study which could be eliminated by further research. The first is with respect to the pre- and post-assessment statement, “the way an experiment is set up affects observation and results.” This concept may have been lost on some students, because the experiment was actually set up for them, due to time restrictions and the logistics of sharing a classroom with another teacher. Moreover, students were not afforded the opportunity to have a role in the experimental design, which was another limitation of this particular study that could be easily eliminated by setting aside more instructional time to implement inquiry-based teaching strategies that would guide students through the process of designing an experiment to answer their investigation question.</p><p>Additionally, the results reflect a narrow scope of the content-based DCI’s, due to the small number of pre- and post-assessment statements. Therefore, a suggestion for further research would be to assess a broader range of DCI’s by including more questions on the pre- and post-assessment.</p><p>Regardless, these results are important because they could help future educators and researchers work together to develop better, more effective modules that use zebrafish as a learning tool, by bringing real-world science into the classroom.</p><h3><strong>Acknowledgements</strong></h3><p>We would like to thank <a href="https://www.linkedin.com/in/bev-marcum-21006a19/">Bev Marcum</a> for helpful conversations about the study, as well as the <a href="http://mjhs.chicousd.org/">Marsh Junior High</a> administration for allowing flexibility with designing curriculum. Work was supported by a <a href="https://www.csuchico.edu/ued/student-awards/index.shtml">Student Research and Creativity award to H.M</a>.</p><h3><strong>Conflicts of Interest</strong></h3><p><a href="https://davidstachura.com/">David Stachura</a> is a scientific consultant and has received compensation from <a href="https://finlessfoods.com/">Finless Foods, Inc.</a> and <a href="https://www.linkedin.com/company/xytogen-biotech-inc/">Xytogen Biotech, Inc</a>. He is the founder and CEO of <a href="https://www.nonprofitbiotech.com/">Philanthropic Pharma</a> and the CSO of <a href="https://factorfiveskin.com/">FactorFive Skincare</a> and <a href="https://www.specbio.com/">SpecBio</a>. These consulting and employment arrangements are unrelated to this study. All other authors declare no competing interests.</p><h3><strong>References</strong></h3><p>Behar, R.z., et al. Identification of Toxicants in Cinnamon-Flavored Electronic Cigarette Refill Fluids. <em>Toxicology in Vitro</em>, vol. 28, no. 2, 2014, pp. 198–208.</p><p>Cullen, Karen A., et al. Notes from the Field: Use of Electronic Cigarettes and Any Tobacco Product Among Middle and High School Students — United States, 2011–2018. MMWR. Morbidity and Mortality Weekly Report, vol. 67, no. 45, 2018, pp. 1276–1277.</p><p>Davis, B., et al. Nicotine Concentrations in Electronic Cigarette Refill and Do-It-Yourself Fluids. <em>Nicotine &amp; Tobacco Research</em>, vol. 17, no. 2, 2014, pp. 134–141.</p><p>Dewey, John. (1938). <em>Experience &amp; Education </em>(1st ed.). Philadelphia, PA: Kappa Delta Pi.</p><p>Fields, Melanie C. et al. (2009). Danio Rerio in K-12 Classrooms: Sparking Interest in the New Generation of Scientists. <em>Zebrafish,</em> <em>6</em>(2), 145–160.</p><p>Finson, Kevin D. et al. (1995). Development and Field Test of a Checklist for the Draw-A-Scientist Test. <em>School Science and Mathematics, 95</em>(4), 195–205.</p><p>Gos, D., et al. (2016). Be Healthy as a Fish Educational Program at the International Institute of Molecular Biology in Warsaw, Poland. <em>Zebrafish,</em> <em>13</em>(4), 266–271.</p><p>Guerra-Varela, Jorge et al. (2016). “A Zebra in the Water”: Inspiring Science in Spain. <em>Zebrafish, 13(4), </em>241–247.</p><p>Lindemann, Samantha et al. (2011). Using Zebrafish to Learn Analysis and Mendelian Genetics. <em>Zebrafish, 8(2).</em></p><p>National Research Council. (2012). <em>A Framework for K-12 Science Education: Practices, Crosscutting Concepts, and Core Ideas</em>. Washington, DC: The National Academies Press.</p><p>Kolb, David. (1984). <em>Experiential Learning: Experience as the Source of Learning and Development</em>. (1st ed.). Upper Saddle River, NJ: Prentice Hall.</p><p>McKay, Betsy, and Jennifer Maloney. “Youth Vaping Has Soared in 2018, New Data Show.” <em>The Wall Street Journal</em>, 21 Sept. 2018.</p><p>Pierret, Chris et al. (2012). Improvement in Student Science Proficiency Through InSciEd Out. <em>Zebrafish</em>. <em>9</em>(4), 155–168.</p><p>Rana, Neha et al. (2010). Caffeine-Induced Effects on Heart Rate in Zebrafish Embryos and Possible Mechanisms of Action: An Effective System for Experiments in Chemical Biology. <em>Zebrafish. 7</em>(1), 69–81.</p><p>Scheffler, Stefanie et al. Evaluation of E-Cigarette Liquid Vapor and Mainstream Cigarette Smoke after Direct Exposure of Primary Human Bronchial Epithelial Cells. <em>International Journal of Environmental Research and Public Health</em>, vol. 12, no. 4, 2015, pp. 3915–3925.</p><p>Shuda, Jamie at al. (2009). Outreach: Empowering Students and Teachers to <em>Fish</em> Outside the Box. <em>Zebrafish. 6(2), </em>133–138.</p><p>Shuda, Jamie at al. (2016). Project BioEYES: Accessible Student-Driven Science for K-12 Students and Teachers. <em>PLoS Biology, 14(11).</em></p><p>Tolentino, Jia. “The Promise of Vaping and the Rise of Juul.” <em>The New Yorker</em>, 7 May 2018.</p><p>Tomasiewicz, Henry G. et al. (2014). Zebrafish as a Model System for Environmental Health Studies in the Grade 9–12 Classroom.<em> Zebrafish.</em> <em>11</em>(4), 384–395.</p><p>Tyler, Mary. Developmental Biology; A Guide for Experimental Study. 3rd ed., Sinauer Associates, 2010, pp. 275–312.</p><p>Varlet, Vincent, et al. Toxicity Assessment of Refill Liquids for Electronic Cigarettes. <em>International Journal of Environmental Research and Public Health</em>, vol. 12, no. 5, 2015, pp. 4796–4815.</p><p>Wilk, Rebecca et al. (2018). Using Zebrafish to Bring Hands-On Laboratory Experiences to Urban Classrooms. <em>Zebrafish.</em> <em>15</em>(2),<em> </em>156–178.</p><p>Yang, Joanna et al., (2016). Students Being and Becoming Scientists: Measured Success in a Novel Science Education Partnership. <em>Palgrave Communications.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=250f9902fbe0" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Human stem cell proteins: a tool to fight the negative effects of aging]]></title>
            <link>https://medium.com/@davidstachura/human-stem-cell-proteins-a-tool-to-fight-the-negative-effects-of-aging-82b6efd30ce0?source=rss-f5f2bd708a77------2</link>
            <guid isPermaLink="false">https://medium.com/p/82b6efd30ce0</guid>
            <category><![CDATA[anti-aging-treatments]]></category>
            <category><![CDATA[skincare]]></category>
            <category><![CDATA[chico-state]]></category>
            <category><![CDATA[david-stachura]]></category>
            <category><![CDATA[stem-cells]]></category>
            <dc:creator><![CDATA[David Stachura, PhD]]></dc:creator>
            <pubDate>Wed, 03 Apr 2024 19:40:32 GMT</pubDate>
            <atom:updated>2024-06-13T19:03:09.225Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Human stem cell proteins: tools to fight the negative effects of aging skin</strong></h3><p><a href="https://www.linkedin.com/in/davidstachura/">David L Stachura</a> and <a href="https://www.linkedin.com/in/kristen-rueb-ba4557202/">Kristen F Rueb</a></p><h4><strong>What is aging?</strong></h4><p>In simple terms, aging is the process of growing old. All organisms, including humans, age over time. All of our organ systems are constantly getting older and reducing their physiological function. This process is almost imperceptible on a daily basis, but it is always occurring. There are multiple hallmarks of aging, such as cell death coupled with an inability of stem cells to replace those that are dying [1]. Cells don’t communicate with each other as well; their ability to promote normal tissue homeostasis becomes altered [1]. Additionally, many believe that the underpinnings of aging is due to low-grade molecular inflammation and oxidative stress [2]. Inflammation and stress are normal events in our body, but as we age, our bodies don’t handle them as well, which leads to age-related diseases such as atherosclerosis, arthritis, cancer, diabetes, osteoporosis, dementia, vascular diseases, obesity and metabolic syndrome [3].</p><p>Basically, aging comes down to two main factors: there is intrinsic and extrinsic damage done to our bodies over time. The intrinsic factors are things that we have little control over- they are genetic. Cells have a finite lifespan, and when they die, there is a loss of homeostasis in tissue. Cells can no longer “talk” to each other, secrete extracellular matrix (ECM) proteins, or repair cellular damage as efficiently as they did when they were younger. Decreases in our metabolism and hormonal signaling ensure that aging tissues aren’t going to function as well as they once did. The other factors that affect aging are extrinsic, which we have more control over. They involve our diet, levels of exercise and stress, and exposure to pollutants and other environmental factors. Together, these intrinsic and extrinsic forces play a huge role in aging.</p><h4><strong>What’s special about aging skin?</strong></h4><p>Intrinsic and extrinsic forces of aging also affect our skin. Skin is the largest organ system in our body and it has numerous essential physiological functions. Skin protects us against microbes and the environment, helps us regulate body temperature and internal hydration, is a critical part of our immune system, and is necessary for sensory functions. Aging skin obviously loses elasticity and becomes more wrinkled, but that is just a small, visible part of what is going on. Your skin is composed of three stratified layers; there is the outer epidermis, the middle layer of dermis, and the deepest layer, the hypodermis, which is comprised of subcutaneous fat. As our skin ages, all of these layers thin considerably and lose essential functions (<strong>Figure 1</strong>) [4,5]. In the epidermis, keratinocytes, the most common skin cell, start to change shape and are not replaced as quickly [4]. Active melanocytes, the cells that give our skin color and protect us from ultraviolet radiation, start to decline, giving aging skin uneven pigmentation [6]. And although the number of sweat glands doesn’t decrease, older skin secretes less sebum, which reduces skin moisturizing and antioxidant activity [7]. Moving down to the dermis, aging causes a decrease in cellularity and in vascularity, so blood flow and immune cells are reduced [4,5]. This aging of the dermis results in less glycosaminoglycan production [8], which is important for</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*-VdiXymFGl8DZGw6" /></figure><p><strong><em>Figure 1: Skin thins and is less functional as it ages.</em></strong><em> Epidermis (top layer), dermis (middle layer), and hypodermis (bottom fatty layer) of skin in young (left) and older skin (right). All layers thin over time, sweat glands secrete less sebum, the tissue is less vascularized, and the number of ADMSCs (blue cells) are reduced (image by </em><a href="https://www.linkedin.com/in/kristine-cordy/"><em>Kristine Cordy</em></a><em>).</em></p><p>the support of collagen and elastin, important ECM proteins that keep skin tight and youthful. Not surprisingly, these essential ECM proteins are also reduced in aging skin [9], in addition to there being less hyaluronic acid secreted from fibroblasts [8]. Finally, the subcutaneous fat layers in skin diminish significantly, which is important because that’s where adipose derived mesenchymal stem cells (ADMSCs) reside [10], which are essential for tissue homeostasis. Throughout aging skin there is an increase in reactive oxygen species (ROS), which are by-products of cellular metabolism [4,5,11,12]. In younger skin, ROS are processed by the body and rendered harmless, while in aging skin these molecules cause damage to cells and proteins. Most extrinsic factors that have a role in aging seem to do so by causing oxidative stress. Exposure to UV light, which is prevalent especially on the face, hands, neck, and arms accelerates this process, as does exposure to environmental pollutants and lifestyle choices. Importantly, skin is affected by diet, exercise, and stress [reviewed in 13,14]. Overall, the intrinsic and extrinsic forces work hand-in-hand; skin cells and proteins work less efficiently at handling normal tissue homeostasis as they age, and this process is exacerbated by outside forces acting on the skin.</p><p>In essence, skin is a unique organ system. It’s exposed to the elements, so it gets barraged constantly by the outside world, especially UV radiation, which causes severe damage to our DNA and proteins on a daily basis. And, it’s the most visible of all our organs, so it indicates an outward appearance of aging to others.</p><h4><strong>Why do stem cell products uniquely help ameliorate aging?</strong></h4><p>Sadly, aging is a fact of life. While the appearance of our skin is important, it is also essential for our health and well being. How can we promote healthy skin and fight aging? There are lots of products and procedures promoted that are “anti-aging.” Unfortunately, most products simply address aesthetic issues, and these treatments do very little to actually address aging, which is why they are temporary and lose efficacy over time. There are several treatments for skin aging that address the underlying physiological changes that occur in older skin, such as retinoid treatment and hormone replacement therapy (for postmenopausal women). Another promising treatment is using stem cells and the proteins that they secrete to treat aging.</p><p>What are stem cells? Briefly, they are unique cells that live in our bodies that replenish dying mature cells. Every organ has stem cells responsible for it’s replenishment in adults, and skin is no different; over 30,000 skin cells are produced every minute. While there is a population of stem cells that regenerate in the skin’s epidermis [15], the main stem cells present in skin, ADMSCs, reside in the hypodermis [10]. Research shows that these ADMSCs can differentiate into epidermal stem cells [16], indicating that they are likely the most important stem cell population for skin. Sadly, as you grow older, ADMSCs are also susceptible to the intrinsic and extrinsic forces of aging; ADMSCs die off and aren’t replaced as quickly in older skin [reviewed in 17]. Research also shows that these older stem cells lose their ability to secrete proteins and antioxidants, allowing ECM to break down and ROS to further damage tissue. This is unfortunate, because healthy surviving ADMSCs contribute to regeneration of skin during aging [18,19]. ADMSCs secrete ECM proteins like collagen and elastin that reduce fine lines and wrinkles [20] as well as signaling molecules that instruct cells to grow and home to a site of injury [reviewed in 21]. Proteins produced by these stem cells can remodel scar tissue, increase blood flow, and modulate the immune system [22]. Additionally, they block ROS activity by secreting antioxidants [18,19]. There have been transplantation studies that indicate young ADMSCs effectively rejuvenate aging skin [23,24], and ADMSCs secrete a multitude of growth factors that promote cellular homeostasis and repair [25]. Excitingly, you don’t need to actually inject the ADMSCs into your skin to get anti-aging results- the cells secrete proteins into the extracellular space to exert all these actions. Numerous studies show that just using the proteins secreted from ADMSCs helps with a multitude of skin issues, including reducing the appearance of aging [18–25].</p><p>Unfortunately, there is no preventing the aging process. Our bodies are not meant to last forever; even the stem cells that keep our bodies functioning eventually start to lose their efficacy. While the molecular underpinnings of aging are somewhat enigmatic, there are ways to counteract the intrinsic and extrinsic factors that affect aging. Human stem cells and secreted stem cell proteins have shown proven efficacy to do just that, with little to no discernible side effects, unlike some other anti-aging treatments like hormone-replacement therapy. The amount of products on the market to “fight” aging is staggering. However, they don’t really address the fact that your skin is changing physiologically and needs to be supplemented instead of just made to look more aesthetically pleasing. The main benefit to using human stem cell-derived products is that they really repair the damage caused by aging in a meaningful way to effectively make your skin look more youthful and healthy.</p><h4><strong>Works Cited</strong></h4><ol><li>Li Z, Zhang Z, Ren Y, Wang Y, Fang J, Yue H, Ma S, Guan F. Aging and age-related diseases: from mechanisms to therapeutic strategies. Biogerontology. 2021 Apr;22(2):165–187. doi: 10.1007/s10522–021–09910–5. Epub 2021 Jan 27. PMID: 33502634; PMCID: PMC7838467.</li><li>Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009 Jan;8(1):18–30. doi: 10.1016/j.arr.2008.07.002. Epub 2008 Jul 18. PMID: 18692159; PMCID: PMC3782993.</li><li>Yu BP, Chung HY. Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev. 2006 May;127(5):436–43. doi: 10.1016/j.mad.2006.01.023. Epub 2006 Feb 23. PMID: 16497363.</li><li>Bonté F, Girard D, Archambault JC, Desmoulière A. Skin Changes During Ageing. Subcell Biochem. 2019;91:249–280. doi: 10.1007/978–981–13–3681–2_10. PMID: 30888656.</li><li>Karim, PL, Inda Astri Aryani, &amp; Nopriyati. (2021). Anatomy and Histologic of Intrinsic Aging Skin. <em>Bioscientia Medicina : Journal of Biomedicine and Translational Research</em>, <em>5</em>(11), 1065–1077. <a href="https://doi.org/10.32539/bsm.v5i11.417">https://doi.org/10.32539/bsm.v5i11.417</a></li><li>Kang HY, Lee JW, Papaccio F, Bellei B, Picardo M. Alterations of the pigmentation system in the aging process. Pigment Cell Melanoma Res. 2021 Jul;34(4):800–813. doi: 10.1111/pcmr.12994. Epub 2021 Jun 15. PMID: 34048137.</li><li>Farage, M.A., Miller, K.W., Maibach, H.I. (2017). Degenerative Changes in Aging Skin. In: Farage, M., Miller, K., Maibach, H. (eds) Textbook of Aging Skin. Springer, Berlin, Heidelberg. <a href="https://doi.org/10.1007/978-3-662-47398-6_4">https://doi.org/10.1007/978-3-662-47398-6_4</a></li><li>Südel KM, Venzke K, Mielke H, Breitenbach U, Mundt C, Jaspers S, Koop U, Sauermann K, Knussman-Hartig E, Moll I, Gercken G, Young AR, Stäb F, Wenck H, Gallinat S. Novel aspects of intrinsic and extrinsic aging of human skin: beneficial effects of soy extract. Photochem Photobiol. 2005 May-Jun;81(3):581–7. doi: 10.1562/2004–06–16-RA-202. PMID: 15623355.</li><li>Duncan KO, Leffell DJ. Preoperative assessment of the elderly patient. Dermatol Clin. 1997 Oct;15(4):583–93. doi: 10.1016/s0733–8635(05)70468-x. PMID: 9348459.</li><li>Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002 Dec;13(12):4279–95. doi: 10.1091/mbc.e02–02–0105. PMID: 12475952; PMCID: PMC138633.</li><li>Zhang S, Duan E. Fighting against Skin Aging: The Way from Bench to Bedside. Cell Transplant. 2018 May;27(5):729–738. doi: 10.1177/0963689717725755. Epub 2018 Apr 25. PMID: 29692196; PMCID: PMC6047276.</li><li>Poljšak B, Dahmane RG, Godić A. Intrinsic skin aging: the role of oxidative stress. Acta Dermatovenerol Alp Pannonica Adriat. 2012;21(2):33–6. PMID: 23000938.</li><li>Lephart ED, Naftolin F. Factors Influencing Skin Aging and the Important Role of Estrogens and Selective Estrogen Receptor Modulators (SERMs). Clin Cosmet Investig Dermatol. 2022 Aug 19;15:1695–1709. doi: 10.2147/CCID.S333663. PMID: 36017417; PMCID: PMC9397534.</li><li>Farage MA, Miller KW, Elsner P, Maibach HI. Characteristics of the Aging Skin. Adv Wound Care (New Rochelle). 2013 Feb;2(1):5–10. doi: 10.1089/wound.2011.0356. PMID: 24527317; PMCID: PMC3840548.</li><li>Schneider TE, Barland C, Alex AM, Mancianti ML, Lu Y, Cleaver JE, Lawrence HJ, Ghadially R. Measuring stem cell frequency in epidermis: a quantitative in vivo functional assay for long-term repopulating cells. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11412–7. doi: 10.1073/pnas.2034935100. Epub 2003 Sep 17. PMID: 13679571; PMCID: PMC208771.</li><li>Derby BM, Dai H, Reichensperger J, Cox L, Harrison C, Cosenza N, Yang M, Bueno RA, Neumeister MW. Adipose-derived stem cell to epithelial stem cell transdifferentiation: a mechanism to potentially improve understanding of fat grafting’s impact on skin rejuvenation. Aesthet Surg J. 2014 Jan 1;34(1):142–53. doi: 10.1177/1090820X13515700. Epub 2013 Dec 12. PMID: 24334307.</li><li>Lynch K, Pei M. Age associated communication between cells and matrix: a potential impact on stem cell-based tissue regeneration strategies. Organogenesis. 2014;10(3):289–98. doi: 10.4161/15476278.2014.970089. PMID: 25482504; PMCID: PMC4594597.</li><li>Kim WS, Park BS, Kim HK, Park JS, Kim KJ, Choi JS, Chung SJ, Kim DD, Sung JH. Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci. 2008 Feb;49(2):133–42. doi: 10.1016/j.jdermsci.2007.08.004. Epub 2007 Sep 17. PMID: 17870415.</li><li>Zhang S, Dong Z, Peng Z, Lu F. Anti-aging effect of adipose-derived stem cells in a mouse model of skin aging induced by D-galactose. PLoS One. 2014 May 15;9(5):e97573. doi: 10.1371/journal.pone.0097573. PMID: 24831697; PMCID: PMC4022592.</li><li>Novoseletskaya E, Grigorieva O, Nimiritsky P, Basalova N, Eremichev R, Milovskaya I, Kulebyakin K, Kulebyakina M, Rodionov S, Omelyanenko N, Efimenko A. Mesenchymal Stromal Cell-Produced Components of Extracellular Matrix Potentiate Multipotent Stem Cell Response to Differentiation Stimuli. <em>Front Cell Dev Biol</em>. 2020 Sep 22;8:555378.</li><li>Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. <em>NPJ Regen Med</em>. 2019 Dec 2;4:22.</li><li>Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. <em>Stem Cells Transl Med</em>. 2013 Jun;2(6):455–63.</li><li>Bernardini FP, Gennai A, Izzo L, Zambelli A, Repaci E, Baldelli I, Fraternali-Orcioni G, Hartstein ME, Santi PL, Quarto R. Superficial Enhanced Fluid Fat Injection (SEFFI) to Correct Volume Defects and Skin Aging of the Face and Periocular Region. Aesthet Surg J. 2015 Jul;35(5):504–15. doi: 10.1093/asj/sjv001. Epub 2015 Apr 24. PMID: 25911629.</li><li>Gennai A, Zambelli A, Repaci E, Quarto R, Baldelli I, Fraternali G, Bernardini FP. Skin Rejuvenation and Volume Enhancement with the Micro Superficial Enhanced Fluid Fat Injection (M-SEFFI) for Skin Aging of the Periocular and Perioral Regions. Aesthet Surg J. 2017 Jan;37(1):14–23. doi: 10.1093/asj/sjw084. Epub 2016 May 30. PMID: 27241362.</li><li>Park BS, Jang KA, Sung JH, Park JS, Kwon YH, Kim KJ, Kim WS. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg. 2008 Oct;34(10):1323–6. doi: 10.1111/j.1524–4725.2008.34283.x. Epub 2008 Jun 27. PMID: 18616537.</li></ol><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=82b6efd30ce0" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>